503651854 O O
WGH O O

4959433 O O

288418 O O

2823104 O O

7/31/2004 O O
12:00:00 O O
AM O O

ED O O
Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

ED O O
DISCHARGE O O
NOTIFICATION O O
/ O O
SUMMARY O O

A O O
, O O
WALINA O O

MRN O O
: O O

4959433 O O

Age O O
: O O

32y O O

REGISTRATION O O
DATE O O
: O O

07/31/2004 O O
11:24 O O
AM O O

Provider O O
: O O

PADA O O
MEEDHUANG O O

PRELIMINARY O O
REPORT O O

PCP O O
notified O O
by O O
MD O O
: O O

E-mail O O
PCP O O

Benefits O O
Assigned O O
: O O

Y O O

Discharge O O
Date O O
/ O O
Time O O
: O O

07/31/2004 O O
12:58 O O

Discharge O O
Status O O
: O O

Discharged O O

Condition O O
on O O
Discharge O O
: O O

Stable O O

Patient O O
States O O
Complaint O O
: O O

S O O
/ O O
P O O
MVA O O

Diagnosis O O
: O O

head B-Disease B-Disease
trauma I-Disease I-Disease
- O O
mva O O

Treatment O O
Rendered O O
: O O

history O O
, O O
physical O O
, O O
neuro O O
exam O O
normal O O

Discharge O O
Medications O O
: O O

tylenol O O
as O O
needed O O
. O O

refrain O O
from O O
motrin O O
at O O
this O O
time O O
. O O

Follow O O
up O O
Service O O
: O O

f O O
/ O O
u O O
with O O
dr. O O
white O O

Disposition O O
, O O
Follow O O
up O O
and O O
Instructions O O
to O O
Patient O O
: O O

monitor O O
/ O O
return O O
for O O
nausea B-Disease B-Disease
/ O O
vomiting B-Disease B-Disease
, O O
headache B-Disease B-Disease
, O O
visual B-Disease B-Disease
/ I-Disease I-Disease
mental I-Disease I-Disease
status I-Disease I-Disease
changes I-Disease I-Disease
or O O
other B-Disease B-Disease
concerns I-Disease I-Disease
. O O

PCP O O
Name O O
: O O

WHITE O O
, O O
ELVNO O O
R O O

Provider O O
Number O O
: O O

70468 O O

This O O
report O O
was O O
created O O
by O O
MEEDHUANG O O
, O O
PADA O O
07/31/2004 O O
12:59 O O
PM O O

974381789 O O

PUOMC O O

0520610 O O

70648 O O

390115 O O

12/25/1996 O O
12:00:00 O O
AM O O

ATRIAL B-Disease B-Disease
FIBRILLATION I-Disease I-Disease
. O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

DISCHARGE O O
SUMMARY O O

NAME O O
: O O

LENKPRUSKIHKOOGLEKIH O O
, O O
NIEKERO O O
C O O

UNIT O O
NUMBER O O
: O O

449-50-82 O O

ADMISSION O O
DATE O O
: O O

12/25/96 O O

DISCHARGE O O
DATE O O
: O O

12/29/96 O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

Atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
. O O

ASSOCIATED O O
DIAGNOSIS O O
: O O

History O O
of O O
multinodular B-Disease B-Disease
goiter I-Disease I-Disease
; O O
history O O
of O O
hypertension B-Disease B-Disease
; O O
history O O
of O O
subtotal O O
thyroidectomy O O
. O O

PRINCIPAL O O
PROCEDURE O O
: O O

Electrical O O
cardioversion O O
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Ms. O O
Lenkpruskihkooglekih O O
is O O
a O O
63-year-old O O
lady O O
with O O
a O O
history O O
of O O
frequent B-Disease B-Disease
premature I-Disease I-Disease
ventricular I-Disease I-Disease
contractions I-Disease I-Disease
and O O
infrequent B-Disease O
short I-Disease O
runs I-Disease O
of I-Disease O
non-sustained I-Disease B-Disease
ventricular I-Disease I-Disease
tachycardia I-Disease I-Disease
( O O
one O O
four-beat O O
run O O
) O O
in O O
1991 O O
, O O
for O O
which O O
several O O
antiarrhythmic O O
agents O O
including O O
Propranolol O O
, O O
Quinidine O O
, O O
Procainamide O O
, O O
Tenormin O O
, O O
Norpace O O
, O O
Corgard O O
, O O
and O O
Flecainide O O
were O O
used O O
, O O
but O O
were O O
stopped O O
because O O
of O O
intolerance B-Disease B-Disease
. O O

At O O
that O O
time O O
, O O
she O O
had O O
clear O B-Disease
coronary O I-Disease
arteries O I-Disease
on O O
coronary O O
angiography O O
and O O
an O O
ejection O O
fraction O O
greater O O
than O O
50% O O
. O O

She O O
did O O
well O O
off O O
antiarrhythmic O O
agents O O
until O O
October O O
of O O
this O O
year O O
when O O
she O O
was O O
noted O O
to O O
have O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
with O O
a B-Disease B-Disease
rapid I-Disease I-Disease
ventricular I-Disease I-Disease
rate I-Disease I-Disease
after O O
several O O
days O O
of O O
decreased B-Disease B-Disease
exercise I-Disease I-Disease
tolerance I-Disease I-Disease
. O O

She O O
was O O
started O O
on O O
Coumadin O O
and O O
had O O
a O O
failed O O
attempt O O
at O O
DC O O
electrical O O
cardioversion O O
on O O
11/16/96 O O
. O O

She O O
has O O
been O O
on O O
Coumadin O O
since O O
and O O
has O O
continued O O
to O O
have O O
occasional B-Disease B-Disease
palpitations I-Disease I-Disease
and O O
mild B-Disease B-Disease
shortness I-Disease I-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Includes O O
a O O
history O O
of O O
hypertension B-Disease B-Disease
; O O
multinodular B-Disease B-Disease
goiter I-Disease I-Disease
; O O
subtotal O O
thyroidectomy O O
. O O

MEDICATIONS O O
: O O

Include O O
Cardizem O O
CD O O
180 O O
mg O O
daily O O
; O O
Monopril O O
10 O O
mg O O
daily O O
; O O
Digoxin O O
.25 O O
mg O O
daily O O
; O O
and O O
Lasix O O
40 O O
mg O O
every O O
other O O
day O O
. O O

ALLERGIES O O
: O O

To O O
Quinidine O O
, O O
Procardia O O
, O O
and O O
sulfa O O
antibiotics O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

On O O
examination O O
, O O
blood O O
pressure O O
was O O
200/100 O O
; O O
heart O O
rate O O
120 O O
per O O
minute O O
( O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
) O I-Disease
. O O

The O O
patient O O
was O O
noted O O
to O O
be O O
anxious B-Disease B-Disease
. O O

There O O
was O O
no O O
neck B-Disease B-Disease
vein I-Disease I-Disease
distension I-Disease I-Disease
or O O
carotid B-Disease B-Disease
bruits I-Disease I-Disease
. O O

Heart O O
sounds O O
were O O
normal O O
. O O

The O O
lungs O O
were O O
clear O O
. O O

The O O
abdominal O O
examination O O
was O O
benign O O
. O O

There O O
was O O
no O O
peripheral B-Disease B-Disease
edema I-Disease I-Disease
. O O

Pulses O O
were O O
all O O
easily O O
palpable O O
. O O

LABORATORY O O
DATA O O
: O O

A O O
12-lead O O
electrocardiogram O O
showed O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
with O O
a O O
QT O O
interval O O
of O O
.46 O O
seconds O O
. O O

There O O
were O O
diffuse B-Disease B-Disease
ST I-Disease I-Disease
segment I-Disease I-Disease
and I-Disease I-Disease
T-wave I-Disease I-Disease
abnormalities I-Disease I-Disease
, O O
which O O
were O O
nonspecific O O
. O O

A O O
complete O O
blood O O
count O O
, O O
electrolytes O O
, O O
BUN O O
and O O
creatinine O O
were O O
within O O
normal O O
limits O O
. O O

INR O O
was O O
elevated O B-Disease
at O O
2.5 O O
. O O

An O O
echocardiogram O O
was O O
performed O O
, O O
which O O
showed O O
completely O O
normal O O
left O O
ventricular O O
systolic O O
function O O
with O O
an O O
ejection O O
fraction O O
calculated O O
at O O
.74 O O
. O O

There O O
was O O
no O O
evidence O O
of O O
left B-Disease B-Disease
ventricular I-Disease I-Disease
hypertrophy I-Disease I-Disease
or O O
asymmetric B-Disease B-Disease
septal I-Disease I-Disease
hypertrophy I-Disease I-Disease
, O O
which O O
had O O
been O O
an O O
issue O O
that O O
had O O
been O O
raised O O
on O O
an O O
echocardiogram O O
in O O
Ownra O O
Cin O O
, O O
New O O
Mexico O O
on O O
12/06/96 O O
. O O

HOSPITAL O O
COURSE O O
AND O O
TREATMENT O O
: O O

The O O
patient O O
was O O
started O O
on O O
Propafenone O O
300 O O
mg O O
three O O
times O O
a O O
day O O
and O O
underwent O O
an O O
attempt O O
at O O
electrical O O
cardioversion O O
after O O
seven O O
doses O O
of O O
this O O
. O O

This O O
failed O O
, O O
despite O O
one O O
shock O O
at O O
300 O O
joules O O
and O O
two O O
shocks O O
at O O
360 O O
joules O O
. O O

The O O
Propafenone O O
was O O
stopped O O
, O O
and O O
the O O
patient O O
was O O
changed O O
to O O
Amiodarone O O
400 O O
mg O O
t.i.d. O O
, O O
which O O
was O O
continued O O
for O O
two O O
days O O
. O O

The O O
patient O O
was O O
discharged O O
to O O
home O O
on O O
Amiodarone O O
200 O O
mg O O
daily O O
on O O
12/29/96 O O
. O O

An O O
electrocardiogram O O
showed O O
no O O
evidence O O
of O O
QT B-Disease B-Disease
prolongation I-Disease I-Disease
prior O O
to O O
discharge O O
, O O
and O O
pulmonary O O
function O O
tests O O
will O O
be O O
performed O O
before O O
the O O
patient O O
goes O O
home O O
today O O
. O O

The O O
patient O O
will O O
follow O O
up O O
with O O
Dr. O O
Ther O O
Ludzjesc O O
at O O
Shiekeu O O
Hospital O O
Medical O O
Centers O O
in O O
Connecticut O O
. O O

In O O
addition O O
, O O
she O O
will O O
return O O
to O O
this O O
hospital O O
in O O
early O O
February O O
for O O
repeat O O
attempt O O
at O O
electrical O O
cardioversion O O
on O O
Amiodarone O O
. O O

She O O
will O O
continue O O
her O O
Coumadin O O
until O O
then O O
and O O
arrangements O O
for O O
her O O
readmission O O
can O O
be O O
made O O
through O O
Dr. O O
Iceca O O
Rhaltkaaispehbreun O O
's O O
office O O
here O O
. O O

MEDICATIONS O O
: O O

Other O O
than O O
the O O
addition O O
of O O
Amiodarone O O
200 O O
mg O O
daily O O
, O O
will O O
be O O
the O O
same O O
as O O
her O O
admission O O
medications O O
. O O

STA O O
BODEJOVE O O
, O O
M.D. O O

DICTATING O O
FOR O O
: O O

ICECA O O
RHALTKAAISPEHBREUN O O
, O O
M.D. O O

cc O O
: O O

Dr. O O
Ther O O
Ludzjesc O O
Director O O
, O O
Section O O
of O O
Cardiology O O
Shiekeu O O
Hospital O O
Medical O O
Centers O O
NC O O

TR O O
: O O

sip O O

DD O O
: O O

12/29/96 O O

TD O O
: O O

12/29/96 O O
10:03 O O
A O O

cc O O
: O O

ICECA O O
RHALTKAAISPEHBREUN O O
, O O
M.D. O O

500472963 O O

PUOMC O O

9506800 O O

464389 O O

651486 O O

9/20/2000 O O
12:00:00 O O
AM O O

ED O O
Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

ED O O
DISCHARGE O O
NOTIFICATION O O

FYFEUARDFEL O O
, O O
TADE O O

MRN O O
: O O

9506800 O O

Age O O
: O O

65y O O

REGISTRATION O O
DATE O O
: O O

09/20/2000 O O
12:41 O O
PM O O

PRELIMINARY O O
REPORT O O

This O O
is O O
to O O
notify O O
you O O
that O O
your O O
patient O O
, O O
FYFEUARDFEL O O
, O O
TADE O O
arrived O O
in O O
the O O
Emergency O O
Department O O
at O O
Ph O O
University O O
Of O O
Medical O O
Center O O
on O O
09/20/2000 O O
12:41 O O
PM O O
. O O

The O O
patient O O
presented O O
with O O
a O O
chief O O
complaint O O
of O O
ABD B-Disease B-Disease
PAIN I-Disease I-Disease
. O O

Following O O
evaluation O O
and O O
treatment O O
, O O
the O O
patient O O
&apos;s O O
disposition O O
at O O
the O O
end O O
of O O
the O O
visit O O
was O O
ADMITTED O O
AS O O
AN O O
INPATIENT O O
TO O O
PH O O
UNIVERSITY O O
OF O O
MEDICAL O O
CENTER O O
. O O

Your O O
patient O O
was O O
admitted O O
under O O
the O O
care O O
of O O
FONG O O
, O O
CONEY O O
N O O
with O O
a O O
preliminary O O
diagnosis O O
of O O
PERFORATION B-Disease B-Disease
. O O

If O O
you O O
need O O
additional O O
information O O
please O O
call O O
639-873-2993 O O
. O O

Admission O O
Date O O
: O O

2016-07-18 O O

Discharge O O
Date O O
: O O

2016-07-21 O O

Date O O
of O O
Birth O O
: O O

1969-11-05 O O

Sex O O
: O O

M O O

Service O O
: O O

MEDICINE O O

Allergies O O
: O O

Penicillins O O

Attending O O
: O O
Daniel O O
Z. O O
H. O O
Walton O O
, O O
M.D. O O

Chief O O
Complaint O O
: O O

Dyspnea B-Disease B-Disease

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

None O O

History O O
of O O
Present O O
Illness O O
: O O

46 O O
- O O
yo-man O O
w/ O O
active O O
cocaine O O
use O O
presents O O
w/ O O
LE B-Disease B-Disease
edema I-Disease I-Disease
. O O

10 O O
days O O
ago O O
, O O
he O O
developed O O
b/l B-Disease B-Disease
LE I-Disease I-Disease
edema I-Disease I-Disease
that O O
has O O
gotten O O
progressively O O
worse O O
until O O
now O O
. O O

Three O O
days O O
ago O O
, O O
he O O
developed O O
dyspnea B-Disease B-Disease
on O O
exertion O O
when O O
climbing O O
stairs O O
, O O
assoc O O
w/ O O
2-pillow B-Disease O
orthopnea I-Disease B-Disease
and O O
PND B-Disease B-Disease
. O O

He O O
denies O O
any B-Disease B-Disease
recent I-Disease I-Disease
chest I-Disease I-Disease
pain I-Disease I-Disease
, O O
palpitations B-Disease B-Disease
, O O
headache B-Disease B-Disease
, O O
confusion B-Disease B-Disease
, O O
weakness B-Disease B-Disease
, O O
numbness B-Disease B-Disease
, O O
abd B-Disease B-Disease
pain I-Disease I-Disease
, O O
or O O
hematuria B-Disease B-Disease
. O O

No O O
recent B-Disease B-Disease
viral I-Disease I-Disease
syndromes I-Disease I-Disease
or O O
URI B-Disease B-Disease
s. I-Disease O

He O O
does O O
admit O O
to O O
cocaine O O
use O O
last O O
night O O
. O O

Today O O
, O O
his O O
wife O O
convinced O O
him O O
to O O
present O O
to O O
the O O
Deanna O O
for O O
evaluation O O
. O O

In O O
the O O
Deanna O O
, O O
his O O
BP O O
was O O
230/170 O O
. O O

BNP O O
was O O
elevated O B-Disease
at O O
7500 O O
. O O

CXR O O
revealed O O
evidence O O
of O O
cardiomegaly B-Disease B-Disease
and O O
pulm B-Disease B-Disease
edema I-Disease I-Disease
. O O

He O O
was O O
treated O O
w/ O O
ASA O O
325 O O
mg O O
, O O
lasix O O
10 O O
mg O O
IV O O
, O O
and O O
hydralazine O O
10 O O
mg O O
IV O O
x O O
2 O O
. O O

He O O
responded O O
well O O
to O O
lasix O O
w/ O O
good O O
UOP O O
, O O
but O O
diastolic O O
BP O O
remained O O
elevated B-Disease B-Disease
at O O
170 O O
, O O
prompting O O
initiation O O
of O O
nitroprusside O O
gtt O O
. O O

He O O
is O O
now O O
admitted O O
to O O
the O O
CCU O O
for O O
further O O
care O O
. O O

Past O O
Medical O O
History O O
: O O

none O O

Social O O
History O O
: O O

significant O O
for O O
current O O
tobacco O O
use O O
. O O

Drinks O O
3-4 O O
beers O O
a O O
few O O
times O O
weekly O O
, O O
no O O
h/o O O
withdrawal B-Disease B-Disease
symptoms I-Disease I-Disease
, O O
seizures B-Disease B-Disease
or O O
DT B-Disease B-Disease
s. I-Disease O

Snorts O O
cocaine O O
1-2 O O
times O O
monthly O O
. O O

Never O O
injected O O
drugs O O
. O O

Family O O
History O O
: O O

There O O
is O O
no O O
family O O
history O O
of O O
premature B-Disease B-Disease
coronary I-Disease I-Disease
artery I-Disease I-Disease
Disease I-Disease I-Disease
or O O
sudden B-Disease B-Disease
death I-Disease I-Disease
. O O

Physical O O
Exam O O
: O O

VS O O
: O O
T, O O
BP O O
181/122 O O
, O O
HR O O
84 O O
, O O
RR O O
12 O O
, O O
O2 O O
98% O O
2L/m O O

Gen O O
: O O
lying O O
flat O O
in O O
bed O O
, O O
pleasant O O
and O O
conversational O O
, O O
NAD B-Disease B-Disease

HEENT O O
: O O
NCAT B-Disease O
. O O

Sclera B-Disease B-Disease
anicteric I-Disease I-Disease
. O O

PERRL O O
, O O
EOMI O B-Disease
. O O

OP O O
clear O O
w/ O O
MMM O O
. O O

Neck O O
: O O
Supple O O
with O O
JVP O O
of O O
8 O O
cm O O
. O O

CV O O
: O O
reg O O
s1 O O
, O O
loud B-Disease B-Disease
s2 I-Disease I-Disease
, O O
+ O O
2/6 B-Disease B-Disease
systolic I-Disease I-Disease
murmur I-Disease I-Disease
radiating I-Disease O
to I-Disease O
axilla I-Disease O
, O O
no O O
s3/s4/r B-Disease B-Disease

Pulm O O
: O O
CTA O O
b/l O O
w/ O O
no O O
crackles B-Disease B-Disease
or O O
wheezing B-Disease B-Disease

Abd O O
: O O
obese B-Disease B-Disease
, O O
+BS O B-Disease
, O O
soft O O
, O O
NTND B-Disease B-Disease
. O O

Ext O O
: O O
warm O O
, O O
2+ O O
DP O O
b/l O O
, O O
2+ B-Disease O
pitting I-Disease B-Disease
edema I-Disease I-Disease
to I-Disease I-Disease
knees I-Disease I-Disease
b/l I-Disease O

Neuro O O
: O O
a/o O O
x O O
3 O O
, O O
CN O O
04-04 O O
intact O O

Pertinent O O
Results O O
: O O

2016-07-18 O O
05:30 O O
PM O O

WBC O O
- O O
7.7 O O
RBC O O
- O O
5.00 O O
HGB O O
- O O
15.0 O O
HCT O O
- O O
42.8 O O
MCV O O
- O O
86 O O
MCH O O
- O O
30.0 O O
MCHC O O
- O O
35.0 O O
RDW O O
- O O
14.6 O O

2016-07-18 O O
05:30 O O
PM O O

PLT O O
COUNT O O
- O O
315 O O

2016-07-18 O O
05:30 O O
PM O O

CK-MB O O
- O O
4 O O
proBNP O O
- O O
7489 O O
* O O

2016-07-18 O O
05:30 O O
PM O O

cTropnT O O
- O O
0.02 O O
* O O

2016-07-18 O O
05:30 O O
PM O O

ALT(SGPT) O O
- O O
77 O O
* O O
AST(SGOT) O O
- O O
60 O O
* O O
CK(CPK) O O
- O O
195 O O
* O O
ALK O O
PHOS O O
- O O
104 O O
AMYLASE O O
- O O
100 O O
TOT O O
BILI O O
- O O
0.4 O O

EKG O O
demonstrated O O
NSR O O
at O O
87 O O
bpm O O
, O O
nl O O
axis O O
, O O
nl O O
int O O
, O O
LVH B-Disease B-Disease
w/ O I-Disease
strain B-Disease I-Disease
pattern I-Disease I-Disease
, O O
no O O
ischemic B-Disease B-Disease
changes I-Disease I-Disease
. O O

CXR O O
: O O

Moderate B-Disease B-Disease
to I-Disease I-Disease
severe I-Disease I-Disease
enlargement I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
cardiac I-Disease I-Disease
silhouette I-Disease I-Disease
, O O
and O O
particularly O O
the O O
left O O
atrium O O
accompanied O O
by O O
pulmonary B-Disease B-Disease
vascular I-Disease I-Disease
congestion I-Disease I-Disease
and O O
mild B-Disease B-Disease
pulmonary I-Disease I-Disease
edema I-Disease I-Disease
consistent O O
with O O
heart B-Disease B-Disease
failure I-Disease I-Disease
. O O

Conclusions O O
: O O

The O O
left O O
atrium O O
is O O
moderately B-Disease B-Disease
dilated I-Disease I-Disease
. O O

There O O
is O O
moderate B-Disease B-Disease
symmetric I-Disease I-Disease
left I-Disease I-Disease
ventricular I-Disease I-Disease
hypertrophy I-Disease I-Disease
with O O
mild B-Disease B-Disease
cavity I-Disease I-Disease
dilation I-Disease I-Disease
and O O
severe B-Disease B-Disease
global I-Disease I-Disease
hypokinesis I-Disease I-Disease
. O O

No O O
left B-Disease B-Disease
ventricular I-Disease I-Disease
thrombus I-Disease I-Disease
is O O
seen O O
. O O

Tissue O O
Doppler O O
imaging O O
suggests O O
an B-Disease B-Disease
increased I-Disease I-Disease
left I-Disease I-Disease
ventricular I-Disease I-Disease
filling I-Disease I-Disease
pressure I-Disease I-Disease
( O O
PCWP O O
> O O
18 O O
mmHg O O
). O O

The O O
right O O
ventricular O O
cavity O O
is O O
mildly B-Disease B-Disease
dilated I-Disease I-Disease
with O O
severe B-Disease B-Disease
free I-Disease I-Disease
wall I-Disease I-Disease
hypokinesis I-Disease I-Disease
. O O

The O O
aortic O O
valve O O
leaflets O O
( O O
3 O O
) O O
are O O
minimally B-Disease B-Disease
thickened I-Disease I-Disease
. O O

No O O
aortic B-Disease B-Disease
stenosis I-Disease I-Disease
or O O
aortic B-Disease B-Disease
regurgitation I-Disease I-Disease
is O O
seen O O
. O O

The O O
mitral O O
valve O O
leaflets O O
are O O
structurally O O
normal O O
. O O

There O O
is O O
no O O
mitral B-Disease B-Disease
valve I-Disease I-Disease
prolapse I-Disease I-Disease
. O O

Mild B-Disease B-Disease
( I-Disease I-Disease
1+ I-Disease I-Disease
) I-Disease I-Disease
mitral I-Disease I-Disease
regurgitation I-Disease I-Disease
is O O
seen O O
. O O

There O O
is O O
moderate B-Disease B-Disease
pulmonary I-Disease I-Disease
artery I-Disease I-Disease
systolic I-Disease I-Disease
hypertension I-Disease I-Disease
. O O

There O O
is O O
a B-Disease B-Disease
very I-Disease I-Disease
small I-Disease I-Disease
circumferential I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
. O O

IMPRESSION O O
: O O
Moderate B-Disease B-Disease
symmetric I-Disease I-Disease
eft I-Disease I-Disease
ventricular I-Disease I-Disease
hypertrophy I-Disease I-Disease
with O O
severe B-Disease B-Disease
global I-Disease I-Disease
biventricular I-Disease I-Disease
hypokinesis I-Disease I-Disease
c/w O I-Disease
diffuse B-Disease I-Disease
process I-Disease I-Disease
( O I-Disease
toxin B-Disease I-Disease
, O O
metabolic O O
, O O
cannot O O
exclude O O
myocarditis B-Disease B-Disease
; O O
in O O
the O O
absence O O
of O O
LVH B-Disease B-Disease
on O O
ECG O O
, O O
an B-Disease B-Disease
infiltrative I-Disease I-Disease
process I-Disease I-Disease
should O O
also O O
be O O
considered O O
). O O

Mild B-Disease B-Disease
mitral I-Disease I-Disease
regurgitation I-Disease I-Disease
. O O

Moderate B-Disease B-Disease
pulmonary I-Disease I-Disease
arterial I-Disease I-Disease
hypertension I-Disease I-Disease
. O O

Very B-Disease B-Disease
small I-Disease I-Disease
circumferential I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
. O O

Possible O B-Disease
abnormality B-Disease I-Disease
on I-Disease I-Disease
the I-Disease I-Disease
aortic I-Disease I-Disease
valve I-Disease I-Disease
as O O
described O O
above O O
without O O
aortic B-Disease B-Disease
regurgitation I-Disease I-Disease
. O O

If O O
clinically O O
indicated O O
a O O
TEE O O
would O O
be O O
better O O
able O O
to O O
define O O
an B-Disease B-Disease
abnormality I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
aortic I-Disease I-Disease
valve I-Disease I-Disease
. O O

Brief O O
Hospital O O
Course O O
: O O

46 O O
- O O
yo-man O O
w/ O O
cocaine O O
abuse O O
presents O O
w/ O O
LE B-Disease B-Disease
edema I-Disease I-Disease
and O O
DOE B-Disease B-Disease
likely O O
from O O
diastolic B-Disease B-Disease
heart I-Disease I-Disease
failure I-Disease I-Disease
in O O
the O O
setting O O
of O O
cocaine O O
use O O
complicated O O
by O O
hypertensive B-Disease B-Disease
urgency I-Disease I-Disease
. O O

Hypertensive B-Disease B-Disease
urgency I-Disease I-Disease
: O O

BP O O
230/170 O O
on O O
presentation O O
, O O
most O O
likely O O
from O O
chronic B-Disease B-Disease
HTN I-Disease I-Disease
exacerbated O O
by O O
cocaine O O
use O O
. O O

No O O
signs O O
of O O
end-organ B-Disease B-Disease
damage I-Disease I-Disease
at O O
present O O
except O O
for O O
elevated B-Disease B-Disease
creatinine I-Disease I-Disease
, O O
which O O
is O O
more O O
likely O O
a B-Disease B-Disease
chronic I-Disease I-Disease
problem I-Disease I-Disease
. O O

The O O
patient O O
was O O
started O O
on O O
labetalol O O
and O O
Lisinopril O O
. O O

His O O
blood O O
pressure O O
was O O
taken O O
down O O
from O O
230 O O
systolic O O
to O O
approx O O
160 O O
systolic O O
/ O O
100 O O
diastolic O O
on O O
discharge O O
. O O

His B-Disease B-Disease
lower I-Disease I-Disease
extremity I-Disease I-Disease
edema I-Disease I-Disease
improved O O
with O O
diuresis O O
. O O

An O O
echo O O
performed O O
on O O
admission O O
showed O O
an O O
LF O O
EF O O
of O O
25% O O
. O O

It O O
is O O
hoped O O
with O O
good O O
blood O O
pressure O O
control O O
and O O
use O O
of O O
an O O
ACE-I O O
with O O
follow O O
up O O
in O O
addition O O
to O O
cocaine O O
abstaining O O
will O O
improved O O
his O O
cardiac O O
function O O
. O O

Renal B-Disease B-Disease
Failure I-Disease I-Disease
: O O
creatinine O O
on O O
admission O O
was O O
1.6 O O
Likely O O
acute B-Disease B-Disease
hypertensive I-Disease I-Disease
nephropathy I-Disease I-Disease
plus O O
probalbe O O
long-standing B-Disease B-Disease
hypertensive I-Disease I-Disease
Disease I-Disease I-Disease
. O O

discharged O O
on O O
ACE-I O O
. O O

Substance O O
Use O O
: O O
Social O O
work O O
saw O O
patient O O
and O O
counceled O O
him O O
regarding O O
substance O O
abuse O O
. O O

Discharged O O
with O O
Margaret O O
Hallock O O
, O O
cardiology O O
follow O O
up O O
as O O
well O O
as O O
scheduled O O
appointment O O
with O O
a O O
new O O
PCP O O
@ O O
Newton O O
Health O O
Center O O
. O O

Medications O O
on O O
Admission O O
: O O

none O O

Discharge O O
Medications O O
: O O

1. O O
Aspirin O O
325 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

2. O O
Hydrochlorothiazide O O
25 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
2 O O
* O O

3. O O
Labetalol O O
200 O O
mg O O
Tablet O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

Disp O O
:* O O
120 O O
Tablet O O
(s)* O O
Refills O O
:* O O
2 O O
* O O

4. O O
Lisinopril O O
20 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
2 O O
* O O

Discharge O O
Disposition O O
: O O

Home O O

Discharge O O
Diagnosis O O
: O O

Primary O O
: O O

- O O
hypertensive B-Disease B-Disease
emergency I-Disease I-Disease

- O O
ARF B-Disease B-Disease

- O O
mild B-Disease B-Disease
transaminitis I-Disease I-Disease
likely O O
03-25 O O
etoh O O
and O O
cocaine O O
abuse O O

- O O
cocaine O O
abuse O O

- O O
lower B-Disease B-Disease
extremity I-Disease I-Disease
edema I-Disease I-Disease
improved O O

Discharge O O
Condition O O
: O O

well O O

Discharge O O
Instructions O O
: O O

You O O
came O O
in O O
with O O
hypertensive B-Disease B-Disease
emergency I-Disease I-Disease
. O O

You O O
were O O
treated O O
with O O
medications O O
to O O
improve O O
your O O
blood O O
pressure O O
. O O

Notably O O
you O O
were O O
discharged O O
on O O
: O O

1. O O
Lisinopril O O
20 O O
mg O O
daily O O

2. O O
HCTZ O O
25 O O
mg O O
daily O O

3. O O
Labetalol O O
400 O O
mg O O
bid O O

4. O O
ASA O O
162mg O O
daily O O

It O O
is O O
extremely O O
important O O
for O O
you O O
to O O
take O O
these O O
medications O O
. O O

It O O
is O O
very O O
important O O
that O O
you O O
followup O O
with O O
your O O
cardiology O O
. O O

Please O O
return O O
to O O
the O O
Deanna O O
if O O
you O O
experience O O
SOB B-Disease B-Disease
, O O
chest B-Disease B-Disease
pain I-Disease I-Disease
, O O
fevers B-Disease B-Disease
, O O
chills B-Disease B-Disease
, O O
dizziness B-Disease B-Disease
, O O
decreased B-Disease B-Disease
urine I-Disease I-Disease
output I-Disease I-Disease
. O O

It O O
is O O
also O O
very O O
important O O
that O O
you O O
abstain O O
from O O
cocaine O O
use O O
. O O

Followup O O
Instructions O O
: O O

Please O O
see O O
Dr. O O
Villani O O
on O O
Monday O O
2016-07-25 O O
at O O
10:00 O O
in O O
Smith O O
7th O O
. O O

It O O
is O O
extremely O O
important O O
for O O
you O O
to O O
keep O O
this O O
appointment O O
. O O

You O O
have O O
a O O
Primary O O
Care O O
Physician O O
B. O O
Schumacher O O
on O O
07-29 O O
@ O O
1:45 O O
pm O O
. O O

Please O O
arrive O O
1 O O
hour O O
prior O O
to O O
the O O
appointment O O
to O O
complete O O
the O O
Free O O
Care O O
Application O O
there O O
. O O

You O O
need O O
to O O
bring O O
a O O
picture O O
ID O O
, O O
proof O O
of O O
citizenship O O
, O O
proof O O
of O O
address O O
. O O

The O O
Clinci O O
phone O O
number O O
is O O
( O O
754 O O
) O O
280-1011 O O

Please O O
followup O O
with O O
Dr. O O
Lesha O O
Lefebvre O O
on O O
08-15 O O
at O O
10:30 O O
am O O
. O O

His O O
number O O
is O O
( O O
532-803-1162 O O
. O O

His O O
secretary O O
can O O
help O O
you O O
clarify O O
your O O
insurance O O
. O O

Ralph O O
Katherine O O
MD O O
31-164 O O

Completed O O
by O O
: O O
Terry O O
Smith O O
MD O O
12-201 O O
2016-07-21 O O
@ O O
1848 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Jennifer O O
Applebee O O
on O O
: O O
Sandra O O
2016-07-21 O O
9:54 O O
PM O O

( O O
End O O
of O O
Report O O
) O O

060376519 O O
DH O O

0649031 O O

323495 O O

3838556 O O

4/5/2003 O O
12:00:00 O O
AM O O

ED O O
Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

ED O O
DISCHARGE O O
NOTIFICATION O O
/ O O
SUMMARY O O

SELCFARST O O
, O O
NAORLY O O

MRN O O
: O O

0649031 O O

Age O O
: O O

49y O O

REGISTRATION O O
DATE O O
: O O

04/05/2003 O O
11:47 O O
AM O O

Provider O O
: O O

STIEGE O O
, O O
M.D. O O
TLANDJESC O O

PRELIMINARY O O
REPORT O O

PCP O O
notified O O
by O O
MD O O
: O O

E-mail O O
PCP O O

Discharge O O
Date O O
/ O O
Time O O
: O O

04/05/2003 O O
22:06 O O

Discharge O O
Status O O
: O O

Discharged O O

Condition O O
on O O
Discharge O O
: O O

Stable O O

Patient O O
States O O
Complaint O O
: O O

DIZZINESS B-Disease B-Disease

Standardized O O
Discharge O O
Instructions O O
: O O

The O O
patient O O
was O O
given O O
printed O O
instructions O O
for O O
dizziness B-Disease B-Disease
( O O
English O O
) O O
. O O

Diagnosis O O
: O O

Benign B-Disease B-Disease
positional I-Disease I-Disease
vertigo I-Disease I-Disease
vs O O
labyrinthitis B-Disease B-Disease

Treatment O O
Rendered O O
: O O

Head O O
CT O O
negative O O
. O O

Discharge O O
Medications O O
: O O

Meclizine O O
25 O O
mg O O
po O O
bid O O
. O O

Disposition O O
, O O
Follow O O
up O O
and O O
Instructions O O
to O O
Patient O O
: O O

Return O O
to O O
ED O O
or O O
call O O
PCP O O
if O O
symptoms B-Disease B-Disease
worsen O O
or O O
if O O
fever B-Disease B-Disease
with O O
headache B-Disease B-Disease
. O O

Pt O O
d O O
/ O O
c&apos;d O O
home O O
in O O
stable O O
condition O O
. O O

PCP O O
Name O O
: O O

GUYNLORDSMANTDOUET O O
, O O
RYLA O O
B O O

Provider O O
Number O O
: O O

26596 O O

This O O
report O O
was O O
created O O
by O O
TLANDJESC O O
, O O
IECELANE O O
, O O
M.D. O O
04/05/2003 O O
10:09 O O
PM O O

817406016 O O
RWH O O

3154334 O O

554691 O O

3547577 O O

7/6/2005 O O
12:00:00 O O
AM O O

ED O O
Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

ED O O
DISCHARGE O O
NOTIFICATION O O

JEMSKOP O O
, O O
COT O O

MRN O O
: O O

3154334 O O

Age O O
: O O

54y O O

REGISTRATION O O
DATE O O
: O O

07/06/2005 O O
11:11 O O
AM O O

PRELIMINARY O O
REPORT O O

This O O
is O O
to O O
notify O O
you O O
that O O
your O O
patient O O
, O O
JEMSKOP O O
, O O
COT O O
arrived O O
in O O
the O O
Emergency O O
Department O O
at O O
Ro O O
Woodma O O
Healthcare O O
on O O
07/06/2005 O O
11:11 O O
AM O O
. O O

The O O
patient O O
presented O O
with O O
a O O
chief O O
complaint O O
of O O
CP B-Disease B-Disease
. O O

Following O O
evaluation O O
and O O
treatment O O
, O O
the O O
patient O O
&apos;s O O
disposition O O
at O O
the O O
end O O
of O O
the O O
visit O O
was O O
admitted O O
as O O
an O O
inpatient O O
to O O
Ro O O
Woodma O O
Healthcare O O
. O O

The O O
patient O O
&apos;s O O
preliminary O O
admitting O O
physician O O
is O O
KOTEDAIZREKE O O
, O O
LILA O O
and O O
the O O
preliminary O O
admitting O O
diagnosis O O
is O O
CP B-Disease B-Disease
. O O

Please O O
note O O
this O O
information O O
may O O
have O O
been O O
updated O O
on O O
the O O
inpatient O O
unit O O
. O O

If O O
you O O
need O O
additional O O
information O O
please O O
call O O
662-747-1199 O O
. O O

PCP O O
Name O O
: O O

TITCHEAGNERO O O
, O O
TO O O

Provider O O
Number O O
: O O

98076 O O

Admission O O
Date O O
: O O

2011-02-06 O O

Discharge O O
Date O O
: O O

2011-02-08 O O

Date O O
of O O
Birth O O
: O O

Sex O O
: O O

M O O

Service O O
: O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Mr. O O
Pohl O O
is O O
a O O
53 O O
- O O
year-old O O
male O O
with O O
history O O
of O O
alcohol O O
use O O
and O O
hypertension B-Disease B-Disease
. O O

He O O
was O O
found O O
in O O
his O O
apartment O O
lobby O O
" O O
shouting O O
" O O
and O O
very B-Disease B-Disease
agitated I-Disease I-Disease
. O O

The O O
patient O O
states O O
that O O
he O O
recalls O O
going O O
out O O
alone O O
to O O
a O O
cafe O O
the O O
evening O O
prior O O
to O O
admission O O
. O O

There O O
he O O
recalls O O
having O O
pizza O O
and O O
two O O
glasses O O
of O O
red O O
wine O O
. O O

The O O
patient O O
told O O
other O O
staff O O
that O O
he O O
had O O
a O O
few O O
cocktails O O
and O O
drinking O O
a O O
few O O
more O O
glasses O O
of O O
wine O O
when O O
he O O
ran O O
into O O
some O O
friends O O
at O O
a O O
bar O O
. O O

He O O
denies O O
any O O
other O O
drug O O
or O O
toxin O O
ingestion O O
. O O

He O O
does O O
not O O
recall O O
walking O O
home O O
, O O
but O O
he O O
states O O
that O O
the O O
way O O
is O O
well O O
known O O
to O O
him O O
. O O

He O O
has O O
no O O
further O B-Disease
recollection O I-Disease
, O O
until O O
he O O
presented O O
to O O
the O O
emergency O O
room O O
. O O

He O O
by O O
emergency O O
room O O
report O O
, O O
was O O
found O O
in O O
his O O
apartment O O
lobby O O
agitated B-Disease B-Disease
. O O

EMS O O
was O O
called O O
and O O
the O O
patient O O
was O O
taken O O
to O O
the O O
emergency O O
room O O
. O O

Blood O O
alcohol O O
level O O
was O O
383 O O
. O O

Agitated B-Disease O
in O O
emergency O O
room O O
requiring O O
4 O O
leather O O
restraints O O
, O O
received O O
5 O O
mg O O
of O O
Haldol O O
, O O
2 O O
mg O O
of O O
Ativan O O
. O O

He O O
became O O
hypotensive B-Disease B-Disease
in O O
the O O
emergency O O
room O O
with O O
a O O
systolic O O
blood O O
pressure O O
in O O
the O O
80 O O
's O O
and O O
had O O
decreased B-Disease B-Disease
respiratory I-Disease I-Disease
rate I-Disease I-Disease
. O O

He O O
received O O
a O O
normal O O
saline O O
bolus O O
of O O
2 O O
liters O O
of O O
good O O
blood O O
pressure O O
response O O
. O O

The O O
patient O O
was O O
then O O
admitted O O
to O O
the O O
medical O O
Intensive O O
Care O O
Unit O O
for O O
observation O O
of O O
his O O
blood O O
pressure O O
and O O
then O O
transferred O O
to O O
our O O
service O O
on O O
medicine O O
when O O
the O O
blood O O
pressures O O
remained O O
stable O O
overnight O O
. O O

The O O
patient O O
denies O O
any B-Disease B-Disease
chest I-Disease I-Disease
pain I-Disease I-Disease
, O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
, O O
dysuria B-Disease B-Disease
, O O
diarrhea B-Disease B-Disease
, O O
bright B-Disease B-Disease
red I-Disease I-Disease
blood I-Disease I-Disease
per I-Disease I-Disease
rectum I-Disease I-Disease
. O O

He O O
does O O
complain O O
of O O
cold B-Disease B-Disease
symptoms I-Disease I-Disease
times O O
one O O
week O O
. O O

The O O
patient O O
states O O
in O O
the O O
past O O
that O O
he O O
has O O
participated O O
in O O
several O O
alcohol O O
treatment O O
programs O O
, O O
most O O
recently O O
Star O O
which O O
is O O
similar O O
Alcoholics O O
Anonymous O O
. O O

The O O
patient O O
admits O O
that O O
he O O
has O O
had O O
many O O
stressors O O
in O O
his O O
life O O
lately O O
. O O

His O O
job O O
as O O
a O O
computer O O
programmer O O
is O O
unstable O O
. O O

His O O
brother O O
is O O
mentally B-Disease B-Disease
handicapped I-Disease I-Disease
and O O
might O O
be O O
sent O O
away O O
from O O
his O O
instate O O
institution O O
. O O

He O O
is O O
also O O
concerned O O
about O O
the O O
threat O O
of O O
war O O
and O O
is O O
ready O O
to O O
" O O
move O O
to O O
Madagascar O O
". O O

He O O
states O O
that O O
he O O
primarily O O
relies O O
on O O
friends O O
. O O

In O O
the O O
past O O
, O O
he O O
has O O
been O O
very B-Disease B-Disease
depressed I-Disease I-Disease
and O O
has O O
seen O O
a O O
counselor O O
at O O
Greenfield O O
Community O O
College O O
Community O O
Health O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

1. O O
Hypertension B-Disease B-Disease
. O O

2. O O
History O O
of O O
colonic B-Disease B-Disease
polyps I-Disease I-Disease
times O O
3 O O
, O O
benign O O
in O O
2007 O O
, O O
repeat O O
colonoscopy O O
due O O
to O O
in O O
2010 O O
. O O

3. O O
History O O
of O O
right B-Disease B-Disease
inguinal I-Disease I-Disease
hernia I-Disease I-Disease
in O O
2002 O O
. O O

FAMILY O O
HISTORY O O
: O O

Noncontributory O O
. O O

SOCIAL O O
HISTORY O O
: O O

Positive O O
tobacco O O
, O O
10 O O
pack O O
year O O
history O O
, O O
quit O O
for O O
8 O O
years O O
in O O
his O O
40 O O
's O O
and O O
now O O
no O O
cigarettes O O
for O O
one O O
week O O
using O O
no O O
pharmacal O O
therapy O O
. O O

Positive O O
for O O
ETOH O O
( O O
10 O O
glasses O O
a O O
week O O
), O O
positive O O
for O O
drugs O O
, O O
marijuana O O
in O O
college O O
. O O

He O O
denies O O
any O O
IV O O
drug O O
use O O
. O O

The O O
patient O O
currently O O
lives O O
lone O O
in O O
Malden O O
. O O

He O O
came O O
out O O
here O O
for O O
college O O
at O O
BU O O
and O O
works O O
as O O
a O O
computer O O
programmer O O
. O O

Primarily O O
the O O
family O O
lives O O
in O O
Wisconsin O O
. O O

The O O
patient O O
has O O
only O O
male O O
sexual O O
partners O O
and O O
in O O
the O O
last O O
six O O
months O O
has O O
two O O
regular O O
partners O O
who O O
reportedly O O
are O O
human B-Disease B-Disease
immunodeficiency I-Disease I-Disease
virus I-Disease I-Disease
negative O I-Disease
and O O
no O O
IV O O
drug O O
use O O
. O O

He O O
uses O O
condoms O O
consistently O O
. O O

Major O O
stressors O O
in O O
his O O
life O O
include O O
unstable O O
job O O
, O O
brother O O
is O O
mentally B-Disease O
handicapped I-Disease O
, O O
war O O
. O O

ALLERGIES O O
: O O
No O O
known B-Disease B-Disease
drug I-Disease I-Disease
allergies I-Disease I-Disease
. O O

MEDICATIONS O O
AT O O
HOME O O
: O O

1. O O
Lisinopril O O
5 O O
mg O O
p.o. O O
q.d. O O

2. O O
Mavik O O
question O O
of O O
dosage O O
. O O

3. O O
Hydrochlorothiazide O O
question O O
of O O
dosage O O
. O O

MEDICATIONS O O
ON O O
TRANSFER O O
: O O

1. O O
Ranitidine O O
150 O O
mg O O
b.i.d. O O

2. O O
Thiamine O O
100 O O
mg O O
q.d. O O

3. O O
Folic O O
acid O O
1 O O
mg O O
q. O O
d. O O

4. O O
Multivitamin O O

PHYSICAL O O
EXAMINATION O O
: O O

Vitals O O
on O O
admission O O
: O O
Please O O
refer O O
to O O
addendum O O
. O O

Vital O O
signs O O
were O O
stable O O
. O O

Systolic O O
blood O O
pressure O O
in O O
the O O
120 O O
's O O
to O O
130 O O
's. O O

Pulse O O
in O O
the O O
60 O O
's O O
to O O
70 O O
's. O O

The O O
patient O O
was O O
a O O
thin O O
well-appearing O O
man O O
who O O
was O O
visibly B-Disease B-Disease
restless I-Disease I-Disease
in O I-Disease
bed O I-Disease
. O O

Neurological O O
: O O

He O O
was O O
alert O O
and O O
oriented O O
times O O
3 O O
and O O
with O O
slightly B-Disease B-Disease
pressured I-Disease I-Disease
speech I-Disease I-Disease
. O O

He O O
states O O
that O O
mood O O
is O O
depressed B-Disease B-Disease
. O O

He O O
denies O O
auditory B-Disease B-Disease
, I-Disease I-Disease
visual I-Disease I-Disease
or I-Disease I-Disease
tactile I-Disease I-Disease
hallucinations I-Disease I-Disease
. O O

Cranial O O
nerves O O
II-XII O O
are O O
grossly O O
intact O O
, O O
5/5 O O
strength O O
in O O
all O O
extremities O O
, O O
sensation O O
is O O
intact O O
in O O
all O O
extremities O O
. O O

Head O O
, O O
ears O O
, O O
eyes O O
, O O
nose O O
and O O
throat O O
: O O
Atraumatic B-Disease B-Disease
and O I-Disease
normocephalic O I-Disease
. O O

Sclerae O O
were O O
anicteric B-Disease B-Disease
. O O

Oropharynx O O
was O O
benign O O
without O O
exudate B-Disease B-Disease
. O O

Neck O O
: O O

Supple O O
. O O

Cardiovascular O O
: O O

Regular O O
rate O O
and O O
rhythm O O
with O O
normal O O
S1 O O
and O O
S2 O O
. O O

NO O O
murmurs B-Disease B-Disease
, O O
rubs B-Disease B-Disease
or O O
gallops B-Disease B-Disease
. O O

Chest O O
: O O

Rare B-Disease B-Disease
crackles I-Disease I-Disease
on I-Disease I-Disease
the I-Disease I-Disease
right I-Disease I-Disease
base I-Disease I-Disease
, O O
otherwise O O
clear O O
to O O
auscultation O O
bilaterally O O
. O O

Abdomen O O
: O O

Positive O O
bowel O O
sounds O O
, O O
nontender B-Disease B-Disease
and O O
nondistended B-Disease B-Disease
. O O

No O O
hepatosplenomegaly B-Disease B-Disease
. O O

Extremities O O
: O O

He O O
had O O
Dorsalis O O
pedis O O
in O O
radial O O
pulses O O
, O O
hands B-Disease O
and I-Disease O
feet I-Disease O
notably I-Disease O
tremulous I-Disease B-Disease
without O O
asterixis B-Disease B-Disease
. O O

No O O
stigmata B-Disease O
of O O
IV O O
drug O O
use O O
. O O

LABORATORY O O
DATA O O
: O O

CBC O O
: O O
White O O
blood O O
cell O O
count O O
is O O
8.8 O O
, O O
hematocrit O O
35.5 O O
platelets O O
266 O O
, O O
PT O O
13 O O
, O O
PT-T O O
23.3 O O
, O O
INR O O
was O O
1.1 O O
. O O

Chem-7 O O
: O O
Sodium O O
145 O O
, O O
potassium O O
3.4 O O
, O O
chloride O O
116 O O
, O O
bicarb O O
21 O O
, O O
BUN O O
12 O O
, O O
creatinine O O
0.6 O O
, O O
glucose O O
96 O O
, O O
calcium O O
7.2 O O
, O O
phos O O
3.6 O O
, O O
magnesium O O
1.7 O O
. O O

Liver O O
function O O
tests O O
: O O
ALT O O
38 O O
, O O
AST O O
34 O O
, O O
alk O O
phos O O
is O O
107 O O
, O O
albumin O O
is O O
3.2 O O
, O O
peak O O
bili O O
is O O
0.3 O O
, O O
amylase O O
31 O O
, O O
and O O
lipase O O
is O O
32 O O
. O O

UA O O
was O O
negative O O
. O O

Urine O O
tox O O
was O O
negative O O
. O O

Serum O O
tox O O
was O O
positive O O
for O O
ETOH O O
at O O
383 O O
, O O
otherwise O O
negative O O
. O O

Serum O O
osmolality O O
was O O
38397 O O
, O O
calculated O O
osmolality O O
gap O O
was O O
21 O O
. O O

Radiology O O
: O O

chest O O
x-ray O O
from O O
02-07 O O
had O O
linear B-Disease B-Disease
atelectasis I-Disease I-Disease
in I-Disease I-Disease
right I-Disease I-Disease
lower I-Disease I-Disease
lobe I-Disease I-Disease
with O O
no O O
evidence O O
of O O
a B-Disease B-Disease
band-like I-Disease I-Disease
opacity I-Disease I-Disease
in I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
lower I-Disease I-Disease
lobe I-Disease I-Disease
which O O
was O O
evident O O
on O O
the O O
chest O O
x-ray O O
on O O
02-06 O O
. O O

CT O O
of O O
the O O
head O O
on O O
02-06 O O
was O O
negative O O
for O O
hemorrhage B-Disease B-Disease
. O O

There O O
was O O
bran B-Disease B-Disease
atrophy I-Disease I-Disease
and O O
right B-Disease B-Disease
temporal I-Disease I-Disease
encephalomalacia I-Disease I-Disease
. O O

ASSESSMENT O O
AND O O
PLAN O O
: O O

Mr. O O
Pohl O O
is O O
a O O
53 O O
- O O
year-old O O
male O O
with O O
a O O
history O O
of O O
ETOH O O
, O O
hypertension B-Disease B-Disease
who O O
presented O O
int O O
he O O
emergency O O
room O O
with O O
increased B-Disease B-Disease
agitation I-Disease I-Disease
, O O
like O O
secondary O O
to O O
ETOH B-Disease O
intoxication I-Disease O
and O O
developed O O
subsequent B-Disease B-Disease
hypotension I-Disease I-Disease
, O O
systolic O O
blood O O
pressures O O
in O O
the O O
80 O O
's, O O
status O O
post O O
Ativan O O
and O O
Haldol O O
, O O
but O O
was O O
responsive O O

to O O
fluid O O
resuscitation O O
at O O
4 O O
liters O O
and O O
was O O
admitted O O
to O O
the O O
CMED O O
CCU O O
for O O
hemodynamic O O
monitoring O O
. O O

On O O
hospital O O
day O O
#2 O O
, O O
the O O
patient O O
was O O
transferred O O
to O O
the O O
Medicine O O
Ludlow O O
Team O O
. O O

Plan O O
for O O
patient O O
regarding O O
cardiac O O
, O O
unlike O O
hypotension B-Disease B-Disease
of I-Disease O
cardiac I-Disease O
origin I-Disease O
. O O

The O O
patient O O
responded O O
well O O
to O O
fluid O O
resuscitation O O
. O O

Elevated B-Disease B-Disease
CK I-Disease I-Disease
on O O
02-07 O O
is O O
likely O O
secondary O O
to O O
mild B-Disease B-Disease
rhabdomyolysis I-Disease I-Disease
. O O

The O O
patient O O
was O O
hemodynamically O O
stable O O
overnight O O
in O O
the O O
CMED O O
CCU O O
. O O

We O O
decided O O
to O O
discontinue O O
telemetry O O
and O O
held O O
all O O
hypertension O O
medications O O
including O O
Lisinopril O O
, O O
Mavik O O
, O O
hydrochlorothiazide O O
. O O

2. O O
For O O
pulmonary O O
, O O
the O O
patient O O
had O O
a O O
good O O
O2 O O
saturations O O
on O O
room O O
air O O
. O O

He O O
had O O
atelectasis B-Disease B-Disease
in I-Disease I-Disease
the I-Disease I-Disease
right I-Disease I-Disease
lower I-Disease I-Disease
lobe I-Disease I-Disease
by O O
chest O O
x-ray O O
. O O

We O O
encouraged O O
activity O O
and O O
patient O O
out O O
of O O
bed O O
. O O

3. O O
Gastrointestinal O O
: O O

The O O
patient O O
on O O
ranitidine O O
150 O O
mg O O
p.o. O O
b.i.d. O O
for O O
gastrointestinal O O
prophylaxis O O
. O O

4. O O
Urology O O
: O O
Foley O O
was O O
discontinued O O
in O O
the O O
CMED O O
CCU O O
at O O
12 O O
p.m. O O

The O O
patient O O
was O O
urinating O O
without O O
difficulty B-Disease B-Disease
. O O

We O O
gave O O
the O O
patient O O
bathroom O O
privileges O O
. O O

5. O O
FEN O O
: O O

We O O
continued O O
IV O O
fluids O O
at O O
100 O O
cc O O
per O O
hour O O
for O O
one O O
liter O O
secondary O O
to O O
a O O
concern O O
for O O
rhabdomyolysis B-Disease B-Disease
plus O O
kidney O B-Disease
protective O I-Disease
effects O I-Disease
. O O

K O O
was O O
3.4 O O
, O O
repleted O O
, O O
potassium O O
chloride O O
40 O O
mEq O O
times O O
1 O O
dose O O
p.o. O O

Calcium O O
with O O
7.2 O O
corrected O O
to O O
less O O
than O O
8.0, O O
completed O O
calcium O O
carbonate O O
at O O
500 O O
mg O O
blood O O
pressure.o. O O
t.i.d. O O
while O O
in O O
the O O
hospital O O
. O O

Mag O O
was O O
1.7 O O
, O O
repleted O O
with O O
magnesium O O
oxide O O
with O O
400 O O
mg O O
p.o. O O
times O O
one O O
dose O O
. O O

Diet O O
as O O
tolerated O O
. O O

6. O O
Substance O O
use O O
and O O
psychiatry O O
: O O

The O O
patient O O
states O O
that O O
he O O
was O O
willing O O
to O O
speak O O
with O O
someone O O
from O O
addiction O O
services O O
. O O

We O O
were O O
concerned O O
regarding O O
possibly O O
binge O O
drinking O O
or O O
ETOH O O
abuse O O
. O O

The O O
patient O O
seemed O O
notably B-Disease B-Disease
anxious I-Disease I-Disease
and O O
depressed B-Disease B-Disease
. O O

It O O
is O O
possible O O
that O O
the O O
patient O O
is O O
self O O
medicating O O
for O O
underlying B-Disease B-Disease
psychiatric I-Disease I-Disease
disorder I-Disease I-Disease
. O O

We O O
will O O
monitor O O
for O O
signs O O
of O O
alcohol B-Disease O
withdrawal I-Disease O
according O O
to O O
the O O
CIWA O O
scale O O
. O O

We O O
will O O
given O O
valium O O
5 O O
mg O O
p.o. O O
q. O O
3 O O
hours O O
for O O
withdrawal B-Disease B-Disease
. O O

We O O
will O O
consult O O
addiction O O
service O O
in O O
the O O
a.m. O O

We O O
will O O
consider O O
psychiatry O O
consult O O
in O O
the O O
future O O
to O O
assess O O
for O O
underlying B-Disease B-Disease
anxiety I-Disease I-Disease
disorder I-Disease I-Disease
or O O
depression B-Disease B-Disease
. O O

DISPOSITION O O
: O O

The O O
patient O O
may O O
be O O
discharge O O
Harry O O
02-08 O O
pending O O
observations O O
for O O
delirium B-Disease B-Disease
tremens I-Disease I-Disease
after O O
discussion O O
with O O
primary O O
care O O
physician O O
, O O
Dr. O O
Blue O O
who O O
knows O O
the O O
patient O O
well O O
. O O

HOSPITAL O O
COURSE O O
: O O

The O O
patient O O
was O O
transferred O O
to O O
medicine O O
service O O
on O O
hospital O O
day O O
#2 O O
after O O
remaining O O
hemodynamically O O
stable O O
in O O
the O O
CMED O O
CCU O O
overnight O O
. O O

1. O O
Blood O O
pressure O O
: O O

The O O
patient O O
's O O
blood O O
pressure O O
remained O O
stable O O
on O O
hospital O O
day O O
#2 O O
through O O
hospital O O
day O O
#3 O O
status O O
post O O
IV O O
hydration O O
with O O
systolic O O
blood O O
pressures O O
in O O
the O O
120 O O
's O O
to O O
130 O O
's. O O

We O O
continued O O
to O O
hold O O
the O O
patient O O
's O O
home O O
blood O O
pressure O O
medications O O
. O O

The O O
patient O O
was O O
asymptomatic B-Disease B-Disease
without O O
chest B-Disease B-Disease
pain I-Disease I-Disease
, O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
and O O
no O O
mental B-Disease B-Disease
status I-Disease I-Disease
changes I-Disease I-Disease
. O O

2. O O
Substance O O
abuse O O
: O O

On O O
Hospital O O
day O O
#2 O O
through O O
hospital O O
day O O
#3 O O
, O O
the O O
patient O O
had O O
mild B-Disease B-Disease
tremor I-Disease I-Disease
on I-Disease I-Disease
hands I-Disease I-Disease
, O O
but O O
improved O O
over O O
hospital O O
course O O
. O O

The O O
patient O O
became O O
notably B-Disease B-Disease
less I-Disease I-Disease
anxious I-Disease I-Disease
throughout O O
hospital O O
stay O O
. O O

CIWA O O
scale O O
over O O
night O O
was O O
1 O O
for O O
tremor B-Disease B-Disease
and O O
the O O
patient O O
did O O
not O O
require O O
any O O
Valium O O
for O O
alcohol B-Disease O
withdrawal I-Disease O
. O O

We O O
believe O O
that O O
the O O
patient O O
is O O
able O O
to O O
be O O
discharged O O
and O O
to O O
follow O O
up O O
with O O
Dr. O O
Sandra O O
Rose O O
, O O
addiction O O
services O O
as O O
an O O
outpatient O O
. O O

Call O O
for O O
further O O
referral O O
. O O

3. O O
FEN O O
: O O

Calcium O O
carbonate O O
500 O O
mg O O
p.o. O O
t.i.d. O O
, O O
Mag O O
oxide O O
400 O O
mg O O
p.o. O O
times O O
one O O
dose O O
, O O
potassium O O
chloride O O
repleted O O
40 O O
mEq O O
times O O
one O O
dose O O
. O O

DISCHARGE O O
DIAGNOSIS O O
: O O

1. O O
ETOH B-Disease B-Disease
intoxication I-Disease I-Disease
. O O

2. O O
Hypertension B-Disease B-Disease
. O O

3. O O
History O O
of O O
colonic B-Disease B-Disease
polyp I-Disease I-Disease
times O O
3 O O
, O O
benign O O
in O O
2007 O O
, O O
repeat O O
colonoscopy O O
due O O
in O O
2010 O O
. O O

4. O O
History B-Disease O
of I-Disease O
right I-Disease B-Disease
inguinal I-Disease I-Disease
hernia I-Disease I-Disease
in O O
2002 O O
. O O

DISCHARGE O O
STATUS O O
: O O

Home O O
. O O

FOLLOW O O
UP O O
: O O

Follow O O
up O O
with O O
Dr. O O
Marcia O O
Bender O O
to O O
be O O
arranged O O
by O O
the O O
patient O O
. O O

The O O
patient O O
will O O
also O O
call O O
clinical O O
nurse O O
specialist O O
, O O
Sandra O O
Rose O O
at O O
( O O
968 O O
) O O
347-9868 O O
for O O
further O O
referral O O
to O O
addiction O O
services O O
. O O

DISCHARGE O O
MEDICATIONS O O
: O O

Return O O
to O O
home O O
medications O O
: O O

1. O O
Lisinopril O O
5 O O
mg O O
p.o.q.d. O O

2. O O
Mavik O O
unknown O O
dosage O O
. O O

3. O O
Hydrochlorothiazide O O
unknown O O
dosage O O
. O O

MARK O O
T O O
Ragin O O
, O O
M.D. O O
34-329 O O

Dictated O O
By O O
: O O
Alice O O
T. O O
Mahoney O O
, O O
M.D. O O

MEDQUIST36 O O

D O O
: O O
2011-02-08 O O
12:05 O O

T O O
: O O
2011-02-08 O O
12:15 O O

JOB O O
#: O O
77892 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Richard O O
Carlson O O
on O O
: O O
SUN O O
2011-02-20 O O
1:40 O O
PM O O

( O O
End O O
of O O
Report O O
) O O

337702516 O O
WGH O O

9387380 O O

310695 O O

271735 O O

9/15/2000 O O
12:00:00 O O
AM O O

Discharge O O
Summary O O

Signed O O

DIS O O

Report O O
Status O O
: O O

Signed O O

DISCHARGE O O
SUMMARY O O

NAME O O
: O O

FREIERMLINKENEIGHCAABLINFARST O O
, O O
ANEA O O

UNIT O O
NUMBER O O
: O O

008-08-33 O O

ADMISSION O O
DATE O O
: O O

09/15/2000 O O

DISCHARGE O O
DATE O O
: O O

The O O
patient O O
was O O
admitted O O
to O O
the O O
hospital O O
on O O
July O O
12th O O
for O O
a O O
chole O O
with O O
a O O
principle O O
diagnosis O O
of O O
recurrent B-Disease B-Disease
biliary I-Disease I-Disease
colic I-Disease I-Disease
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

The O O
patient O O
is O O
a O O
42 O O
year O O
old O O
with O O
recurrent B-Disease B-Disease
biliary I-Disease I-Disease
colic I-Disease I-Disease
. O O

She O O
has O O
had O O
ultrasound B-Disease O
proven I-Disease B-Disease
gallstones I-Disease I-Disease
for O O
ten O O
years O O
, O O
seen O O
on O O
an O O
earlier O O
obstetric O O
ultrasound O O
. O O

The O O
patient O O
has O O
had O O
no O O
symptoms B-Disease B-Disease
until O O
approximately O O
two O O
years O O
ago O O
when O O
she O O
began O O
having O O
classic B-Disease B-Disease
biliary I-Disease I-Disease
colic I-Disease I-Disease
pain I-Disease I-Disease
with O O
right B-Disease B-Disease
upper I-Disease I-Disease
quadrant I-Disease I-Disease
epigastric I-Disease I-Disease
pain I-Disease I-Disease
radiating O O
to O O
midback O O
with O O
nausea B-Disease B-Disease
, O O
but O O
without O O
vomiting B-Disease B-Disease
. O O

Onset O O
was O O
an O O
hour O O
to O O
1 O O
hour O O
after O O
meals O O
, O O
worse O O
with O O
greasy O O
meals O O
, O O
lasting O O
five O O
minutes O O
to O O
two O O
hours O O
. O O

Episodes B-Disease O
have O O
been O O
increasing O O
in O O
frequency O O
over O O
the O O
last O O
few O O
months O O
. O O

She O O
has O O
had O O
no O O
fevers B-Disease B-Disease
, O O
chills B-Disease B-Disease
, O O
respiratory B-Disease B-Disease
symptoms I-Disease I-Disease
, O O
diarrhea B-Disease B-Disease
, O O
bright B-Disease B-Disease
red I-Disease I-Disease
blood I-Disease I-Disease
per I-Disease I-Disease
rectum I-Disease I-Disease
or O O
melena B-Disease B-Disease
. O O

She O O
has O O
not O O
found O O
any O O
relieve O O
with O O
any O O
over O O
the O O
counter O O
medications O O
. O O

She O O
has O O
no O O
family O O
history O O
of O O
gallbladder B-Disease B-Disease
or O I-Disease
pancreatic B-Disease I-Disease
Disease I-Disease I-Disease
. O O

She O O
has O O
had O O
no O O
significant O B-Disease
weight B-Disease I-Disease
loss I-Disease I-Disease
. O O

No O O
anorexia B-Disease B-Disease
. O O

An O O
ultrasound O O
on O O
1/25/00 O O
showed O O
six B-Disease B-Disease
gallstones I-Disease I-Disease
without O O
cholecystitis B-Disease B-Disease
. O O

She O O
has O O
no O O
history O O
of O O
liver B-Disease B-Disease
Disease I-Disease I-Disease
, O O
hepatitis B-Disease B-Disease
. O O

The O O
patient O O
is O O
from O O
45 O O
Sidewonly O O
Blvd O O
, O O
Fresa O O
Loharanleah O O
, O O
Maryland O O
. O O

Has O O
lived O O
in O O
896 O O
Lokatspur O O
Pkwy O O
, O O
Ingrich O O
Vepobuffh O O
, O O
Indiana O O
for O O
25 O O
years O O
and O O
works O O
as O O
a O O
teaching O O
assistant O O
in O O
a O O
second O O
grade O O
in O O
Satlnonew O O
Rollglend O O
Pabridrham O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Significant O O
for O O
a O O
left O O
ear O O
operation O O
approximately O O
30 O O
years O O
ago O O
with O O
left O O
TM O O
reconstruction O O
in O O
December O O
1999 O O
at O O
Hitch O O
Hospital O O
. O O

MEDS O O
ON O O
ADMISSION O O
: O O

Only O O
multivitamins O O
. O O

ALLERGIES O O
: O O

No O O
known B-Disease B-Disease
drug I-Disease I-Disease
allergies I-Disease I-Disease

SOCIAL O O
HISTORY O O
: O O

The O O
patient O O
denies O O
tobacco O O
and O O
/ O O
or O O
alcohol O O
use O O
. O O

REVIEW O O
OF O O
SYSTEMS O O
: O O

Noncontributory O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

The O O
patient O O
is O O
a O O
healthy O O
appearing O O
female O O
looking O O
her O O
stated O O
age O O
in O O
no O O
apparent B-Disease B-Disease
distress I-Disease I-Disease
. O O

She O O
is O O
anicteric B-Disease B-Disease
without O O
rash B-Disease B-Disease
or O O
HEENT O B-Disease
. O O

Significant O O
for O O
left B-Disease B-Disease
TM I-Disease I-Disease
scarring I-Disease I-Disease
without O O
acute B-Disease B-Disease
inflammation I-Disease I-Disease
or O O
drainage B-Disease B-Disease
. O O

Oropharynx O O
is O O
moist O O
. O O

No O O
lymphadenopathy B-Disease B-Disease
is O O
noted O O
. O O

Thyroid O O
is O O
nonpalpable O O
. O O

She O O
is O O
without O O
bruits B-Disease B-Disease
or O O
JVD B-Disease B-Disease
. O O

Lungs O O
are O O
bilaterally O O
clear O O
to O O
auscultation O O
. O O

Cardiac O O
exam O O
; O O
she O O
has O O
positive O O
S1 O O
, O O
S2 O O
without O O
murmur B-Disease B-Disease
, O O
rub B-Disease B-Disease
or O O
gallop B-Disease B-Disease
. O O

Rate O O
was O O
75 O O
. O O

Abdomen O O
is O O
soft O O
and O O
nontender B-Disease B-Disease
without O O
hepatosplenomegaly B-Disease B-Disease
or O O
mass B-Disease B-Disease
. O O

She O O
has O O
no O O
rebound B-Disease B-Disease
or O O
guarding B-Disease B-Disease
. O O

Her O O
rectal O O
exam O O
is O O
guaiac O O
negative O O
. O O

Her O O
extremities O O
are O O
without O O
normal O O
limits O O
with O O
+2 O O
pulses O O
throughout O O
. O O

She O O
is O O
neurologically O O
intact O O
. O O

HOSPITAL O O
COURSE O O
: O O

The O O
patient O O
was O O
admitted O O
for O O
the O B-Disease
lap O I-Disease
coli O I-Disease
with O O
an O O
intraoperative O O
cholangiogram O O
by O O
Dr. O O
Sterp O O
under O O
general O O
anesthesia O O
. O O

A O O
separate O O
operative O O
note O O
has O O
been O O
dictated O O
. O O

Operative O O
course O O
and O O
recovery O O
were O O
without O O
complication B-Disease B-Disease
. O O

The O O
patient O O
was O O
admitted O O
to O O
floor O O
. O O

The O O
patient O O
was O O
afebrile B-Disease B-Disease
, O O
vital O O
signs O O
were O O
stable O O
. O O

She O O
is O O
taking O O
po O O
&apos;s O O
. O O

She O O
is O O
ambulatory O O
. O O

The O O
patient O O
will O O
be O O
discharged O O
to O O
home O O
in O O
stable O O
condition O O
with O O
a O O
follow O O
up O O
appointment O O
with O O
Dr. O O
Sterp O O
. O O

DISCHARGE O O
MEDICATIONS O O
: O O

Percocet O O
5 O O
mg O O
in O O
325 O O
mg O O
one O O
to O O
two O O
tabs O O
po O O
q4 O O
to O O
6 O O
prn O O
pain B-Disease B-Disease
. O O

The O O
patient O O
will O O
be O O
discharged O O
in O O
stable O O
condition O O
. O O

Follow O O
up O O
as O O
mentioned O O
will O O
be O O
with O O
Dr. O O
Sterp O O
. O O

______________________ O O
SANTDEL O O
GLOTZRHALT O O
, O O
M.D. O O

TR O O
: O O

sxu O O

DD O O
: O O

09/15/2000 O O

TD O O
: O O

09/21/2000 O O
10:58 O O
P O O

cc O O
: O O

MINAQUEENALT O O
MASHINEUSSHA O O
STERP O O
, O O
M.D. O O

105732749 O O

FIH O O

7017973 O O

715894 O O

55714 O O

9/10/1999 O O
12:00:00 O O
AM O O

Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

DISCHARGE O O
SUMMARY O O
NAME O O
: O O

STERPKOTENEISH O O
, O O
LYDELL O O
A O O

UNIT O O
NUMBER O O
: O O

712-67-96 O O

ADMISSION O O
DATE O O
: O O

09/10/1999 O O

DISCHARGE O O
DATE O O
: O O

09/14/1999 O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

Pancreatic B-Disease B-Disease
carcinoma I-Disease I-Disease
. O O

PRINCIPAL O O
PROCEDURE O O
: O O

Laparoscopy O O
with O O
biopsy O O
for O O
diagnosis O O
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Ms. O O
Sterpkoteneish O O
is O O
a O O
69-year-old O O
woman O O
, O O
who O O
over O O
the O O
past O O
six O O
months O O
has O O
noted O O
increasing B-Disease B-Disease
pain I-Disease I-Disease
in I-Disease I-Disease
her I-Disease I-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
quadrant I-Disease I-Disease
radiating O O
to O O
the O O
back O O
. O O

She O O
described O O
the B-Disease B-Disease
pain I-Disease I-Disease
as O O
being O O
exacerbated O O
by O O
eating O O
and O O
described O O
an B-Disease B-Disease
associated I-Disease I-Disease
weight I-Disease I-Disease
loss I-Disease I-Disease
. O O

She O O
presented O O
to O O
her O O
primary O O
care O O
physician O O
, O O
Dr. O O
Tlandtaze O O
, O O
in O O
Aersing O O
Rocuch O O
Sun O O
, O O
who O O
obtained O O
a O O
CT O O
scan O O
, O O
which O O
demonstrated O O
a B-Disease B-Disease
mass I-Disease I-Disease
in O I-Disease
the O I-Disease
tail O I-Disease
of O I-Disease
the O I-Disease
pancreas O I-Disease
. O O

She O O
was O O
then O O
referred O O
to O O
the O O
Fairm O O
of O O
Ijordcompmac O O
Hospital O O
under O O
the O O
El O O
Memorial O O
and O O
was O O
seen O O
by O O
Dr. O O
Blinjesc O O
, O O
who O O
scheduled O O
her O O
for O O
an O O
exploratory O O
laparoscopy O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Is O O
significant O O
for O O
spinal B-Disease B-Disease
stenosis I-Disease I-Disease
and O O
a O O
series O O
of O O
operations O O
including O O
repair O O
of O O
a B-Disease B-Disease
ureteral I-Disease I-Disease
stricture I-Disease I-Disease
; O O
cataract O O
implants O O
; O O
two O O
partial O O
hysterectomies O O
; O O
and O O
an O O
appendectomy O O
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

Oxycontin O O
10 O O
mg O O
PO O O
q.day O O
. O O

Darvocet O O
. O O

Estratab O O
. O O

Aspirin O O
325 O O
mg O O
PO O O
q.day O O
. O O

ALLERGIES O O
: O O

No O O
known B-Disease B-Disease
drug I-Disease I-Disease
allergies I-Disease I-Disease
. O O

PHYSICAL O O
EXAMINATION O O
: O O

The O O
blood O O
pressure O O
was O O
150/86 O O
; O O
pulse O O
82 O O
; O O
respirations O O
16 O O
. O O

Lungs O O
were O O
clear O O
to O O
auscultation O O
bilaterally O O
. O O

Heart O O
: O O

regular O O
S1 O O
and O O
S2 O O
; O O
no O O
murmurs B-Disease B-Disease
. O O

Abdomen O O
: O O

soft O O
; O O
nontender O B-Disease
; O O
no O O
palpable B-Disease B-Disease
masses I-Disease I-Disease
. O O

HOSPITAL O O
COURSE O O
AND O O
TREATMENT O O
: O O

The O O
patient O O
was O O
admitted O O
through O O
same O O
day O O
surgery O O
and O O
taken O O
to O O
the O O
operating O O
room O O
where O O
Dr. O O
Blinjesc O O
, O O
assisted O O
by O O
Dr. O O
Zockbeathe O O
, O O
performed O O
a O O
diagnostic O O
laparoscopy O O
with O O
peritoneal O O
washings O O
. O O

Findings O O
included O O
no B-Disease O
gross I-Disease B-Disease
evidence I-Disease I-Disease
seating I-Disease I-Disease
in I-Disease I-Disease
the I-Disease I-Disease
abdominal I-Disease I-Disease
wall I-Disease I-Disease
; O O
one B-Disease B-Disease
nodule I-Disease I-Disease
on O O
the O O
posterior O O
surface O O
of O O
the O O
right O O
lobe O O
of O O
the O O
liver O O
; O O
one B-Disease B-Disease
nodule I-Disease I-Disease
in O I-Disease
the O I-Disease
inferior O I-Disease
edge O I-Disease
of O I-Disease
the O I-Disease
falciform O I-Disease
ligament O I-Disease
. O O

Specimens O O
sent O O
to O O
pathology O O
included O O
peritoneal O O
washings O O
and O O
permanent O O
specimens O O
from O O
the O O
liver O O
and O O
falciform B-Disease B-Disease
nodules I-Disease I-Disease
. O O

There O O
were O O
no O O
complications B-Disease B-Disease
, O O
and O O
the O O
patient O O
tolerated O O
the O O
procedure O O
well O O
. O O

Postoperatively O O
, O O
the O O
patient O O
had O O
some B-Disease B-Disease
abdominal I-Disease I-Disease
bloating I-Disease I-Disease
with O O
evidence O O
of O O
subcutaneous B-Disease B-Disease
emphysema I-Disease I-Disease
over I-Disease I-Disease
the I-Disease I-Disease
abdomen I-Disease I-Disease
. O O

She O O
was O O
uncomfortable B-Disease B-Disease
and O O
slow O O
to O O
have O O
bowel O O
movements O O
, O O
although O O
she O O
did O O
have O O
flatus O O
. O O

She O O
tolerated O O
a O O
full O O
diet O O
well O O
, O O
but O O
continued O O
to O O
have O O
abdominal B-Disease B-Disease
cramping I-Disease I-Disease
and O O
a B-Disease B-Disease
mild I-Disease I-Disease
ileus I-Disease I-Disease
for O O
the O O
following O O
three O O
days O O
. O O

She O O
was O O
treated O O
with O O
repeated O O
Fleet O O
&apos;s O O
enemas O O
, O O
and O O
on O O
postoperative O O
day O O
three O O
, O O
she O O
had O O
a O O
number O O
of O O
bowel O O
movements O O
, O O
was O O
considerably O O
more O O
comfortable O O
, O O
and O O
deemed O O
ready O O
for O O
discharge O O
. O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

Was O O
excellent O O
. O O

MEDICATIONS O O
ON O O
DISCHARGE O O
: O O

Included O O
aspirin O O
325 O O
mg O O
PO O O
q.day O O
. O O

Percocet O O
one O O
to O O
two O O
whenever O O
necessary O O
q. O O
four O O
to O O
six O O
hours O O
for O O
pain B-Disease B-Disease
. O O

Estratab O O
one O O
PO O O
q.day O O
. O O

At O O
the O O
time O O
of O O
discharge O O
, O O
cytopathology O O
specimens O O
had O O
been O O
negative O O
, O O
and O O
surgical O O
pathology O O
specimens O O
were O O
still O O
pending O O
. O O

She O O
was O O
instructed O O
to O O
call O O
Dr. O O
Blinjesc O O
for O O
the O O
results O O
of O O
these O O
tests O O
and O O
to O O
follow O O
up O O
with O O
him O O
for O O
further O O
management O O
if O O
necessary O O
. O O

STA O O
BODEJOVE O O
, O O
M.D. O O

DICTATING O O
FOR O O
: O O

______________________________ O O
LONSHI O O
OCK O O
, O O
M.D. O O

TR O O
: O O

hjr O O

DD O O
: O O

09/14/1999 O O

TD O O
: O O

09/17/1999 O O
2:26 O O
P O O

cc O O
: O O

LONSHI O O
OCK O O
, O O
M.D. O O

cc O O
: O O

Telshey O O
K. O O
Swatlleebtik O O
, O O
M.D. O O
Rinime O O
Hawnspantkote O O
Arkansas O O

517414339 O O

PUOMC O O

4351342 O O

88500 O O

099515 O O

12/26/1996 O O
12:00:00 O O
AM O O

HYPERPARATHYROIDISM B-Disease B-Disease
. O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

DISCHARGE O O
SUMMARY O O

NAME O O
: O O

HOUGHTJESCSLEM O O
, O O
RIESHINJIN O O
R O O

UNIT O O
NUMBER O O
: O O

948-14-32 O O

ADMISSION O O
DATE O O
: O O

12/26/96 O O

DISCHARGE O O
DATE O O
: O O

01/01/97 O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

hyperparathyroidism B-Disease B-Disease
. O O

ASSOCIATED O O
DIAGNOSIS O O
: O O

1. O O
status O O
post O O
mitral O O
valve O O
replacement O O
, O O

2. O O
hypertension B-Disease B-Disease
, O O

3. O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
, O O

4. O O
hypertrophic B-Disease B-Disease
obstructive I-Disease I-Disease
cardiomyopathy I-Disease I-Disease
, O O

5. O O
osteoarthritis B-Disease B-Disease
, O O

6. O O
right B-Disease B-Disease
cheek I-Disease I-Disease
basal I-Disease I-Disease
cell I-Disease I-Disease
carcinoma I-Disease I-Disease
, O O

7. O O
glaucoma B-Disease B-Disease
, O O

8. O O
non-insulin B-Disease B-Disease
dependent I-Disease I-Disease
diabetes I-Disease I-Disease
mellitus I-Disease I-Disease
, O O

9. O O
status O O
post O O
laparoscopic O O
cholecystectomy O O
, O O

10. O O
status O O
post O O
dilation O B-Disease
and O O
curettage O O
, O O

11. O O
status O O
post O O
cataract O O
surgery O O
, O O

12. O O
status O O
post O O
left O O
breast O O
biopsy O O
. O O

PRINCIPAL O O
PROCEDURE O O
: O O

Parathyroidectomy O O
on O O
12-27-96 O O
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

The O O
patient O O
is O O
an O O
83-year-old O O
female O O
who O O
presents O O
for O O
surgical O O
evaluation O O
for O O
her B-Disease B-Disease
hyperparathyroidism I-Disease I-Disease
. O O

This O O
is O O
an O O
83-year-old O O
female O O
with O O
a O O
history O O
of O O
hypertrophic B-Disease B-Disease
obstructive I-Disease I-Disease
cardiomyopathy I-Disease I-Disease
, O O
status O O
post O O
mitral O O
valve O O
replacement O O
in O O
1988 O O
, O O
chronic B-Disease B-Disease
atrial I-Disease I-Disease
fibrillation I-Disease I-Disease
, O O
hypertension B-Disease B-Disease
, O O
who O O
presents O O
for O O
parathyroidectomy O O
. O O

In O O
August O O
of O O
1996 O O
while O O
the O O
patient O O
was O O
at O O
Retelk O O
County O O
Medical O O
Center O O
for O O
replacement O O
of O O
her O O
knees O O
bilaterally O O
, O O
and O O
on O O
preoperative O O
evaluation O O
she O O
was O O
noted O O
to O O
have O O
a B-Disease B-Disease
high I-Disease I-Disease
calcium I-Disease I-Disease
and O O
therefore O O
the O O
surgery O O
was O O
canceled O O
. O O

Further O O
testing O O
revealed O O
hyperparathyroidism B-Disease B-Disease
as O O
evidenced O O
by O O
an B-Disease B-Disease
elevated I-Disease I-Disease
PTH I-Disease I-Disease
. O O

The O O
patient O O
reports O O
no O O
masses B-Disease B-Disease
in I-Disease I-Disease
her I-Disease I-Disease
neck I-Disease I-Disease
. O O

She O O
has O O
noticed O O
some O B-Disease
generalized B-Disease I-Disease
hoarseness I-Disease I-Disease
in I-Disease O
her I-Disease O
voice I-Disease O
for O O
the O O
past O O
5-6 O O
months O O
. O O

In O O
addition O O
, O O
she O O
has O O
some B-Disease B-Disease
dysphagia I-Disease I-Disease
, O O
particularly O O
has O O
had O O
some B-Disease B-Disease
difficulties I-Disease I-Disease
with I-Disease I-Disease
swallowing I-Disease I-Disease
. O O

She O O
has O O
been O O
seen O O
by O O
Dr. O O
Tokbelb O O
, O O
her O O
primary O O
care O O
physician O O
in O O
Itgreenredan O O
Hospital O O
, O O
and O O
also O O
Dr. O O
Kotefyfechird O O
, O O
her O O
cardiologist O O
, O O
and O O
also O O
an O O
endocrinologist O O
at O O
Retelk O O
County O O
Medical O O
Center O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

1. O O
status O O
post O O
mitral O O
valve O O
replacement O O
in O O
1988 O O
. O O

She O O
has O O
a O O
St. O O
Jude O O
&apos;s O O
mechanical O O
valve O O
and O O
has O O
been O O
on O O
Coumadin O O
since O O
then O O
, O O

2. O O
hypertension B-Disease B-Disease
, O O
she O O
has O O
had O O
hypertension B-Disease B-Disease
for O O
15 O O
years O O
, O O

3. O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
, O O
she O O
is O O
status O O
post O O
cardioversion O O
3-25-94 O O
, O O

4. O O
hypertrophic B-Disease B-Disease
obstructive I-Disease I-Disease
cardiomyopathy I-Disease I-Disease
, O O

5. O O
osteoarthritis B-Disease B-Disease
; O O
she O O
is O O
to O O
receive O O
bilateral O O
total O O
knee O O
replacements O O
at O O
some O O
time O O
in O O
the O O
near O O
future O O
, O O

6. O O
right B-Disease B-Disease
cheek I-Disease I-Disease
basal I-Disease I-Disease
cell I-Disease I-Disease
carcinoma I-Disease I-Disease
to O O
be O O
removed O O
in O O
the O O
future O O
, O O

7. O O
history O O
of O O
glaucoma B-Disease B-Disease
, O O

8. O O
non B-Disease B-Disease
insulin I-Disease I-Disease
dependent I-Disease I-Disease
diabetes I-Disease I-Disease
mellitus I-Disease I-Disease
which O O
was O O
diagnosed O O
in O O
March O O
, O O
1995 O O
, O O

9. O O
shingles B-Disease B-Disease
. O O

PAST O O
SURGICAL O O
HISTORY O O
: O O

1. O O
laparoscopic O O
cholecystectomy O O
03/93 O O
by O O
Dr. O O
Sapmal O O
, O O

2. O O
dilation O B-Disease
and O O
curettage O O
in O O
1992 O O
for O O
polyps B-Disease B-Disease
, O O

3. O O
left O O
breast O O
biopsy O O
which O O
was O O
benign O O
, O O

4. O O
cataract O O
surgery O O
. O O

ALLERGIES O O
: O O

No O O
known B-Disease B-Disease
drug I-Disease I-Disease
allergies I-Disease I-Disease
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

1. O O
Lopid O O
600 O O
mg O O
PO O O
b.i.d. O O
, O O

2. O O
K-Dur O O
20 O O
mg O O
PO O O
q.day O O
, O O

3. O O
Lasix O O
40 O O
mg O O
PO O O
q.day O O
, O O

4. O O
Coumadin O O
2.5 O O
mg O O
PO O O
q.day O O
which O O
was O O
last O O
taken O O
two O O
days O O
prior O O
to O O
admission O O
, O O

5. O O
Norvasc O O
500 O O
mg O O
PO O O
q.day O O
, O O

6. O O
Digoxin O O
.25 O O
mg O O
PO O O
q.day O O
, O O

7. O O
Lopressor O O
50 O O
mg O O
PO O O
b.i.d. O O
, O O

8. O O
Glucotrol O O
10 O O
XL O O
qam O O
, O O

9. O O
Timoptic O O
0.5% O O
b.i.d. O O
to O O
both O O
eyes O O
, O O

10. O O
Pilocarpine O O
gel O O
qhs O O
to O O
both O O
eyes O O
. O O

FAMILY O O
HISTORY O O
: O O

There O O
is O O
no O O
family O O
history O O
of O O
parathyroid B-Disease B-Disease
or I-Disease I-Disease
thyroid I-Disease I-Disease
Diseases I-Disease I-Disease
. O O

SOCIAL O O
HISTORY O O
: O O

The O O
patient O O
is O O
widowed O O
. O O

She O O
lives O O
alone O O
but O O
is O O
completely O O
independent O O
. O O

She O O
visits O O
her O O
daughter O O
once O O
a O O
week O O
. O O

No O O
ethanol O O
or O O
tobacco O O
use O O
. O O

REVIEW O O
OF O O
SYSTEMS O O
: O O

The O O
review O O
of O O
systems O O
is O O
significant O O
for O O
a O O
history O O
of O O
dyspnea B-Disease B-Disease
on I-Disease O
exertion I-Disease O
. O O

At O O
present O O
, O O
she O O
can O O
walk O O
one O O
to O O
two O O
blocks O O
before O O
having O O
to O O
stop O O
because O O
of O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
. O O

When O O
walking O O
outside O O
, O O
she O O
stops O O
multiple O O
times O O
because O O
of O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
. O O

She O O
sleeps O O
with O O
two O O
pillows O O
at O O
night O O
. O O

She O O
gets O O
short B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
walking O I-Disease
up O I-Disease
steps O I-Disease
. O O

PHYSICAL O O
EXAMINATION O O
: O O

On O O
physical O O
examination O O
, O O
she O O
is O O
a O O
pleasant O O
woman O O
in O O
no O O
acute B-Disease B-Disease
distress I-Disease I-Disease
. O O

Her O O
pulse O O
is O O
72 O O
, O O
irregularly O O
irregular O O
, O O
blood O O
pressure O O
96/60 O O
, O O
temperature O O
97.9 O O
, O O
respirations O O
18 O O
. O O

The O O
head O O
, O O
eyes O O
, O O
ears O O
, O O
nose O O
and O O
throat O O
examination O O
is O O
notable O O
for O O
pupils O O
which O O
have O O
irregular B-Disease B-Disease
border I-Disease I-Disease
and O O
are O O
very B-Disease B-Disease
sluggishly I-Disease I-Disease
reactive I-Disease I-Disease
. O O

The O O
patient O O
reports O O
that O O
she O O
will O O
have O O
revision O O
of O O
cataract O O
surgery O O
. O O

Neck O O
and O O
lungs O O
are O O
unremarkable O O
. O O

Cardiovascular O O
exam O O
: O O

III B-Disease O
/ I-Disease O
VI I-Disease O
systolic I-Disease O
click I-Disease O
and O O
irregularly B-Disease B-Disease
irregular I-Disease I-Disease
rhythm I-Disease I-Disease
. O O

The O O
abdomen O O
was O O
benign O O
. O O

She O O
is O O
guaiac O O
negative O O
on O O
rectal O O
examination O O
. O O

Extremities O O
: O O

unremarkable O O
. O O

LABORATORY O O
DATA O O
: O O

Admission O O
white O O
blood O O
count O O
4.3 O O
, O O
hematocrit O O
31.0 O O
, O O
electrolytes O O
were O O
all O O
within O O
normal O O
limits O O
, O O
glucose O O
218 O O
, O O
prothrombin O O
time O O
on O O
admission O O
was O O
15.1 O O
with O O
INR O O
of O O
1.5 O O
, O O
partial O O
thromboplastin O O
time O O
23.3 O O
. O O

The O O
electrocardiogram O O
showed O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
with O O
slow B-Disease B-Disease
ventricular I-Disease I-Disease
response I-Disease I-Disease
and O O
digitalis B-Disease B-Disease
effect I-Disease I-Disease
as O O
well O O
as O O
left B-Disease B-Disease
ventricular I-Disease I-Disease
hypertrophy I-Disease I-Disease
. O O

IMPRESSION O O
ON O O
ADMISSION O O
: O O

Impression O O
was O O
that O O
this O O
was O O
an O O
83-year-old O O
female O O
with O O
cardiac B-Disease O
history I-Disease O
, O O
dyspnea B-Disease B-Disease
on I-Disease O
exertion I-Disease O
, O O
increased B-Disease B-Disease
calcium I-Disease I-Disease
and O O
hyperparathyroidism B-Disease B-Disease
who O O
presents O O
for O O
parathyroidectomy O O
. O O

HOSPITAL O O
COURSE O O
AND O O
TREATMENT O O
: O O

On O O
the O O
day O O
of O O
admission O O
, O O
the O O
patient O O
was O O
brought O O
to O O
the O O
operating O O
room O O
for O O
parathyroidectomy O O
. O O

The O O
right O O
superior O O
parathyroid O O
gland O O
was O O
found O O
to O O
be O O
markedly B-Disease B-Disease
enlarged I-Disease I-Disease
and O O
consistent O O
with O O
an B-Disease B-Disease
adenoma I-Disease I-Disease
. O O

Her O O
right O O
superior O O
parathyroid O O
gland O O
was O O
removed O O
and O O
the O O
rest O O
of O O
her O O
parathyroid O O
glands O O
were O O
left O O
in O O
place O O
. O O

Postoperatively O O
, O O
the O O
patient O O
did O O
well O O
and O O
was O O
able O O
to O O
cough O B-Disease
and O O
phonate O O
completely O O
with O O
no O O
changes B-Disease O
from O O
preoperative O O
. O O

The O O
plan O O
was O O
to O O
start O O
her O O
on O O
heparin O O
and O O
Coumadin O O
and O O
discontinue O O
her O O
heparin O O
when O O
her O O
Coumadin O O
levels O O
became O O
therapeutic O O
as O O
judged O O
by O O
the O O
prothrombin O O
time O O
/ O O
INR O O
. O O

However O O
, O O
on O O
postoperative O O
day O O
number O O
two O O
, O O
the O O
patient O O
in O O
the O O
afternoon O O
noticed O O
some B-Disease B-Disease
tingling I-Disease I-Disease
in I-Disease I-Disease
her I-Disease I-Disease
hands I-Disease I-Disease
and O O
also O O
some B-Disease B-Disease
tingling I-Disease I-Disease
hear I-Disease I-Disease
her I-Disease I-Disease
perioral I-Disease I-Disease
region I-Disease I-Disease
. O O

She O O
had O O
a O O
negative O O
Chvostek O O
&apos;s O O
and O O
negative O O
Trousseau O O
&apos;s O O
sign O O
. O O

She O O
had O O
no O O
muscular B-Disease B-Disease
weakness I-Disease I-Disease
noted O O
. O O

An O O
ionized O O
calcium O O
was O O
drawn O O
which O O
was O O
low O O
at O O
1.0 O O
. O O

As O O
a O O
result O O
, O O
the O O
patient O O
was O O
started O O
on O O
Os-Cal O O
250 O O
mg O O
PO O O
q.i.d. O O
On O O
postoperative O O
day O O
number O O
three O O
, O O
her O O
ionized O O
calcium O O
was O O
1.06 O O
and O O
her O O
Os-Cal O O
was O O
increased O O
to O O
500 O O
q.i.d. O O

However O O
, O O
her B-Disease O
ionized I-Disease O
calcium I-Disease O
decreased I-Disease O
to O O
0.97 O O
and O O
she O O
was O O
given O O
one O O
amp O O
of O O
calcium O O
gluconate O O
. O O

On O O
postoperative O O
day O O
number O O
five O O
, O O
the O O
patient O O
felt O O
fine O O
and O O
had O O
an O O
INR O O
of O O
1.9 O O
with O O
a O O
prothrombin O O
time O O
of O O
16.6 O O
. O O

Her O O
calcium O O
was O O
8.5 O O
, O O
albumin O O
3.6 O O
, O O
and O O
phosphate O O
4.5 O O
. O O

She O O
had O O
had O O
no O O
further O O
episodes O O
of O O
tingling B-Disease B-Disease
in I-Disease I-Disease
her I-Disease I-Disease
fingers I-Disease I-Disease
after O O
the O B-Disease
initial O I-Disease
episode O I-Disease
which O O
had O O
prompted O O
us O O
originally O O
to O O
draw O O
the O O
ionized O O
calcium O O
. O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

Good O O
. O O

MEDICATIONS O O
ON O O
DISCHARGE O O
: O O

1. O O
Coumadin O O
5 O O
mg O O
PO O O
q.day O O
, O O
then O O
she O O
will O O
follow O O
up O O
with O O
her O O
primary O O
care O O
physician O O
and O O
decide O O
the O O
dosage O O
thereafter O O
, O O

2. O O
Lopid O O
600 O O
mg O O
PO O O
b.i.d. O O
, O O

3. O O
K-Dur O O
20 O O
mg O O
PO O O
q.day O O
, O O

4. O O
Os-Cal O O
500 O O
mg O O
PO O O
q.i.d. O O
, O O

5. O O
Rocaltrol O O
0.25 O O
mg O O
PO O O
b.i.d. O O
, O O

6. O O
Lasix O O
40 O O
mg O O
PO O O
q.day O O
, O O

7. O O
Norvasc O O
5 O O
mg O O
PO O O
q.day O O
, O O

8. O O
Digoxin O O
.25 O O
mg O O
PO O O
q.day O O
, O O

9. O O
Lopressor O O
50 O O
mg O O
PO O O
b.i.d. O O
, O O

10. O O
Glucotrol O O
10 O O
mg O O
qam O O
. O O

FOLLOW O O
UP O O
: O O

For O O
follow O O
up O O
, O O
the O O
patient O O
is O O
to O O
call O O
for O O
an O O
appointment O O
with O O
Dr. O O
Sapmal O O
. O O

In O O
addition O O
, O O
she O O
is O O
to O O
follow O O
up O O
with O O
her O O
primary O O
care O O
physician O O
to O O
check O O
her O O
prothrombin O O
time O O
/ O O
INR O O
as O O
well O O
as O O
calcium O O
, O O
albumin O O
and O O
phosphate O O
levels O O
. O O

She O O
will O O
be O O
sent O O
home O O
with O O
home O O
Arnsperni O O
Health O O
. O O

LENNI O O
BREUTZOLN O O
, O O
M.D. O O

DICTATING O O
FOR O O
: O O

_____________________ O O
RIEEA O O
SAPMAL O O
, O O
M.D. O O

TR O O
: O O

hzu O O

DD O O
: O O

New O O
Years O O
Day O O

TD O O
: O O

01/06/97 O O
2:48 O O
P O O

cc O O
: O O

RIEEA O O
ODEE O O
SAPMAL O O
, O O
M.D. O O
CEALME O O
LEOE O O
MARESSYTHE O O
Dr. O O
Tokbelb O O
Welle O O
Health O O
Sonsant O O
. O O

Admission O O
Date O O
: O O

2016-11-21 O O

Discharge O O
Date O O
: O O

2016-11-30 O O

Date O O
of O O
Birth O O
: O O

1953-10-19 O O

Sex O O
: O O

M O O

Service O O
: O O

CMED O O
CCU O O

CHIEF O O
COMPLAINT O O
AND O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Mr. O O
Jackson O O
is O O
a O O
63-year-old O O
male O O
with O O
squamous B-Disease B-Disease
cell I-Disease I-Disease
carcinoma I-Disease I-Disease
of O I-Disease
the O I-Disease
floor O I-Disease
of O I-Disease
mouth O I-Disease
( O O
stage B-Disease O
T2 I-Disease O
N0 I-Disease O
) O O
that O O
was O O
biopsied O O
by O O
his O O
dentist O O
. O O

Pathology O O
was O O
reviewed O O
revealing O O
invasive B-Disease B-Disease
squamous I-Disease I-Disease
cell I-Disease I-Disease
carcinoma I-Disease I-Disease
. O O

He O O
presented O O
on O O
2016-11-21 O O
for O O
resection O O
. O O

He O O
was O O
admitted O O
on O O
2016-11-21 O O
following O O
his O O
surgery O O
. O O

He O O
underwent O O
a O O
joint O O
procedure O O
by O O
Otolaryngology O O
and O O
Plastic O O
Surgery O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Includes O O
hypertension B-Disease B-Disease
and O O
chronic B-Disease B-Disease
obstructive I-Disease I-Disease
pulmonary I-Disease I-Disease
Disease I-Disease I-Disease
. O O

PAST O O
SURGICAL O O
HISTORY O O
: O O

Polypectomy O O
in O O
2011 O O
, O O
tooth O O
extraction O O
( O O
all O O
) O O
in O O
1980 O O
, O O
and O O
hernia B-Disease B-Disease
in O O
1977 O O
. O O

ALLERGIES O O
: O O

TOMATO O O
( O O
causing O O
anaphylaxis B-Disease B-Disease
) O I-Disease
and O O
TETANUS O B-Disease
SHOT O I-Disease
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

Triamterene/hydrochlorothiazide O O
37.5/25 O O
mg O O
one O O
tablet O O
by O O
mouth O O
once O O
daily O O
and O O
lorazepam O O
1 O O
mg O O
three O O
times O O
daily O O
as O O
needed O O
( O O
for O O
anxiety B-Disease B-Disease
) O I-Disease
. O O

SOCIAL O O
HISTORY O O
: O O

He O O
has O O
a O O
half-pack O O
per O O
day O O
smoking O O
history O O
and O O
drinks O O
approximately O O
three O O
to O O
four O O
alcoholic O O
beverages O O
per O O
day O O
. O O

PROCEDURES O O
PERFORMED: O O

1. O O
Tracheostomy O O
. O O

2. O O
Diagnostic O O
laryngoscopy O O
and O O
biopsy O O
. O O

3. O O
Bilateral O O
supraomohyoid O O
neck O O
dissection O O
. O O

4. O O
Resection O O
of O O
floor O B-Disease
of O I-Disease
mouth B-Disease I-Disease
tumor I-Disease I-Disease
. O O

SUMMARY O O
OF O O
HOSPITAL O O
COURSE O O
: O O

Surgeon O O
was O O
Dr. O O
Kelsey O O
K O O
Sanchez O O
. O O

Assistant O O
was O O
Dr. O O
Justin O O
K.. O O
Velez O O
. O O

Frozen O O
section O O
sent O O
to O O
pathology O O
revealing O O
invasive B-Disease B-Disease
squamous I-Disease I-Disease
cell I-Disease I-Disease
carcinoma I-Disease I-Disease
. O O

No O O
complications B-Disease B-Disease
. O O

The O O
Plastic O O
Team O O
then O O
took O O
over O O
for O O
reconstruction O O
consisting O O
of O O
radial O O
forearm O O
free O O
flap O O
to O O
floor O O
of O O
mouth O O
. O O

Surgeon O O
was O O
Dr. O O
Jude. O O
Christopher O O
Swinney O O
. O O

Total O O
intravenous O O
fluids O O
of O O
7300 O O
cc O O
. O O

Estimated B-Disease B-Disease
blood I-Disease I-Disease
loss I-Disease I-Disease
of O O
300 O O
cc O O
. O O

Urine O O
output O O
of O O
900 O O
cc O O
. O O

No O O
complications B-Disease B-Disease
. O O

In O O
addition O O
, O O
the O O
patient O O
was O O
prepared O O
for O O
an O O
attempted O O
percutaneous O O
endoscopic O O
gastrostomy O O
tube O O
. O O

The O O
percutaneous O O
endoscopic O O
gastrostomy O O
was O O
unsuccessful O O
, O O
and O O
the O O
procedure O O
was O O
converted O O
to O O
an O O
open O O
gastrostomy O O
tube O O
which O O
then O O
proceeded O O
without O O
complications B-Disease B-Disease
. O O

The O O
patient O O
was O O
admitted O O
to O O
the O O
Surgical O O
Intensive O O
Care O O
Unit O O
postoperatively O O
. O O

He O O
was O O
sedated O O
and O O
ventilated O O
by O O
his O O
tracheostomy O O
6 O O
cuff O O
Shiley O O
tube O O
. O O

He O O
had O O
three O O
Westwood-Pocasset O O
drains O O
- O O
two O O
in O O
the O O
neck O O
and O O
one O O
in O O
his O O
right O O
arm O O
. O O

G-tube O O
was O O
to O O
gravity O O
, O O
Foley O O
to O O
gravity O O
, O O
left O O
radial O O
A-line O O
. O O

The O O
flap O O
was O O
pink O O
with O O
a O B-Disease
strong O I-Disease
Doppler O I-Disease
signal O I-Disease
. O O

He O O
underwent O O
flap O O
checks O O
every O O
15 O O
minutes O O
initially O O
with O O
a O O
dextran O O
infusion O O
. O O

He O O
was O O
placed O O
on O O
Unasyn O O
3 O O
grams O O
IV O O
q.6h. O O

Nothing O O
by O O
mouth O O
initially O O
with O O
morphine O O
as O O
needed O O
for O O
pain B-Disease B-Disease
and O O
Ativan O O
around O O
the O O
clock O O
for O O
delirium O O
tremens O O
prophylaxis O O
. O O

In O O
addition O O
, O O
he O O
received O O
metoprolol O O
q.4.h. O O
, O O
a O O
regular O O
insulin O O
sliding O O
scale O O
, O O
and O O
adequate O O
gastrointestinal O O
prophylaxis O O
with O O
Protonix O O
. O O

Postoperative O O
laboratories O O
revealed O O
sodium O O
was O O
134 O O
, O O
potassium O O
was O O
4.1 O O
, O O
chloride O O
was O O
102 O O
, O O
bicarbonate O O
was O O
28 O O
, O O
blood O O
urea O O
nitrogen O O
was O O
18 O O
, O O
creatinine O O
was O O
0.8 O O
, O O
and O O
glucose O O
was O O
148 O O
. O O

Calcium O O
was O O
7.6 O O
. O O

Magnesium O O
was O O
2.2 O O
. O O

Complete O O
blood O O
count O O
revealed O O
white O O
count O O
was O O
5.4 O O
, O O
hematocrit O O
was O O
31.3 O O
, O O
and O O
platelets O O
were O O
160 O O
. O O

ALT O O
was O O
14 O O
, O O
AST O O
was O O
31 O O
, O O
alkaline O O
phosphatase O O
was O O
42 O O
, O O
total O O
bilirubin O O
was O O
0.9 O O
, O O
albumin O O
was O O
2.2 O O
. O O

A O O
chest O O
x-ray O O
postoperatively O O
showed O O
clear O B-Disease
lung O I-Disease
fields O I-Disease
. O O

Tracheostomy O O
tube O O
in O O
good O O
position O O
. O O

No O O
pneumothorax B-Disease B-Disease
. O O

By O O
systems O O
: O O

CMED O O
CSRU O O
and O O
Plastic O O
Surgery O O
flap O O
checks O O
, O O
tracheostomy O O
care O O
, O O
and O O
Westwood-Pocasset O O
management. O O

Cardiovascular O O
: O O

Lopressor O O
5 O O
intravenously O O
q.4.h. O O

Respiratory O O
: O O

Nebulizers O O
as O O
needed O O
, O O
weaning O O
from O O
ventilation O O
. O O

Gastrointestinal O O
: O O

Medications O O
per O O
gastrostomy O O
tube O O
on O O
postoperative O O
day O O
one O O
. O O

Genitourinary O O
: O O

Foley O O
catheter O O
for O O
strict O O
monitoring O O
of O O
ins O O
and O O
outs O O
. O O

Hematologic O O
: O O

Hematocrit O O
stable O O
. O O

Infectious O O
Disease O O
: O O

Unasyn O O
for O O
antibiotic O O
coverage O O
. O O

Flap O O
checks O O
carried O O
out O O
q.2h. O O
initially O O
in O O
the O O
Surgical O O
Intensive O O
Care O O
Unit O O
showing O O
positive B-Disease B-Disease
biphasic I-Disease I-Disease
Doppler I-Disease I-Disease
signals I-Disease I-Disease
. O O

Pink O O
flap O O
with O O
good O O
refill O O
. O O

Right O O
arm O O
neurovascularly O O
intact O O
. O O

He O O
was O O
weaned O O
from O O
ventilation O O
on O O
postoperative O O
day O O
one O O
to O O
pressure O O
support O O
ventilation O O
and O O
then O O
to O O
spontaneous O O
breathing O O
on O O
postoperative O O
day O O
two O O
. O O

His O O
Westwood-Pocasset O O
output O O
for O O
postoperative O O
day O O
one O O
on O O
the O O
left O O
was O O
60 O O
, O O
right O O
neck O O
93 O O
, O O
in O O
the O O
arm O O
20 O O
. O O

Tube O O
feedings O O
were O O
started O O
48 O O
hours O O
after O O
the O O
procedure O O
. O O

The O O
cuff O O
on O O
his O O
tracheostomy O O
tube O O
was O O
put O O
down O O
on O O
11-23 O O
, O O
postoperative O O
day O O
two O O
which O O
he O O
tolerated O O
well O O
with O O
minimal B-Disease B-Disease
secretions I-Disease I-Disease
and O O
a O B-Disease
strong O I-Disease
adequate O I-Disease
cough O I-Disease
. O O

Due O O
to O O
bed O O
issues O O
, O O
he O O
was O O
transferred O O
from O O
the O O
Surgical O O
Intensive O O
Care O O
Unit O O
to O O
the O O
Medical O O
Intensive O O
Care O O
Unit O O
on O O
postoperative O O
day O O
three O O
. O O

His O O
tube O O
feedings O O
were O O
advanced O O
. O O

He O O
was O O
out O O
of O O
bed O O
to O O
a O O
chair O O
. O O

He O O
continued O O
with O O
pulmonary O O
toilet O O
and O O
q.2h. O O
flap O O
checks O O
. O O

The O O
Westwood-Pocasset O O
in O O
his O O
right O O
arm O O
was O O
removed O O
on O O
2016-11-25 O O
. O O

His O O
tracheostomy O O
was O O
changed O O
to O O
a O O
6 O O
cuffless O O
Shiley O O
on O O
2016-11-26 O O
and O O
sutures O O
in O O
place O O
with O O
a O O
3-0 O O
silk O O
. O O

The O O
patient O O
tolerated O O
this O O
procedure O O
well O O
. O O

This O O
is O O
the O O
end O O
of O O
part O O
1 O O
of O O
this O O
dictation O O
summary O O
for O O
Patricia O O
Jackson O O
. O O

To O O
be O O
continued O O
in O O
a O O
separate O O
dictation O O
. O O

Nola O O
Daniel O O
, O O
Hawaii O O
31699 O O

Dictated O O
By:Joe O O
C. O O
Roa O O
, O O
M.D. O O

MEDQUIST36 O O

D O O
: O O

2016-11-30 O O
10:56:11 O O

T O O
: O O

2016-11-30 O O
11:44:01 O O

Job# O O
: O O

77004 O O

Signed O O
electronically O O
by O O
: O O

DR. O O
Michael O O
Z O O
Waldroup O O
on O O
: O O

MON O O
2016-12-19 O O
10:13 O O
AM O O

( O O
End O O
of O O
Report O O
) O O

Admission O O
Date O O
: O O

2017-08-14 O O

Discharge O O
Date O O
: O O

2017-08-23 O O

Date O O
of O O
Birth O O
: O O

1943-08-23 O O

Sex O O
: O O

M O O

Service O O
: O O

MEDICINE O O

Allergies O O
: O O

Sulfonamides O O

Attending O O
: O O
Marcus O O
W. O O
Kelley O O
, O O
M.D. O O

Chief O O
Complaint O O
: O O

Transfer O O
from O O
Athol O O
Memorial O O
Hospital O O
for O O
acute O B-Disease
on O I-Disease
chronic B-Disease I-Disease
respiratory I-Disease I-Disease
distress I-Disease I-Disease
. O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

Lumbar O O
puncture O O
on O O
08-16 O O

History O O
of O O
Present O O
Illness O O
: O O

Mr. O O
Lockley O O
is O O
a O O
73 O O
yo O O
male O O
with O O
a O O
complicated O O
past O O
medical O O
history O O
, O O
recently O O
discharged O O
from O O
St. O O
Margaret O O
's O O
Center O O
for O O
Women O O
& O O
Infants O O
on O O
08-02 O O
following O O
a O O
prolonged O O
admission O O
for O O
STEMI B-Disease B-Disease
, O O
respiratory B-Disease B-Disease
failure I-Disease I-Disease
felt O O
secondary O O
to O O
pulmonary B-Disease B-Disease
edema I-Disease I-Disease
requiring O O
intubation O O
and O O
subsequent O O
tracheostomy O O
02-22 O O
failure B-Disease B-Disease
to I-Disease I-Disease
wean I-Disease I-Disease
, O O
sepsis B-Disease B-Disease
and O O
C.difficile B-Disease B-Disease
colitis I-Disease I-Disease
treated O O
with O O
Vancomycin O O
and O O
Flagyl O O
with O O
a O O
course O O
of O O
Levophed O O
. O O

He O O
was O O
discharged O O
to O O
Athol O O
Memorial O O
Hospital O O
for O O
continued O O
weaning O O
. O O

Per O O
Dr. O O
John O O
C. O O
Corrigan O O
Mental O O
Health O O
Center O O
, O O
patient O O
remained O O
ventilator B-Disease B-Disease
dependent I-Disease I-Disease
, O O
intermittently O O
on O O
PS O O
20/5 O O
and O O
back O O
on O O
AC O O
15/5/500/0.35 O O
on O O
08-08 O O
. O O

At O O
OSH O O
, O O
sputum O O
cultures O O
grew O O
Pseudomonas B-Disease B-Disease
and O O
MRSA B-Disease B-Disease
, O O
and O O
he O O
was O O
restarted O O
on O O
Zosyn O O
( O O
08-08 O O
) O O
and O O
Vancomycin O O
( O O
08-09 O O
). O O

He O O
completed O O
his O O
course O O
of O O
Vancomycin O O
on O O
2017-08-10 O O
. O O

However O O
, O O
today O O
around O O
17:45 O O
, O O
while O O
being O O
moved O O
by O O
the O O
nursing O O
staff O O
, O O
Mr. O O
Lockley O O
Bosche O O
started O O
coughing B-Disease B-Disease
. O O

Suctioned O O
X O O
1 O O
, O O
mucus O O
not O O
cleared O O
. O O

He O O
then O O
became O O
dusky B-Disease B-Disease
and O O
cyanotic B-Disease B-Disease
, O O
and O O
stopped B-Disease O
breathing I-Disease O
on O O
his O O
own O O
. O O

A O O
code O O
was O O
called O O
, O O
+ O O
pulse O O
. O O

Patient O O
placed O O
on O O
FiO2 O O
100% O O
. O O

Vitals O O
reportedly O O
HR O O
88-98 O O
, O O
BP O O
150/80 O O
. O O

ABG O O
done O O
on O O
FiO2 O O
100% O O
7.36/66/417/98% O O
. O O

At O O
Vencor O O
Hospital O O
, O O
BP B-Disease O
dropped I-Disease O
to O O
90 O O
, O O
and O O
patient O O
was O O
started O O
on O O
NS O O
IVF O O
, O O
with O O
improvement O O
in O O
BP O O
. O O

EKG O O
without O O
acute B-Disease B-Disease
changes I-Disease I-Disease
. O O

He O O
was O O
transferred O O
to O O
St. O O
Margaret O O
's O O
Center O O
for O O
Women O O
& O O
Infants O O
John O O
for O O
further O O
management O O
on O O
AC O O
, O O
RR O O
15 O O
, O O
PEEP O O
5 O O
, O O
Vt O O
500 O O
, O O
Fi02 O O
1.0 O O
. O O

In O O
John O O
, O O
BP O O
80/60 O O
, O O
HR O O
80 O O
. O O

Continued O O
on O O
IVF O O
( O O
received O O
total O O
2300 O O
cc O O
) O O
, O O
with O O
improved O O
BP O O
to O O
SBP O O
105-118 O O
. O O

Stool O O
sent O O
for O O
C.diff B-Disease O
and O O
given O O
Flagyl O O
500 O O
mg O O
PO O O
X O O
1 O O
dose O O
. O O

Past O O
Medical O O
History O O
: O O

1. O O
Non-small B-Disease B-Disease
cell I-Disease I-Disease
lung I-Disease I-Disease
cancer I-Disease I-Disease
s/p O O
XRT O O
and O O
chemotherapy O O
in O O
French O O
Guiana O O
, O O
s/p O O
right O O
pneumonectomy O O
in O O
2016-09-21 O O
for O O
recurrence B-Disease B-Disease
. O O

Chronic B-Disease B-Disease
left I-Disease I-Disease
pleural I-Disease I-Disease
effusion I-Disease I-Disease
. O O

2. O O
SSS B-Disease O
status O O
post O O
PM/ICD O O
placement O O

3. O O
COPD/bronchiectasis B-Disease B-Disease

4. O O
Hypertension B-Disease B-Disease

5. O O
CAD B-Disease B-Disease
, O O
with O O
known O O
TO O O
RCA O O
. O O

6. O O
CHF B-Disease B-Disease
with O O
EF O O
25% O O
on O O
last O O
echo O O
on O O
2017-07-19 O O

7. O O
BPH B-Disease B-Disease

8. O O
Depression B-Disease B-Disease

9. O O
Left B-Disease B-Disease
femoral I-Disease I-Disease
AV I-Disease I-Disease
fistula I-Disease I-Disease
2017-04-19 O O

10. O O
Recent B-Disease B-Disease
MRSA I-Disease I-Disease
pneumonia I-Disease I-Disease
and O O
sepsis B-Disease B-Disease
2017-07-21 O O
, O O
treated O O
with O O
Vancomycin O O

11. O O
C. B-Disease B-Disease
difficile I-Disease I-Disease
colitis I-Disease I-Disease
treated O O
with O O
Flagyl O O
( O O
completed O O
08-10 O O
) O O

12. O O
Status O O
post O O
PEG O O
tube O O
placement O O
2017-07-21 O O

13. O O
Status O O
post O O
tracheostomy O O
2017-07-21 O O
02-22 O O
failure B-Disease B-Disease
to I-Disease I-Disease
wean I-Disease I-Disease

14. O O
Status O O
post O O
partial O O
colectomy O O
1972 O O

Social O O
History O O
: O O

Son O O
is O O
next O O
of O O
kin O O
. O O

See O O
below O O
for O O
contact O O
information O O
. O O

He O O
has O O
been O O
living O O
at O O
The O O
Cooley O O
Dickinson O O
Hospital O O
House O O
since O O
2017-08-02 O O
. O O

Per O O
Dr. O O
John O O
C. O O
Corrigan O O
Mental O O
Health O O
Center O O
, O O
at O O
baseline O O
, O O
patient O O
not O O
interactive O O
. O O

Opens O O
eyes O O
spontaneously O O
, O O
withdraws O O
to O O
painful O O
stimulus O O
. O O

Family O O
History O O
: O O

Non-contributory O O

Physical O O
Exam O O
: O O

PHYSICAL O O
EXAM O O
on O O
admission O O
: O O

VITALS O O
: O O

BP O O
90s-118/47-59 O O
, O O
HR O O
80-90s O O
. O O

Vent O O
: O O

AC O O
, O O
RR O O
15 O O
, O O
PEEP O O
5 O O
, O O
Vt O O
500 O O
cc O O
, O O
FiO2 O O
1.0 O O
. O O

GEN O O
: O O

Intubated O O
, O O
opens O O
eyes O O
, O O
responds O O
to O O
painful O O
stimulus O O
. O O

HEENT O O
: O O

Pupils B-Disease O
minimally I-Disease O
reactive I-Disease O
. O O

Sclera B-Disease B-Disease
anicteric I-Disease I-Disease
. O O

NECK O O
: O O

Unable O O
to O O
assess O O
JVP O O
. O O

RESP O O
: O O

Bronchial B-Disease O
breathing I-Disease O
over I-Disease O
right I-Disease O
hemithorax I-Disease O
. O O

Ronchorous B-Disease B-Disease
breath I-Disease I-Disease
sounds I-Disease I-Disease
left I-Disease I-Disease
chest I-Disease I-Disease
. O O

Limited O O
examination O O
. O O

CVS O O
: O O

RRR O O
. O O

Normal O O
S1 O O
, O O
S2 O O
. O O

+ O O
S4 B-Disease O
. O O

No O O
murmur B-Disease B-Disease
appreciated O O
. O O

GI O O
: O O

PEG O O
in O O
place O O
, O O
site O O
without O O
drainage B-Disease O
. O O

BS O O
present O O
, O O
hypoactive B-Disease B-Disease
. O O

Abdomen O O
soft O O
. O O

No O O
grimacing B-Disease B-Disease
with O O
palpation O O
. O O

CMED O O
: O O

Foley O O
in O O
place O O
. O O

EXT O O
: O O

2+ B-Disease O
edema I-Disease B-Disease
both I-Disease I-Disease
upper I-Disease I-Disease
extremities I-Disease I-Disease
, O O
sacral B-Disease B-Disease
edema I-Disease I-Disease
. O O

Cool B-Disease O
extremities I-Disease O
. O O

Good O O
pedal O O
pulses O O
peripherally O O
. O O

NEURO O O
: O O

Limited O O
examination O O
. O O

Withdraws O O
to O O
painful O O
stimulus O O
. O O

Moves O O
all O O
4 O O
extremities O O
. O O

Pertinent O O
Results O O
: O O

LABS O O
: O O

WBC O O
- O O
4.9 O O
RBC O O
- O O
2.92 O O
* O O
HGB O O
- O O
8.8 O O
* O O
HCT O O
- O O
26.2 O O
* O O
MCV O O
- O O
90 O O
MCH O O
- O O
30.1 O O
MCHC O O
- O O
33.5 O O
RDW O O
- O O
18.5 O O
* O O
NEUTS O O
- O O
86.5 O O
* O O
LYMPHS O O
- O O
7.5 O O
* O O
MONOS O O
- O O
4.7 O O
EOS O O
- O O
1.2 O O
BASOS O O
- O O
0.1 O O
PLT O O
COUNT O O
- O O
145 O O
* O O
GLUCOSE O O
- O O
91 O O
UREA O O
N O O
- O O
21 O O
* O O
CREAT O O
- O O
0.6 O O
SODIUM O O
- O O
143 O O
POTASSIUM O O
- O O
4.2 O O
CHLORIDE O O
- O O
106 O O
TOTAL O O
CO2 O O
- O O
32 O O
ANION O O
GAP O O
- O O
9 O O
LACTATE O O
- O O
1.4 O O
K+ O O
- O O
3.9 O O

ABG O O
: O O

2017-08-14 O O
07:30 O O
PM O O
TYPE O O
- O O
ART O O
PO2 O O
- O O
468 O O
* O O
PCO2 O O
- O O
44 O O
PH O O
- O O
7.50 O O
* O O
TOTAL O O
CO2 O O
- O O
36 O O
* O O
BASE O O
XS O O
- O O
10 O O
INTUBATED O O
- O O
INTUBATED O O

EKG O O
( O O
at O O
Athol O O
Memorial O O
Hospital O O
, O O
17:11 O O
) O O
: O O

Atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
, O O
occasional O O
V-paced O O
, O O
rate O O
74 O O
. O O

Normal O O
axis O O
. O O

Old B-Disease O
TWI I-Disease O
V4-6 I-Disease O
. O O

EKG O O
in O O
John O O
: O O

Afib B-Disease B-Disease
, O O
occasional O O
V-paced O O
, O O
rate O O
83 O O
bpm O O
. O O

Normal O O
axis O O
. O O

Long B-Disease O
QT I-Disease O
interval I-Disease O
( O O
QTc O O
462 O O
ms O O
). O O

ST B-Disease B-Disease
depressions I-Disease I-Disease
V4 I-Disease I-Disease
, I-Disease O
5 I-Disease O
. O O

Mild B-Disease B-Disease
ST I-Disease I-Disease
elevation I-Disease I-Disease
in I-Disease I-Disease
V3 I-Disease I-Disease
. O O

Old B-Disease O
TWI I-Disease O
V4-6 I-Disease O
. O O

**************** O O

IMAGING O O
: O O

2017-08-14 O O
CXR O O
: O O

ETT O O
in O O
correct O O
position O O
. O O

PM O O
wires O O
in O O
good O O
position O O
. O O

S/p O O
right O O
pneumonectomy O O
. O O

Blunting B-Disease O
of I-Disease O
left I-Disease B-Disease
CPA I-Disease I-Disease
likely O I-Disease
effusion B-Disease I-Disease
. O O

New B-Disease B-Disease
lower I-Disease I-Disease
left I-Disease I-Disease
lateral I-Disease I-Disease
CW I-Disease I-Disease
opacity I-Disease I-Disease
, O O
likely O O
loculated B-Disease B-Disease
pleural I-Disease I-Disease
fluid I-Disease I-Disease
. O O

2017-07-19 O O
ECHO O O
: O O

Left-to-right B-Disease O
shunt I-Disease O
across I-Disease O
the I-Disease O
interatrial I-Disease O
septum I-Disease O
. O O

LVEF O O
25% O O
. O O

Resting O O
WMA O O
include O O
mid B-Disease B-Disease
to I-Disease I-Disease
distal I-Disease I-Disease
septal I-Disease I-Disease
akinesis I-Disease I-Disease
, O O
apical B-Disease B-Disease
akinesis I-Disease I-Disease
, O O
inferior B-Disease B-Disease
akinesis/hypokinesis I-Disease I-Disease
, O O
and O O
mid B-Disease B-Disease
to I-Disease I-Disease
distal I-Disease I-Disease
anterolateral I-Disease I-Disease
hypokinesis I-Disease I-Disease
/ O O
akinesis B-Disease B-Disease
. O O

No O O
definite O B-Disease
apical B-Disease I-Disease
thrombus I-Disease I-Disease
seen O O
( O O
cannot O O
exclude O O
). O O

01-22+ O O
AR B-Disease O
. O O

Trivial B-Disease B-Disease
MR I-Disease I-Disease
. O O

1+ O O
TR B-Disease O
. O O

2017-08-16 O O
CT O O
head O O
: O O

New B-Disease B-Disease
rounded I-Disease I-Disease
low-density I-Disease I-Disease
area I-Disease I-Disease
measuring O O
2.5 O O
cm O O
in O O
left O O
basal O O
ganglia O O
, O O
which O O
partially O O
extends O O
to O O
the O O
left O O
thalamus O O
, O O
probably O O
representing O O
subacute B-Disease B-Disease
infarction I-Disease I-Disease
. O O

On O O
this O O
head O O
CT O O
without O O
contrast O O
, O O
the O O
evaluation O O
is O O
limited O O
. O O

2017-08-16 O O
CTA O O
chest O O
: O O

No O O
evidence O O
for O O
pulmonary B-Disease B-Disease
embolism I-Disease I-Disease
. O O

Findings O O
consistent O O
with O O
failure B-Disease B-Disease
or O O
fluid B-Disease B-Disease
overload I-Disease I-Disease
. O O

Development O O
of O O
small B-Disease B-Disease
loculated I-Disease I-Disease
pleural I-Disease I-Disease
fluid I-Disease I-Disease
collection I-Disease I-Disease
along I-Disease I-Disease
the I-Disease I-Disease
periphery I-Disease I-Disease
of O I-Disease
the O I-Disease
left O I-Disease
major O I-Disease
fissure O I-Disease
or O O
so-called B-Disease B-Disease
pseudotumor I-Disease I-Disease
, O O
consistent O O
with O O
the O O
recent O O
chest O O
x-ray O O
. O O

Unchanged O O
appearance O O
of O O
right O O
pneumonectomy O O
. O O

2017-08-16 O O
ECHO O O
: O O

The O O
left O O
atrium O O
is O O
normal O O
in O O
size O O
. O O

Overall O O
LVEF O O
is O O
difficult O O
to O O
assess O O
due O O
to O O
poor O B-Disease
echo O I-Disease
windows O I-Disease
although O O
the O O
basal O O
LV O O
appeas O O
hyperdynamic B-Disease B-Disease
without O O
regional B-Disease B-Disease
contraction I-Disease I-Disease
abnormality I-Disease I-Disease
( O O
suspect O O
significant O O
improvement O O
compared O O
to O O
prior O O
study O O
dated O O
2017-07-18 O O
). O O

No O O
masses B-Disease B-Disease
or O O
thrombi B-Disease B-Disease
are O O
seen O O
in O O
the O O
left O O
ventricle O O
( O O
due O O
to O O
poor O B-Disease
echo O I-Disease
windows O I-Disease
cannot O O
fully O O
exclude O O
). O O

The O O
ascending O O
aorta O O
is O O
mildly B-Disease B-Disease
dilated I-Disease I-Disease
. O O

There O O
is O O
no O O
aortic B-Disease B-Disease
valve I-Disease I-Disease
stenosis I-Disease I-Disease
. O O

Mild B-Disease B-Disease
( I-Disease I-Disease
1+ I-Disease I-Disease
) I-Disease I-Disease
aortic I-Disease I-Disease
regurgitation I-Disease I-Disease
is O O
seen O O
. O O

Trivial B-Disease B-Disease
mitral I-Disease I-Disease
regurgitation I-Disease I-Disease
is O O
seen O O
. O O

The O O
left O O
ventricular O O
inflow O O
pattern O O
suggests O O
impaired B-Disease B-Disease
relaxation I-Disease I-Disease
. O O

There O O
is O O
a B-Disease B-Disease
small I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
. O O

There O O
are O O
no O O
echocardiographic O O
signs O O
of O O
tamponade B-Disease B-Disease

2017-08-17 O O
EEG O O
: O O

Markedly B-Disease B-Disease
abnormal I-Disease I-Disease
portable I-Disease I-Disease
EEG I-Disease I-Disease
due O O
to O O
the B-Disease B-Disease
voltage I-Disease I-Disease
suppression I-Disease I-Disease
over I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
hemisphere I-Disease I-Disease
and O O
due O O
to O O
the B-Disease O
bursts I-Disease O
of I-Disease O
generalized I-Disease B-Disease
slowing I-Disease I-Disease
and O O
right B-Disease B-Disease
hemisphere I-Disease I-Disease
slowing I-Disease I-Disease
. O O

The B-Disease B-Disease
first I-Disease I-Disease
abnormality I-Disease I-Disease
raises O O
the O O
possibility O O
of O O
material B-Disease B-Disease
( I-Disease O
such I-Disease O
as I-Disease O
subdural I-Disease O
fluid I-Disease O
) I-Disease O
interposed I-Disease O
between I-Disease O
the I-Disease O
brain I-Disease O
and O O
recording O O
electrodes O O
or O O
widespread B-Disease B-Disease
cortical I-Disease I-Disease
dysfunction I-Disease I-Disease
on I-Disease I-Disease
that I-Disease I-Disease
side I-Disease I-Disease
. O O

Anatomic O O
correlation O O
would O O
be O O
of O O
interest O O
if O O
clinically O O
indicated O O
. O O

The B-Disease B-Disease
generalized I-Disease I-Disease
slowing I-Disease I-Disease
indicates O O
a B-Disease B-Disease
non I-Disease I-Disease
specific I-Disease I-Disease
dysfunction I-Disease I-Disease
in I-Disease I-Disease
midline I-Disease I-Disease
structures I-Disease I-Disease
. O O

There O O
was O O
also O O
evidence O O
of O O
subcortical B-Disease B-Disease
dysfunction I-Disease I-Disease
on I-Disease I-Disease
the I-Disease I-Disease
right I-Disease I-Disease
side I-Disease I-Disease
. O O

No O O
epileptiform B-Disease B-Disease
features I-Disease I-Disease
were O O
seen O O
. O O

MICRO O O
DATA O O
: O O

2017-08-17 O O
STOOL O O
CLOSTRIDIUM O O
DIFFICILE O O
TOXIN O O
ASSAY O O
- O O
PENDING O O

2017-08-16 O O
CSF O O
; O O
SPINAL O O
FLUID O O
GRAM O O
STAIN O O
- O O
neg O O
FLUID O O
CULTURE O O
- O O
neg O O
; O O
FUNGAL O O
CULTURE O O
- O O
PENDING O O
; O O
ACID O O
FAST O O
CULTURE O O
- O O
PENDING O O
; O O
VIRAL O O
CULTURE O O
- O O
PENDING O O

2017-08-15 O O
SPUTUM O O
CULTURE O O
- O O
PRELIMINARY O O
{ O O
PSEUDOMONAS B-Disease O
AERUGINOSA I-Disease O
} O O

2017-08-15 O O
BLOOD O O
CULTURE O O
NGTD O O

2017-08-15 O O
URINE O O
CULTURE O O
- O O
FINAL O O

2017-08-15 O O
BLOOD O O
CULTURE O O
NGTD O O

Brief O O
Hospital O O
Course O O
: O O

Mr. O O
Lockley O O
was O O
admitted O O
with O O
respiratory B-Disease B-Disease
failure I-Disease I-Disease
, O O
thought O O
to O O
be O O
related O O
to O O
mucus B-Disease B-Disease
plugging I-Disease I-Disease
as O O
well O O
as O O
a B-Disease B-Disease
pseudomonal I-Disease I-Disease
pneumonia I-Disease I-Disease
. O O

Both O O
of O O
these O B-Disease
etiologies O I-Disease
were O O
treated O O
, O O
and O O
he O O
continued O O
to O O
oxygenate O O
and O O
ventilate O O
well O O
on O O
his O O
usual O O
ventilator O O
settings O O
. O O

However O O
, O O
the O O
issue O O
that O O
dominated O O
the O O
admission O O
was O O
his B-Disease B-Disease
recent I-Disease I-Disease
acute I-Disease I-Disease
decline I-Disease I-Disease
in I-Disease I-Disease
mental I-Disease I-Disease
status I-Disease I-Disease
. O O

He O O
was O O
thoroughly O O
evaluated O O
by O O
neurology O O
and O O
underwent O O
head O O
CT O O
, O O
MRI O O
, O O
LP O O
, O O
and O O
EEG O O
. O O

This O O
work-up O O
demonstrated O O
a B-Disease B-Disease
small I-Disease I-Disease
left I-Disease I-Disease
basal I-Disease I-Disease
ganglia I-Disease I-Disease
infarct I-Disease I-Disease
, O O
likely O O
cardioembolic B-Disease B-Disease
. O O

However O O
, O O
they O O
felt O O
this O B-Disease
event O I-Disease
could O O
not O O
account O O
for O O
his B-Disease B-Disease
new I-Disease I-Disease
, I-Disease I-Disease
severe I-Disease I-Disease
global I-Disease I-Disease
deficit I-Disease I-Disease
; O O
this O O
was O O
thought O O
to O O
be O O
secondary O O
to O O
a B-Disease B-Disease
more I-Disease I-Disease
pervasive I-Disease I-Disease
process I-Disease I-Disease
, O O
likely O O
anoxic B-Disease B-Disease
encephalopathy I-Disease I-Disease
, O O
for O O
which O O
the O O
prognosis O O
is O O
extremely O O
grim O O
. O O

This O O
was O O
discussed O O
at O O
length O O
in O O
several O O
family O O
meetings O O
involving O O
the O O
patient O O
's O O
wife O O
, O O
son O O
, O O
primary O O
care O O
doctor O O
, O O
ICU O O
attending O O
, O O
and O O
neurology O O
consultant O O
in O O
the O O
presence O O
of O O
a O O
Asian O O
interpreter O O
. O O

The O O
end O O
result O O
of O O
these O O
discussion O O
was O O
that O O
the O O
patient O O
's O O
wishes O O
would O O
not O O
be O O
consistent O O
with O O
this O O
new O O
level O O
of O O
functioning O O
from O O
which O O
he O O
had O O
little O O
hope O O
of O O
recovery O O
; O O
the O O
family O O
decided O O
to O O
make O O
him O O
comfort O O
measures O O
only O O
. O O

He O O
was O O
disconnected O O
from O O
the O O
ventilator O O
and O O
all O O
medications O O
beyond O O
a O O
morphine O O
drip O O
were O O
stopped O O
, O O
and O O
he O O
expired O O
shortly O O
thereafter O O
. O O

The O O
family O O
was O O
present O O
. O O

Medications O O
on O O
Admission O O
: O O

Jevity O O
1.2 O O
65 O O
mL O O
/ O O
hour O O
continuous O O
with O O
water O O
240 O O
cc O O
q O O
8 O O
hours O O

Lasix O O
40 O O
mg O O
IV O O
QAM O O
( O O
given O O
08-14 O O
) O O

Vancomycin O O
1 O O
gm O O
IV O O
q O O
36 O O
hours O O
( O O
last O O
dose O O
at O O
2000 O O
on O O
08-13 O O
) O O
. O O

Started O O
on O O
08-09 O O
) O O

ASA O O
325 O O
mg O O
PO O O
QD O O

Lansoprazole O O
30 O O
mg O O
PO O O
QAM O O

Heparin O O
5000 O O
units O O
SC O O
TID O O

Zosyn O O
4.5 O O
gm O O
IV O O
q O O
8 O O
hours O O
( O O
last O O
dose O O
on O O
08-14 O O
at O O
1400 O O
) O O
, O O
started O O
08-08 O O
. O O

Metoprolol O O
37.5 O O
mg O O
q O O
12 O O
hours O O
( O O
last O O
dose O O
07/25 O O
in O O
AM O O
) O O

Protein O O
/ O O
Soy O O
supplement O O
2 O O
scoops O O
q O O
12 O O
hours O O

Ipratropium O O
/ O O
Albuterol O O
inhaler O O
4 O O
puffs O O
QID O O

Completed O O
course O O
of O O
Flagyl O O
07-25 O O
--> O O
08-10 O O
. O O

Discharge O O
Disposition O O
: O O

Expired O O

Discharge O O
Diagnosis O O
: O O

Anoxic B-Disease B-Disease
encephalopathy I-Disease I-Disease

Acute B-Disease B-Disease
respiratory I-Disease I-Disease
failure I-Disease I-Disease

Chronic B-Disease B-Disease
respiratory I-Disease I-Disease
failure I-Disease I-Disease

Pseudomonal B-Disease B-Disease
pneumonia I-Disease I-Disease

Volume B-Disease B-Disease
overload I-Disease I-Disease

Chronic B-Disease B-Disease
obstructive I-Disease I-Disease
pulmonary I-Disease I-Disease
Disease I-Disease I-Disease

Bronchiectasis B-Disease B-Disease

Hyponatremia B-Disease B-Disease

Anemia B-Disease B-Disease
of I-Disease O
chronic I-Disease B-Disease
Disease I-Disease I-Disease

Secondary O O
: O O

1. O O
Non-small B-Disease B-Disease
cell I-Disease I-Disease
lung I-Disease I-Disease
cancer I-Disease I-Disease
s/p O O
XRT O O
and O O
chemotherapy O O
in O O
Western O O
Sahara O O
, O O
s/p O O
right O O
pneumonectomy O O
in O O
2016-09-21 O O
for O O
recurrence B-Disease O
. O O

Chronic B-Disease B-Disease
left I-Disease I-Disease
pleural I-Disease I-Disease
effusion I-Disease I-Disease
. O O

2. O O
Sick B-Disease B-Disease
Sinus I-Disease I-Disease
Syndrome I-Disease I-Disease
status O O
post O O
PM/ICD O O
placement O O

3. O O
COPD/bronchiectasis B-Disease B-Disease

4. O O
Hypertension B-Disease B-Disease

5. O O
CAD B-Disease B-Disease
, O O
with O O
known O O
TO O O
RCA O O
. O O

6. O O
CHF B-Disease B-Disease
with O O
EF O O
25% O O
on O O
last O O
echo O O
on O O
2017-07-19 O O

7. O O
BPH B-Disease B-Disease

8. O O
Depression B-Disease B-Disease

9. O O
Left B-Disease B-Disease
femoral I-Disease I-Disease
AV I-Disease I-Disease
fistula I-Disease I-Disease
2017-04-19 O O

10. O O
Recent B-Disease B-Disease
MRSA I-Disease I-Disease
pneumonia I-Disease I-Disease
and O O
sepsis B-Disease B-Disease
2017-07-21 O O
, O O
treated O O
with O O
Vancomycin O O

11. O O
C. B-Disease B-Disease
difficile I-Disease I-Disease
colitis I-Disease I-Disease
treated O O
with O O
Flagyl O O
( O O
completed O O
08-10 O O
) O O

12. O O
Status O O
post O O
PEG O O
tube O O
placement O O
2017-07-21 O O

13. O O
Status O O
post O O
tracheostomy O O
2017-07-21 O O
02-22 O O
failure B-Disease B-Disease
to I-Disease I-Disease
wean I-Disease I-Disease

14. O O
Status O O
post O O
partial O O
colectomy O O
1972 O O

Discharge O O
Condition O O
: O O

Expired O O

Johnnie O O
Callez O O
MD O O
61-750 O O

Completed O O
by O O
: O O
Opal O O
Anne O O
MD O O
40-158 O O
2017-08-23 O O
@ O O
2054 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Teresa O O
Loper O O
on O O
: O O
FRI O O
2017-09-22 O O
4:29 O O
PM O O

( O O
End O O
of O O
Report O O
) O O

095889687 O O
WGH O O

9786774 O O

224527 O O

311732 O O

10/24/2001 O O
12:00:00 O O
AM O O

ED O O
Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

ED O O
DISCHARGE O O
NOTIFICATION O O
/ O O
SUMMARY O O

SOURS O O
, O O
NANONIFF O O
ELLMI O O

MRN O O
: O O

9786774 O O

Age O O
: O O

31y O O

REGISTRATION O O
DATE O O
: O O

10/24/2001 O O
07:57 O O
AM O O

Provider O O
: O O

LICHEREANYVE O O
CHIRDKOTEKERTH O O

PRELIMINARY O O
REPORT O O

Benefits O O
Assigned O O
: O O

Y O O

Discharge O O
Date O O
/ O O
Time O O
: O O

10/24/2001 O O
10:07 O O

Discharge O O
Status O O
: O O

Discharged O O
Condition O O
on O O
Discharge O O
: O O

Stable O O
Patient O O
States O O
Complaint O O
: O O

SWOLLEN B-Disease B-Disease
PAINFUL I-Disease I-Disease
L I-Disease I-Disease
SIDE I-Disease I-Disease
FC I-Disease I-Disease

Diagnosis O O
: O O

L B-Disease B-Disease
upper I-Disease I-Disease
lip I-Disease I-Disease
/ I-Disease I-Disease
L I-Disease I-Disease
nostril I-Disease I-Disease
abscess I-Disease I-Disease

Treatment O O
Rendered O O
: O O

5 O O
cc O O
of O O
purulent B-Disease B-Disease
material I-Disease I-Disease
drained O O
by O O
needle O O
aspiration O O

Discharge O O
Medications O O
: O O

Augmentin O O
875 O O
mg O O
twice O O
a O O
day O O
for O O
10 O O
days O O
. O O

Follow O O
up O O
Service O O
: O O

Please O O
see O O
your O O
PCP O O
in O O
follow O O
up O O
. O O

Disposition O O
, O O
Follow O O
up O O
and O O
Instructions O O
to O O
Patient O O
: O O

Return O O
immediately O O
for O O
worsening O B-Disease
signs O I-Disease
of O I-Disease
infection B-Disease I-Disease
( O O
increased B-Disease B-Disease
swelling I-Disease I-Disease
, O O
pain B-Disease B-Disease
, O O
redness B-Disease B-Disease
) O O
or O O
for O O
any B-Disease B-Disease
neurologic I-Disease I-Disease
changes I-Disease I-Disease
( O O
blurry B-Disease B-Disease
or I-Disease I-Disease
double I-Disease I-Disease
vision I-Disease I-Disease
, O O
headaches B-Disease B-Disease
, O O
trouble B-Disease B-Disease
walking I-Disease I-Disease
, O O
etc O O
) O O
. O O

PCP O O
Name O O
: O O

CLEV O O
, O O
NISHA O O

Provider O O
Number O O
: O O

53476 O O

This O O
report O O
was O O
created O O
by O O
CHIRDKOTEKERTH O O
, O O
LICHEREANYVE O O
10/24/2001 O O
10:09 O O
AM O O

Admission O O
Date O O
: O O

2020-03-11 O O

Discharge O O
Date O O
: O O

2020-03-23 O O

Date O O
of O O
Birth O O
: O O

1946-04-03 O O

Sex O O
: O O

M O O

Service O O
: O O

MEDICINE O O

Allergies O O
: O O

Penicillins O O

Attending O O
: O O
Ross O O
Z O O
Kenmore O O
, O O
M.D. O O

Chief O O
Complaint O O
: O O

Transfer O O
from O O
Newton-Wellesley O O
Hospital O O
hospital O O
for O O
epidural B-Disease B-Disease
abscess I-Disease I-Disease

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

1. O O
Partial O O
vertebrectomy O O
of O O
L3 O O
and O O
L4 O O
. O O

2. O O
Fusion O O
at O O
L3-L4 O O
. O O

3. O O
Vertebral O O
Spacer O O
at O O
L3-L4 O O
. O O

4. O O
Anterior O O
instrumentation O O
L3-L4 O O
. O O

5. O O
Autograft O O
, O O
bone O O
morphogenic O O
protein O O
, O O
and O O
allograft O O
. O O

6. O O
Debridement O O

7. O O
Incision O B-Disease
and O I-Disease
drainage O I-Disease

8. O O
Echocardiogram O O

History O O
of O O
Present O O
Illness O O
: O O

73 O O
yo O O
M O O
transferred O O
from O O
Newton-Wellesley O O
Hospital O O
hospital O O
for O O
epidural B-Disease B-Disease
abscess I-Disease I-Disease
. O O

Pt O O
has O O
h/o O O
colon B-Disease O
can I-Disease O
to I-Disease O
liver I-Disease O
, O O
s/p O O
resxn O O
with O O
serosal B-Disease O
implants I-Disease O
in O O
9/03 O O
. O O

Pt O O
states O O
he O O
has O O
been O O
receiving O O
chemotherapy O O
up O O
until O O
1 O O
week O O
ago O O
. O O

States O O
he O O
first O O
developed O O
back B-Disease B-Disease
pain I-Disease I-Disease
5 O O
weeks O O
ago O O
but O O
was O O
still O O
able O O
to O O
ambulate O O
with O O
his O O
cane O O
. O O

Last O O
week O O
it O O
was O O
worse O O
and O O
he O O
was O O
seen O O
in O O
clinic O O
. O O

An O O
MRI O O
was O O
done O O
and O O
this O O
showed O O
a B-Disease O
signal I-Disease O
abno I-Disease O
in I-Disease O
L3 I-Disease O
L4 I-Disease O
? O O
disciitis B-Disease B-Disease
vs O O
osteo B-Disease O
without O O
a B-Disease B-Disease
definitive I-Disease I-Disease
epidural I-Disease I-Disease
abscess I-Disease I-Disease
. O O

Initially O O
on O O
Vanc O O
and O O
Cipro O O
on O O
Friday O O
but O O
then O O
seen O O
by O O
ID O O
who O O
reccommended O O
no O O
abx O B-Disease
but O O
a O O
bone O O
biopsy O O
, O O
blood O O
cx O O
. O O

He O O
was O O
also O O
seen O O
by O O
spine O O
who O O
repeated O O
the O O
MRI O O
and O O
this O O
showed O O
L3-4 B-Disease B-Disease
osteomyelitis I-Disease I-Disease
and O O
discitis B-Disease B-Disease
and O O
an B-Disease B-Disease
epidural I-Disease I-Disease
abscess I-Disease I-Disease
, O O
5cm O O
. O O

He O O
was O O
subsequently O O
restared O O
on O O
Vancomycin O O
for O O
Corynebacterium B-Disease B-Disease
in O I-Disease
blood O I-Disease
cx O I-Disease
from O O
Fri O O
; O O
Followup O O
cx O O
has O O
been O O
NGTD O O
. O O

CXR O O
also O O
showed O O
small B-Disease B-Disease
pleural I-Disease I-Disease
effusion I-Disease I-Disease
and O O
attempt O O
was O O
made O O
to O O
tap O O
it O O
, O O
but O O
pt O O
did O O
not O O
tolerate O O
the O O
procedure O O
and O O
asked O O
that O O
it O O
be O O
deferred O O
. O O

He O O
did O O
undergo O O
a O O
CT-guided O O
aspiration O O
/ O O
biopsy O O
at O O
the O O
L3-4 O O
disc O O
space O O
on O O
2020-03-11 O O
and O O
the O O
pt O O
was O O
transferred O O
to O O
Mediplex O O
Rehab O O
Hospital O O
immediately O O
following O O
this O O
. O O

No O O
results O O
from O O
this O O
were O O
sent O O
. O O

Currently O O
pt O O
denies O O
sensory B-Disease B-Disease
deficits I-Disease I-Disease
or O O
weakness B-Disease B-Disease
. O O

States O O
he O O
is O O
not O O
able O O
to O O
walk O O
because O O
of O O
severe B-Disease B-Disease
pain I-Disease I-Disease
. O O

States O O
pain B-Disease B-Disease
is O O
worst O O
when O O
he O O
sits O O
up O O
or O O
twists O O
his O O
back O O
. O O

No O O
bowel B-Disease B-Disease
or I-Disease I-Disease
bladder I-Disease I-Disease
incontinence I-Disease I-Disease
. O O

Past O O
Medical O O
History O O
: O O

- O O
epidural B-Disease B-Disease
abscess I-Disease I-Disease

- O O
colon B-Disease B-Disease
cancer I-Disease I-Disease
with O O
mets B-Disease O
to I-Disease O
liver I-Disease O
s/p O O
resection O O
09-07 O O
. O O

Oncologist O O
is O O
Dr. O O
Rowles O O
. O O

- O O
CAD B-Disease B-Disease
s/p O O
CABG O O
x4 O O
in O O
' O O
03 O O
. O O

- O O
hypercholesterolemia B-Disease B-Disease

- O O
DM B-Disease B-Disease
with O O
neuropathy B-Disease B-Disease
. O O

- O O
persistent B-Disease B-Disease
R I-Disease I-Disease
foot I-Disease I-Disease
ulcer I-Disease I-Disease

Social O O
History O O
: O O

Lives O O
alone O O
in O O
apartment O O
in O O
Boston O O
. O O

Is O O
married O O
but O O
" O O
separated O O
" O O
from O O
his O O
wife O O
, O O
although O O
they O O
still O O
help O O
each O O
other O O
- O O

he O O
states O O
he O O
gives O O
her O O
one O O
of O O
his O O
pensions O O
and O O
she O O
helps O O
him O O
with O O
medicines O O
etc O O
. O O

Quit O O
tobacco O O
in O O
2003 O O
after O O
smoking O O
1 O O
ppd O O
for O O
" O O
a O O
very O O
long O O
time O O
". O O

Drank O O
ETOH O O
heavily O O
until O O
8 O O
years O O
ago O O
when O O
he O O
quit O O
. O O

Denies O O
IVDU O B-Disease
. O O

Has O O
children O O
but O O
they O O
are O O
not O O
nearby O O
. O O

Family O O
History O O
: O O

NC O O

Physical O O
Exam O O
: O O

98.6 O O
, O O
104/50 O O
, O O
96 O O
, O O
20 O O
, O O
96% O O
RA O O

Gen O O
: O O
in O O
NAD B-Disease B-Disease
, O O
but O O
winces O O
in O O
pain B-Disease B-Disease
with O O
movements O O
of O O
his O O
back O O
. O O

HEENT O O
: O O
Clear O O
OP O O
, O O
MM B-Disease O
very I-Disease B-Disease
dry I-Disease I-Disease
. O O

NECK O O
: O O
Supple O O
, O O
No O O
LAD B-Disease B-Disease
, O O
No O O
JVD B-Disease B-Disease

CHEST O O
: O O
Port O O
a O O
cath O O
in O O
R O O
chest O O
, O O
no O O
erythema B-Disease B-Disease
or O O
tenderness B-Disease B-Disease
. O O

CV O O
: O O
RR O O
, O O
NL O O
rate O O
. O O

NL O O
S1 O O
, O O
S2 O O
. O O

II/VI B-Disease O
SEM I-Disease O
at I-Disease O
LSB I-Disease O
with O O
radiation B-Disease O
to I-Disease O
apex I-Disease O
. O O

LUNGS O O
: O O
+ O O
crackles B-Disease B-Disease
at I-Disease I-Disease
L I-Disease I-Disease
base I-Disease I-Disease
> O I-Disease
R O I-Disease
base O I-Disease
. O O

ABD O O
: O O
Pt O O
very B-Disease B-Disease
tense I-Disease I-Disease
in I-Disease I-Disease
abdomen I-Disease I-Disease
( O O
states O O
belly O O
is O O
fine O O
, O O
but O O
he O O
is O O
weary O O
of O O
his O O
back O O
). O O

Well B-Disease B-Disease
healed I-Disease I-Disease
midline I-Disease I-Disease
scar I-Disease I-Disease
from O O
chest O O
down O O
to O O
pubis O O
. O O

No O O
HSM B-Disease B-Disease
. O O

EXT O O
: O O
No O O
edema B-Disease B-Disease
. O O

Dressing O O
c/d/i O O
over O O
R B-Disease B-Disease
LE I-Disease I-Disease
ulcer I-Disease I-Disease
. O O

1 O O
+ O O
DP O O
pulses O O
BL O O

NEURO O O
: O O
A&Ox3 O O
. O O

Appropriate O O
. O O

CN O O
02-17 O O
grossly O O
intact O O
. O O

Preserved O B-Disease
sensation O I-Disease
throughout O O
. O O

5/5 O O
strength O O
throughout O O
, O O
though O O
weary O O
of O O
moving O O
back O O
. O O

Back O O
: O O
+ O O
ttp B-Disease O
of I-Disease O
lumbar I-Disease O
spine I-Disease O
and I-Disease O
paraspinal I-Disease O
muscles I-Disease O
, O O
R O O
> O O
L O O
. O O

No O O
erythema B-Disease B-Disease
or O O
swelling B-Disease B-Disease
noted O O
. O O

CMED O O
CSRU O O
: O O
Listens O O
and O O
responds O O
to O O
questions O O
appropriately O O
, O O
pleasant O O

Pertinent O O
Results O O
: O O

Na O O
: O O
135 O O
, O O
K O O
4.5 O O
, O O
Cl O O
96 O O
, O O
CO2 O O
27 O O
, O O
BUN O O
12 O O
, O O
Cr O O
0.7 O O
, O O
Glu O O
167 O O
, O O
Ca O O
8.4 O O
, O O
Vanco O O
trough O O
13 O O
, O O
WBC O O
5.3 O O
, O O
Hct O O
32.0 O O
, O O
plt O O
330 O O
, O O
INR O O
1.0 O O
. O O

No O O
culture O O
data O O
was O O
sent O O
. O O

STUDIES O O
: O O

MRI O O
lumbar O O
spine O O
( O O
Youville O O
Hospital O O
2020-03-10 O O
): O O
L3-4 B-Disease B-Disease
osteomyelitis I-Disease I-Disease
, O O
discitis B-Disease B-Disease
, O O
and O O
epidural B-Disease B-Disease
abscess I-Disease I-Disease
. O O

Degenerative B-Disease B-Disease
changes I-Disease I-Disease
including O O
multilevel B-Disease B-Disease
central I-Disease I-Disease
spinal I-Disease I-Disease
stenosis I-Disease I-Disease
. O O

Impression B-Disease O
on I-Disease O
the I-Disease O
anterior I-Disease O
aspect I-Disease O
of I-Disease O
the I-Disease O
lower I-Disease O
spinal I-Disease O
cord I-Disease O
at I-Disease O
T11-12 I-Disease O
by O O
disc B-Disease O
bulge I-Disease O
. O O

Addendum O O
: O O
Findings O O
are O O
c/w O B-Disease
paraspinous B-Disease I-Disease
extension I-Disease I-Disease
of I-Disease I-Disease
infection I-Disease I-Disease
anteriorly O I-Disease
and O O
laterally O O
into O O
the O O
medial O O
aspects O O
of O O
the O O
psoas O O
muscles O O
bilaterally O O
at O O
the O O
L3 O O
and O O
L4 O O
levels O O
. O O

CXR O O
( O O
Youville O O
Hospital O O
2020-03-09 O O
): O O
Persistent B-Disease B-Disease
unchanged I-Disease I-Disease
L I-Disease I-Disease
mid I-Disease I-Disease
and I-Disease I-Disease
lower I-Disease I-Disease
lung I-Disease I-Disease
field I-Disease I-Disease
airspace I-Disease I-Disease
Disease I-Disease I-Disease
with O O
moderate B-Disease B-Disease
L I-Disease I-Disease
pleural I-Disease I-Disease
effusion I-Disease I-Disease
. O O

Brief O O
Hospital O O
Course O O
: O O

73 O O
yo O O
M O O
transferred O O
from O O
Youville O O
Hospital O O
with O O
h/o O O
colon B-Disease B-Disease
cancer I-Disease I-Disease
with O O
known B-Disease B-Disease
liver I-Disease I-Disease
mets I-Disease I-Disease
now O O
with O O
epidural B-Disease B-Disease
abscess I-Disease I-Disease
and O O
corynebacterium B-Disease B-Disease
bacteremia I-Disease I-Disease
: O O

# O O
Epidural B-Disease B-Disease
abscess I-Disease I-Disease
: O O
The O O
patient O O
was O O
evaluated O O
by O O
orthopedic O O
spine O O
consult O O
service O O
and O O
ID O O
. O O

He O O
was O O
continued O O
on O O
IV O O
vancomycin O O
throughout O O
his O O
course O O
and O O
had O O
therapeutic O O
troughs O O
. O O

The O O
patient O O
was O O
taken O O
to O O
the O O
OR O O
twice O O
with O O
orthopaedics O O
. O O

Please O O
see O O
the O O
operation O O
notes O O
for O O
details O O
about O O
the O O
surgeries O O
. O O

The O O
patient O O
was O O
briefly O O
admitted O O
to O O
the O O
ICU O O
for O O
low B-Disease B-Disease
hematocrit I-Disease I-Disease
and O O
hyponatremia B-Disease B-Disease
immediately O O
following O O
the O O
surgery O O
but O O
was O O
then O O
transferred O O
back O O
to O O
the O O
floor O O
in O O
stable O O
condition O O
. O O

The O O
patient O O
had O O
a O O
PICC O O
line O O
placed O O
and O O
will O O
continue O O
a O O
8 O O
week O O
course O O
of O O
antibiotics O O
. O O

The O O
patient O O
will O O
also O O
wear O O
a O O
back O O
brace O O
at O O
all O O
times O O
while O O
out O O
of O O
bed O O
. O O

# O O
Candidemia B-Disease B-Disease
: O O
The O O
patient O O
was O O
noted O O
to O O
have O O
a O B-Disease
positive O I-Disease
blood O I-Disease
culture O I-Disease
from O O
03-12 O O
. O O

The O O
patient O O
was O O
started O O
on O O
Diflucan O O
. O O

Ophthalmology O O
was O O
consulted O O
and O O
ruled O O
out O O
ocular B-Disease B-Disease
spread I-Disease I-Disease
. O O

The O O
patient O O
's O O
portocath O O
was O O
removed O O
. O O

The O O
tip O O
was O O
culture O O
negative O O
. O O

The O O
patient O O
will O O
get O O
a O O
total O O
of O O
a O O
two O O
week O O
course O O
of O O
Diflucan O O
. O O

# O O
Corynebacterium B-Disease B-Disease
bacteremia I-Disease I-Disease
: O O
presumably O O
Corynebacterium B-Disease B-Disease
in O I-Disease
epidural B-Disease I-Disease
abscess I-Disease I-Disease
as O O
well O O
. O O

The O O
patient O O
had O O
no O O
blood O O
cultures O O
to O O
grow O O
corynebacterium B-Disease B-Disease
while O O
hospitalized O O
. O O

# O O
Pleural B-Disease B-Disease
effusion I-Disease I-Disease
: O O
The O O
patient O O
was O O
noted O O
have O O
an B-Disease B-Disease
effusion I-Disease I-Disease
on O O
CXR O O
. O O

IP O O
was O O
consulted O O
and O O
did O O
a O O
thoracentesis O O
. O O

The O O
tap O O
was O O
negative O O
for O O
malignant B-Disease B-Disease
cells I-Disease I-Disease
. O O

A O O
repeat O O
CT O O
was O O
done O O
showing O O
nodular B-Disease B-Disease
thickening I-Disease I-Disease
along O I-Disease
the O I-Disease
right O I-Disease
major O I-Disease
and O I-Disease
minor O I-Disease
fissure O I-Disease
, O O
concerning O O
for O O
intrapleural B-Disease B-Disease
tumor I-Disease I-Disease
implants I-Disease I-Disease
. O O

IP O O
reviewed O O
the O O
films O O
and O O
recommended O O
continue O O
oncologic O O
care O O
according O O
to O O

outpatient O O
course O O
and O O
pleurodesis O O
if O O
the O O
pt O O
becomes O O
symptomatic B-Disease O
02-07 O O
fluid B-Disease B-Disease
accumulation I-Disease I-Disease
. O O

The O O
patient O O
will O O
follow O O
up O O
with O O
his O O
oncologist O O
. O O

# O O
Foot B-Disease B-Disease
ulcer I-Disease I-Disease
: O O
diabetic B-Disease B-Disease
ulcer I-Disease I-Disease
s/p O O
surgery O O
but O O
never O O
healed O O
. O O

Wound O O
care O O
was O O
consulted O O
and O O
made O O
recommendations O O
for O O
ulcer O O
care O O
. O O

His O O
dressings O O
were O O
changed O O
by O O
the O O
nursing O O
staff O O
accordingly O O
. O O

# O O
Anemia B-Disease B-Disease
: O O
His O O
HCT O O
remained O O
stable O O
post-surgery O O
. O O

The O O
patient O O
was O O
continued O O
on O O
his O O
iron O O
supplements O O
. O O

Medications O O
on O O
Admission O O
: O O

- O O
Iron O O
Sulfate O O
300 O O
mg O O
po O O
tid O O

- O O
Procrit O O
40,000 O O
units O O
SC O O
q O O
Friday O O

- O O
Lovenox O O
40 O O
mg O O
SC O O
q24 O O
for O O
DVT O B-Disease
ppx O O

- O O
Albuterol O O
/ O O
Atrovent O O
nebs O O
q4 O O

- O O
Morphine O O
2-4 O O
mg O O
IV O O
q3-4 O O
prn O O

- O O
Mylanta O O
30 O O
cc O O
po O O
q6 O O
prn O O

- O O
Pepcid O O
20 O O
mg O O
po O O
daily O O

- O O
insulin O O
sliding O O
scale O O

- O O
glipizide O O
5 O O
mg O O
po O O
bid O O

- O O
metformin O O
500 O O
mg O O
po O O
bid O O

- O O
metoprolol O O
50 O O
mg O O
po O O
daily O O

- O O
Vancomycin O O
1.5 O O
gm O O
q O O
12 O O
hours O O

Discharge O O
Medications O O
: O O

1. O O
Albuterol O O
Sulfate O O
0.083 O O
% O O
Solution O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Inhalation O O
Q4H O O
( O O
every O O
4 O O
hours O O
) O O
as O O
needed O O
. O O

2. O O
Ipratropium O O
Bromide O O
0.02 O O
% O O
Solution O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Inhalation O O
Q6H O O
( O O
every O O
6 O O
hours O O
) O O
as O O
needed O O
. O O

3. O O
Aluminum-Magnesium O O
Hydroxide O O
225-200 O O
mg O O
/ O O
5 O O
mL O O
Suspension O O
Sig O O
: O O
15-30 O O
MLs O O
PO O O
QID O O
( O O
4 O O
times O O
a O O
day O O
) O O
as O O
needed O O
. O O

4. O O
Glipizide O O
5 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

5. O O
Miconazole O O
Nitrate O O
2 O O
% O O
Powder O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Appl O O
Topical O O
TID O O
( O O
3 O O
times O O
a O O
day O O
) O O
as O O
needed O O
. O O

6. O O
Acetaminophen O O
325 O O
mg O O
Tablet O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Tablet O O
PO O O
Q6H O O
( O O
every O O
6 O O
hours O O
) O O
as O O
needed O O
for O O
fever B-Disease B-Disease
or O O
pain B-Disease B-Disease
. O O

7. O O
Metoprolol O O
Tartrate O O
25 O O
mg O O
Tablet O O
Sig O O
: O O
1.5 O O
Tablets O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

8. O O
Cepacol O O
2 O O
mg O O
Lozenge O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Lozenge O O
Mucous O O
membrane O O
PRN O O
( O O
as O O
needed O O
). O O

9. O O
Docusate O O
Sodium O O
100 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

10. O O
Senna O O
8.6 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
as O O
needed O O
. O O

11. O O
Oxycodone O O
5 O O
mg O O
Tablet O O
Sig O O
: O O
1-2 O O
Tablets O O
PO O O
every O O
4-6 O O
hours O O
as O O
needed O O
for O O
pain B-Disease B-Disease
for O O
14 O O
days O O
. O O

12. O O
Fluconazole O O
200 O O
mg O O
Tablet O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Tablet O O
PO O O
Q24H O O
( O O
every O O
24 O O
hours O O
) O O
for O O
7 O O
days O O
. O O

13. O O
Oxycodone O O
10 O O
mg O O
Tablet O O
Sustained O O
Release O O
12 O O
HR O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
Sustained O O
Release O O
12HR O O
PO O O
Q12H O O
( O O
every O O
12 O O
hours O O
). O O

14. O O
Bisacodyl O O
5 O O
mg O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
as O O
needed O O
. O O

15. O O
Aspirin O O
81 O O
mg O O
Tablet O O
, O O
Chewable O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
, O O
Chewable O O
PO O O
DAILY O O
( O O
Daily O O
). O O

16. O O
Vancomycin O O
in O O
Dextrose O O
1 O O
g O O
/ O O
200 O O
mL O O
Piggyback O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Intravenous O O
Q O O
12H O O
( O O
Every O O
12 O O
Hours O O
): O O
To O O
finish O O
on O O
2020-05-12 O O
. O O

17. O O
Pepcid O O
20 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
once O O
a O O
day O O
. O O

18. O O
Heparin O O
Lock O O
Flush O O
( O O
Porcine O O
) O O
100 O O
unit O O
/ O O
mL O O
Syringe O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
ML O O
Intravenous O O
DAILY O O
( O O
Daily O O
) O O
as O O
needed O O
: O O
10 O O
ml O O
NS O O
followed O O
by O O
2 O O
ml O O
of O O
100 O O
Units O O
/ O O
ml O O
heparin O O
( O O
200 O O
units O O
heparin O O
) O O
each O O
lumen O O
Daily O O
and O O
PRN O O
. O O

Inspect O O
site O O
every O O
shift O O
. O O

19. O O
Insulin O O
Glargine O O
100 O O
unit O O
/ O O
mL O O
Solution O O
Sig O O
: O O
Four O O
( O O
4 O O
) O O
units O O
Subcutaneous O O
at O O
dinner O O
time O O
. O O

20. O O
Insulin O O
Lispro O O
( O O
Human O O
) O O
100 O O
unit O O
/ O O
mL O O
Cartridge O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Subcutaneous O O
four O O
times O O
a O O
day O O
: O O
As O O
directed O O
by O O
sliding O O
scale-please O O
see O O
attached O O
scale O O
. O O

Discharge O O
Disposition O O
: O O

Home O O

Discharge O O
Diagnosis O O
: O O

Primary O O
diagnosis O O
: O O
Epidural B-Disease B-Disease
abscess I-Disease I-Disease

Secondary O O
diagnosis O O
: O O

- O O
colon B-Disease B-Disease
cancer I-Disease I-Disease
with O O
mets B-Disease O
to I-Disease O
liver I-Disease O
s/p O O
resection O O
09-07 O O
. O O

- O O
CAD B-Disease B-Disease
s/p O O
CABG O O
x4 O O
in O O
' O O
03 O O
. O O

- O O
hypercholesterolemia B-Disease B-Disease

- O O
DM B-Disease B-Disease
with O O
neuropathy B-Disease B-Disease
. O O

- O O
persistent B-Disease B-Disease
R I-Disease I-Disease
foot I-Disease I-Disease
ulcer I-Disease I-Disease

Discharge O O
Condition O O
: O O

Stable O O
, O O
afebrile B-Disease B-Disease

Discharge O O
Instructions O O
: O O

You O O
were O O
diagnosed O O
with O O
an B-Disease B-Disease
epidural I-Disease I-Disease
abscess I-Disease I-Disease
. O O

Continue O O
to O O
take O O
the O O
antibiotics O O
as O O
directed O O
. O O

Take O O
the O O
pain O O
medication O O
as O O
directed O O
and O O
do O O
not O O
drive O O
while O O
taking O O
this O O
medication O O
. O O

Call O O
the O O
doctor O O
or O O
return O O
to O O
the O O
Thomas O O
for O O
: O O

- O O
fever B-Disease B-Disease
> O O
102 O O

- O O
chest B-Disease B-Disease
pain I-Disease I-Disease
or O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease

- O O
worsening B-Disease B-Disease
pain I-Disease I-Disease
or O O
weakness B-Disease B-Disease
in I-Disease I-Disease
your I-Disease I-Disease
legs I-Disease I-Disease
, O O
loss B-Disease B-Disease
of I-Disease I-Disease
bowel I-Disease I-Disease
or I-Disease I-Disease
bladder I-Disease I-Disease
function I-Disease I-Disease
or O O
any B-Disease B-Disease
other I-Disease I-Disease
concerning I-Disease I-Disease
symptoms I-Disease I-Disease
. O O

Followup O O
Instructions O O
: O O

Please O O
follow O O
up O O
with O O
Dr. O O
Scott O O
Ann O O
, O O
MD O O
Phone O O
:( O O
921 O O
) O O
538 O O
8079 O O
on O O
2020-04-30 O O
at O O
11:00am O O
. O O

Please O O
follow O O
up O O
with O O
Dr O O
Erb O O
- O O
3/30/07 O O
at O O
10:00am O O
. O O

Please O O
follow O O
up O O
with O O
Dr. O O
Rowles O O
, O O
your O O
oncologist O O
, O O
in O O
2-3 O O
weeks O O

Brooke O O
Donna O O
MD O O
37-421 O O

Completed O O
by O O
: O O
Jessica O O
POPE O O
MD O O
58-704 O O
2020-03-23 O O
@ O O
1515 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Maryjane O O
WS O O
Hammond O O
on O O
: O O
FRI O O
2020-05-01 O O
12:36 O O
AM O O

( O O
End O O
of O O
Report O O
) O O

Admission O O
Date O O
: O O

2015-10-28 O O

Discharge O O
Date O O
: O O

2015-11-13 O O

Date O O
of O O
Birth O O
: O O

1941-08-30 O O

Sex O O
: O O

F O O

Service O O
: O O
CARDIOTHORACIC O O

Allergies O O
: O O

Tape O O
/ O O
Benadryl O O

Attending O O
:Jordan O O
U O O
Kostohryz O O
, O O
M.D. O O

Chief O O
Complaint O O
: O O

Chest B-Disease B-Disease
discomfort I-Disease I-Disease

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

2015-10-30 O O
Left O O
Carotid O O
Stenting O O

2015-11-02 O O
Coronary O O
Artery O O
Bypass O O
Graft O O
x O O
2 O O
( O O
Lima O O
to O O
LAD O O
, O O
SVG O O
to O O
OM O O
) O O

History O O
of O O
Present O O
Illness O O
: O O

Ms. O O
Bridge O O
is O O
a O O
74 O O
y/o O O
female O O
admitted O O
to O O
outside O O
hospital O O
on O O
2015-10-21 O O
with O O
chest B-Disease B-Disease
discomfort I-Disease I-Disease
, O O
vomiting B-Disease B-Disease
and O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
. O O

Initial O O
EKG O O
showed O O
ST B-Disease B-Disease
depressions I-Disease I-Disease
, O O
but O O
cardiac O O
enzymes O O
were O O
not O O
elevated B-Disease O
. O O

She O O
eventually O O
underwent O O
a O O
cardiac O O
cath O O
to O O
assess O O
coronary B-Disease B-Disease
Disease I-Disease I-Disease
which O O
revealed O O
three B-Disease B-Disease
vessel I-Disease I-Disease
coronary I-Disease I-Disease
artery I-Disease I-Disease
Disease I-Disease I-Disease
. O O

She O O
was O O
then O O
transferred O O
to O O
The O O
Hospital O O
for O O
Orthopedics O O
for O O
surgical O O
intervention O O
. O O

Past O O
Medical O O
History O O
: O O

Coronary B-Disease B-Disease
Artery I-Disease I-Disease
Disease I-Disease I-Disease
, O O
Hypertension B-Disease B-Disease
, O O
Hyperlipidemia B-Disease B-Disease
, O O
Diabetes B-Disease B-Disease
Mellitus I-Disease I-Disease
, O O
Hypothyroid B-Disease B-Disease
, O O
h/o O O
Bilateral B-Disease B-Disease
DVT I-Disease I-Disease
's I-Disease O
( O O
on O O
chronic O O
coumadin O O
therapy O O
), O O
Pleural B-Disease B-Disease
disorder I-Disease I-Disease
? O O
Sarcoidosis B-Disease B-Disease
, O O
Gastritis B-Disease B-Disease
, O O
B12 B-Disease B-Disease
deficiency I-Disease I-Disease
, O O
Chronic B-Disease B-Disease
renal I-Disease I-Disease
insufficiency I-Disease I-Disease
, O O
s/p O O
Appendectomy O O
, O O
s/p O O
Lap O O
cholectomy O O
, O O
s/p O O
Total O O
abdominal O O
hysterectomy O O

Social O O
History O O
: O O

Denies O O
tobacco O O
or O O
ETOH O O
use O O
. O O

Lives O O
wth O O
husband O O
. O O

Family O O
History O O
: O O

Mother O O
died O O
of O O
MI B-Disease B-Disease
at O O
age O O
55 O O
. O O

Brother O O
w/ O O
CAD B-Disease B-Disease
since O O
age O O
40 O O
and O O
died O O
in O O
70 O O
's O O
after O O
cardiac O O
surgery O O
. O O

Son O O
died O O
at O O
14 O O
d/t O O
ASD B-Disease B-Disease
. O O

Physical O O
Exam O O
: O O

Gen O O
: O O
NAD B-Disease B-Disease

Neck O O
: O O
Supple O O
, O O
- O O
JVD B-Disease B-Disease
, O O
- O O
Bruits B-Disease B-Disease

Heart O O
: O O
RRR O O
- O O
c/r/m/g B-Disease B-Disease

Lungs O O
: O O
CTAB O O
, O O
coarse B-Disease O

Abd O O
: O O
Soft O O
, O O
NT/NT B-Disease B-Disease
+ O O
BS O O

Ext O O
: O O
Cool O O
, O O
1 O O
+ O O
pedal O O
pulses O O
, O O
- O O
varicosities B-Disease B-Disease
, O O
- O O
edema B-Disease B-Disease

Neuro O O
: O O
A&O O O
x O O
3 O O
, O O
MAE O O
, O O
non-focal O O

Some B-Disease B-Disease
rashes I-Disease I-Disease
on I-Disease O
ACW I-Disease O
around O O
EKG O O
leads O O

Pertinent O O
Results O O
: O O

CNIS O O
10-29 O O
: O O

1. O O
60-69% B-Disease B-Disease
stenosis I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
right I-Disease I-Disease
internal I-Disease I-Disease
carotid I-Disease I-Disease
artery I-Disease I-Disease
. O O

2. O O
80-99% B-Disease B-Disease
stenosis I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
internal I-Disease I-Disease
carotid I-Disease I-Disease
artery I-Disease I-Disease
. O O

Echo O O
11-02 O O
: O O
PRE-BYPASS O O
: O O
Left O O
ventricular O O
wall O O
thickness O O
, O O
cavity O O
size O O
, O O
and O O
systolic O O
function O O
are O O
normal O O
( O O
LVEF>55% O O
). O O

Resting B-Disease B-Disease
regional I-Disease I-Disease
wall I-Disease I-Disease
motion I-Disease I-Disease
abnormalities I-Disease I-Disease
include O O
mild B-Disease B-Disease
apical I-Disease I-Disease
hypokinesis I-Disease I-Disease
. O O

The O O
aortic O O
valve O O
leaflets O O
( O O
3 O O
) O O
appear O O
structurally O O
normal O O
with O O
good O O
leaflet O O
excursion O O
and O O
no O O
aortic B-Disease B-Disease
regurgitation I-Disease I-Disease
. O O

The O O
mitral O O
valve O O
appears O O
structurally O O
normal O O
with O O
trivial B-Disease B-Disease
mitral I-Disease I-Disease
regurgitation I-Disease I-Disease
. O O

There O O
are O O
complex B-Disease B-Disease
(> I-Disease I-Disease
4 I-Disease I-Disease
mm I-Disease I-Disease
) I-Disease I-Disease
atheroma I-Disease I-Disease
in I-Disease O
the I-Disease O
descending I-Disease O
thoracic I-Disease O
aorta I-Disease O
. O O

Mild B-Disease B-Disease
tricuspid I-Disease I-Disease
regurgitation I-Disease I-Disease
. O O

POST-BYPASS O O
: O O
Preserved O O
Kindred O O
/ O O
North O O
Shore O O
- O O
ventricular O B-Disease
systolic O I-Disease
fxn O I-Disease
. O O

Trivial B-Disease B-Disease
MR I-Disease I-Disease
. O O

Edith O O
AI O O
. O O

Aorta O O
intact O O
. O O

CT O O
11-04 O O
: O O
No O O
acute B-Disease B-Disease
intracranial I-Disease I-Disease
hemorrhage I-Disease I-Disease
. O O

Findings O O
consistent O O
with O O
small B-Disease B-Disease
vessel I-Disease I-Disease
ischemic I-Disease I-Disease
changes I-Disease I-Disease
. O O

MRI O O
would O O
be O O
more O O
sensitive O O
for O O
the O O
detection O O
of O O
acute B-Disease B-Disease
infarction I-Disease I-Disease
. O O

CT O O
angiogram O O
demonstrates O O
no O O
stenosis B-Disease B-Disease
or O O
aneurysm B-Disease B-Disease
in I-Disease I-Disease
the I-Disease I-Disease
intracranial I-Disease I-Disease
circulation I-Disease I-Disease
. O O

Slight B-Disease B-Disease
irregularity I-Disease I-Disease
of O I-Disease
the O I-Disease
origin O I-Disease
of O I-Disease
the O I-Disease
right O I-Disease
vertebral O I-Disease
artery O I-Disease
may O O
be O O
atherosclerotic B-Disease B-Disease
in O O
nature O O
. O O

Normal O O
contrast O O
enhancement O O
seen O O
in O O
the O O
left O O
common/internal O O
carotid O O
artery O O
stent O O
. O O

Mild B-Disease B-Disease
stenosis I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
proximal I-Disease I-Disease
right I-Disease I-Disease
internal I-Disease I-Disease
carotid I-Disease I-Disease
artery I-Disease I-Disease
. O O

4 B-Disease B-Disease
mm I-Disease I-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
lobe I-Disease I-Disease
lung I-Disease I-Disease
nodule I-Disease I-Disease
. O O

In O O
the O O
absence O O
of O O
history O O
of O O
malignancy B-Disease B-Disease
, O O
this O O
is O O
statistically O O
benign O O
. O O

One-year O O
followup O O
may O O
be O O
considered O O
. O O

CXR O O
11-06 O O
: O O
Allowing O O
for O O
technical O O
changes O O
, O O
no O O
major B-Disease B-Disease
adverse I-Disease I-Disease
interval I-Disease I-Disease
change I-Disease I-Disease
has O O
occurred O O
. O O

Bibasilar B-Disease B-Disease
subsegmental I-Disease I-Disease
atelectasis I-Disease I-Disease
together O O
with O O
bilateral B-Disease B-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
appear O O
relatively O O
unchanged O O
. O O

The O O
mediastinum O O
appears O O
unchanged O O
. O O

Left-sided O O
subclavian O O
line O O
is O O
unchanged O O
in O O
position O O
. O O

There O O
is O O
evidence O O
of O O
prior O O
cardiac O O
surgery O O
. O O

2015-11-13 O O
06:15 O O
AM O O
BLOOD O O
WBC O O
- O O
8.8 O O
RBC O O
- O O
2.79 O O
* O O
Hgb O O
- O O
8.6 O O
* O O
Hct O O
- O O
25.4 O O
* O O
MCV O O
- O O
91 O O
MCH O O
- O O
30.9 O O
MCHC O O
- O O
33.8 O O
RDW O O
- O O
15.6 O O
* O O
Plt O O
Ct O O
- O O
583 O O
* O O

2015-11-12 O O
06:00 O O
AM O O
BLOOD O O
WBC O O
- O O
7.7 O O
RBC O O
- O O
2.73 O O
* O O
Hgb O O
- O O
8.3 O O
* O O
Hct O O
- O O
25.1 O O
* O O
MCV O O
- O O
92 O O
MCH O O
- O O
30.4 O O
MCHC O O
- O O
33.1 O O
RDW O O
- O O
15.5 O O
Plt O O
Ct O O
- O O
528 O O
* O O

2015-11-13 O O
06:15 O O
AM O O
BLOOD O O
Plt O O
Ct O O
- O O
583 O O
* O O

2015-11-13 O O
06:15 O O
AM O O
BLOOD O O
PT O O
- O O
18.0 O O
* O O
PTT O O
- O O
62.3 O O
* O O
INR(PT) O O
- O O
1.7 O O
* O O

2015-11-12 O O
06:00 O O
AM O O
BLOOD O O
PT O O
- O O
15.5 O O
* O O
PTT O O
- O O
62.4 O O
* O O
INR(PT) O O
- O O
1.4 O O
* O O

2015-11-11 O O
05:45 O O
AM O O
BLOOD O O
PT O O
- O O
14.5 O O
* O O
PTT O O
- O O
51.4 O O
* O O
INR(PT) O O
- O O
1.3 O O
* O O

2015-11-13 O O
06:15 O O
AM O O
BLOOD O O
Glucose O O
- O O
96 O O
UreaN O O
- O O
20 O O
Creat O O
- O O
1.6 O O
* O O
Na O O
- O O
141 O O
K O O
- O O
4.3 O O
Cl O O
- O O
106 O O
HCO3 O O
- O O
24 O O
AnGap O O
- O O
15 O O

2015-11-12 O O
06:00 O O
AM O O
BLOOD O O
Glucose O O
- O O
85 O O
UreaN O O
- O O
19 O O
Creat O O
- O O
1.6 O O
* O O
Na O O
- O O
140 O O
K O O
- O O
4.4 O O
Cl O O
- O O
105 O O
HCO3 O O
- O O
24 O O
AnGap O O
- O O
15 O O

2015-11-11 O O
05:45 O O
AM O O
BLOOD O O
Creat O O
- O O
1.6 O O
* O O
K O O
- O O
4.7 O O

2015-10-28 O O
03:30 O O
PM O O
BLOOD O O
Glucose O O
- O O
98 O O
UreaN O O
- O O
26 O O
* O O
Creat O O
- O O
1.6 O O
* O O
Na O O
- O O
140 O O
K O O
- O O
4.6 O O
Cl O O
- O O
104 O O
HCO3 O O
- O O
27 O O
AnGap O O
- O O
14 O O

Brief O O
Hospital O O
Course O O
: O O

Ms. O O
Bridge O O
was O O
admitted O O
from O O
OSH O O
for O O
coronary O O
artery O O
bypass O O
surgery O O
. O O

She O O
underwent O O
usual O O
pre-operative O O
testing O O
along O O
with O O
carotid O O
ultrasound O O
. O O

CNIS O O
revealed O O
carotid B-Disease B-Disease
stenosis I-Disease I-Disease
and O O
she O O
ultimately O O
underwent O O
left O O
carotid O O
stenting O O
by O O
vascular O O
surgery O O
on O O
10-30 O O
. O O

Please O O
see O O
report O O
for O O
details O O
. O O

On O O
11-02 O O
she O O
was O O
brought O O
to O O
the O O
operating O O
room O O
where O O
she O O
underwent O O
a O O
coronary O O
artery O O
bypass O O
graft O O
x O O
2 O O
. O O

Please O O
see O O
operative O O
report O O
for O O
surgical O O
details O O
. O O

She O O
tolerated O O
the O O
procedure O O
well O O
and O O
was O O
transferred O O
to O O
the O O
CSRU O O
for O O
invasive O O
monitoring O O
in O O
stable O O
condition O O
. O O

Later O O
on O O
op O O
day O O
sedation O O
was O O
weaned O O
, O O
she O O
awoke O O
neurologically O O
intact O O
and O O
was O O
extubated O O
. O O

On O O
post-op O O
day O O
one O O
chest O O
tubes O O
were O O
removed O O
and O O
beta O O
blockers O O
and O O
diuretics O O
were O O
initiated O O
. O O

She O O
was O O
gently O O
diuresed O O
towards O O
her O O
pre-op O O
weight O O
. O O

Also O O
on O O
this O O
day O O
she O O
was O O
transferred O O
to O O
the O O
SDU O O
. O O

Early O O
on O O
post-op O O
day O O
two O O
Ms. O O
Bridge O O
had O O
an O O
episode O O
of O O
aphasia B-Disease B-Disease
. O O

She O O
underwent O O
an O O
immediate O O
head O O
CT O O
and O O
Neuro O O
consult O O
and O O
was O O
transferred O O
back O O
to O O
the O O
CSRU O O
. O O

CT O O
was O O
negative O O
and O O
she O O
returned O O
to O O
baseline O O
neuro O O
status O O
without O O
deficits B-Disease B-Disease
by O O
arrival O O
to O O
CSRU O O
. O O

Neurology O O
concluded O O
episode B-Disease O
was O O
most O O
concerning O O
for O O
TIA B-Disease B-Disease
. O O

Epicardial O O
pacing O O
wires O O
were O O
removed O O
on O O
post-op O O
day O O
four O O
. O O

After O O
remaining O O
stable O O
in O O
the O O
CSRU O O
for O O
several O O
days O O
without O O
change B-Disease O
in I-Disease O
neuro I-Disease O
status I-Disease O
she O O
was O O
transferred O O
back O O
to O O
the O O
SDU O O
on O O
post-op O O
day O O
four O O
. O O

She O O
was O O
then O O
started O O
on O O
Heparin O O
with O O
transition O O
to O O
Coumadin O O
( O O
goal O O
INR O O
of O O
2-3 O O
secondary O O
to O O
h/o O O
bilateral B-Disease B-Disease
DVT I-Disease I-Disease
's). O O

During O O
entire O O
post-op O O
course O O
she O O
was O O
followed O O
by O O
physical O O
therapy O O
for O O
strength O O
and O O
mobility O O
. O O

She O O
continued O O
to O O
improve O O
steadily O O
over O O
the O O
next O O
several O O
days O O
without O O
any O O
other O O
post-op O O

complications B-Disease B-Disease
. O O

She O O
was O O
discharged O O
on O O
post-op O O
day O O
11 O O
. O O

Medications O O
on O O
Admission O O
: O O

Meds O O
at O O
home O O
: O O
Coumadin O O
, O O
Levoxyl O O
, O O
Folate O O
, O O
Colace O O
, O O
Byetta O O
, O O
Verapamil O O
, O O
Lisinopril O O
, O O
Pravachol O O
, O O
Nexium O O
, O O
Lasix O O
, O O
Celexa O O

Meds O O
at O O
transfer O O
: O O
Levoxyl O O
, O O
Celexa O O
, O O
Folate O O
, O O
Lopressor O O
, O O
Colace O O
, O O
RISS O O
, O O
B12 O O
, O O
Protonix O O
, O O
Lasix O O
, O O
Zocor O O
, O O
Verapamil O O
, O O
Lovenox O O
, O O
Lisinopril O O

Discharge O O
Medications O O
: O O

1. O O
Aspirin O O
81 O O
mg O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
)(s)* O O
Refills O O
:* O O
0 O O
* O O

2. O O
Pantoprazole O O
40 O O
mg O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
PO O O
Q24H O O
( O O
every O O
24 O O
hours O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
)(s)* O O
Refills O O
:* O O
0 O O
* O O

3. O O
Levothyroxine O O
125 O O
mcg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

4. O O
Simvastatin O O
40 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

5. O O
Citalopram O O
20 O O
mg O O
Tablet O O
Sig O O
: O O
0.5 O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

6. O O
Clopidogrel O O
75 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

7. O O
Ferrous O O
Gluconate O O
300 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

8. O O
Ascorbic O O
Acid O O
500 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

9. O O
Folic O O
Acid O O
1 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

10. O O
Metoprolol O O
Tartrate O O
25 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

Disp O O
:* O O
60 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

11. O O
Docusate O O
Sodium O O
100 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

Disp O O
:* O O
30 O O
Capsule O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

12. O O
Coumadin O O
5 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
once O O
a O O
day O O
: O O
Check O O
INR O O
11-15 O O
with O O
results O O
called O O
to O O
Dr. O O
Lynn O O
. O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

13. O O
Tramadol O O
50 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
Q4-6H O O
( O O
every O O
4 O O
to O O
6 O O
hours O O
) O O
as O O
needed O O
. O O

Disp O O
:* O O
50 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

14. O O
Lasix O O
40 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
once O O
a O O
day O O
: O O
40 O O
mg O O
daily O O
x O O
1 O O
week O O
then O O
40 O O
mg O O
every O O
other O O
day O O
as O O
prior O O
to O O
surgery O O
. O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

Discharge O O
Disposition O O
: O O

Extended O O
Care O O

Discharge O O
Diagnosis O O
: O O

Coronary B-Disease B-Disease
Artery I-Disease I-Disease
Disease I-Disease I-Disease
s/p O O
Coronary O O
Artery O O
Bypass O O
Graft O O
x O O
2 O O

Post-operative B-Disease B-Disease
Transient I-Disease I-Disease
Ischemic I-Disease I-Disease
Attack I-Disease I-Disease

Carotid B-Disease B-Disease
Stenosis I-Disease I-Disease
s/p O O
Left O O
Carotid O O
Stenting O O

PMH O O
: O O
Hypertension B-Disease B-Disease
, O O
Hyperlipidemia B-Disease B-Disease
, O O
Diabetes B-Disease B-Disease
Mellitus I-Disease I-Disease
, O O
Hypothyroid B-Disease B-Disease
, O O
h/o O O
Bilateral B-Disease B-Disease
DVT I-Disease I-Disease
's, I-Disease O
Pleural B-Disease B-Disease
disorder I-Disease I-Disease
? O O
Sarcoidosis B-Disease B-Disease
, O O
Gastritis B-Disease B-Disease
, O O
B12 B-Disease B-Disease
deficiency I-Disease I-Disease
, O O
Chronic B-Disease B-Disease
renal I-Disease I-Disease
insufficiency I-Disease I-Disease
, O O
s/p O O
Appendectomy O O
, O O
s/p O O
Lap O O
cholectomy O O
, O O
s/p O O
Total O O
abdominal O O
hysterectomy O O

Discharge O O
Condition O O
: O O

good O O

Discharge O O
Instructions O O
: O O

Patient O O
may O O
shower O O
, O O
no O O
baths O O
. O O

No O O
creams O O
, O O
lotions O O
or O O
ointments O O
to O O
incisions B-Disease B-Disease
. O O

No O O
driving O O
for O O
at O O
least O O
one O O
month O O
. O O

No O O
lifting O O
more O O
than O O
10 O O
lbs O O
for O O
at O O
least O O
10 O O
weeks O O
from O O
the O O
date O O
of O O
surgery O O
. O O

Monitor O O
wounds B-Disease B-Disease
for O O
signs B-Disease O
of I-Disease O
infection I-Disease B-Disease
. O O
Please O O
call O O
with O O
any O O
concerns O O
or O O
questions O O
. O O

VVp O O
Instructions O O
: O O

Dr. O O
von O O
Sampson O O
in O O
4 O O
weeks O O

Dr O O
Royer O O
in O O
2-3 O O
weeks O O

Dr. O O
Lynn O O
in O O
1-2 O O
weeks O O

Peterson O O
ver O O
Vasquez O O
MD O O
07-506 O O

Completed O O
by O O
: O O
Theresa O O
Leonore O O
NP O O
80-BXH O O
2015-11-13 O O
@ O O
1100 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Ruby O O
von O O
der O O
Smith O O
on: O O
WED O O
2015-12-09 O O
3:34 O O
PM O O

( O O
End O O
of O O
Report O O
) O O

843566350 O O
RWH O O

0025596 O O

526208 O O

0555812 O O

1/12/2005 O O
12:00:00 O O
AM O O

ED O O
Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

ED O O
DISCHARGE O O
NOTIFICATION O O
/ O O
SUMMARY O O

KOTEA O O
, O O
TORTHEOA O O

MRN O O
: O O

0025596 O O

Age O O
: O O

47y O O

REGISTRATION O O
DATE O O
: O O

01/12/2005 O O
06:07 O O
AM O O

Provider O O
: O O

THAA O O
WAGES O O

PRELMINARY O O
REPORT O O

Benefits O O
Assigned O O
: O O

N O O

Discharge O O
Note O O

Date O O
/ O O
Time O O
: O O

01/12/2005 O O
09:17 O O

Discharge O O
Status O O
: O O

Discharged O O

Condition O O
on O O
Discharge O O
: O O

Stable O O

Patient O O
States O O
Complaint O O
: O O

MIGRAINES B-Disease B-Disease
FOR O O
10 O O
DAYS O O

Standardized O O
Discharge O O
Instructions O O
: O O

The O O
patient O O
was O O
given O O
printed O O
instructions O O
for O O
headache B-Disease B-Disease
( O O
English O O
) O O
. O O

Diagnosis O O
: O O

Headache B-Disease B-Disease

Treatment O O
Rendered O O
: O O

MD O O
evaluation O O
, O O
head O O
CT O O

Discharge O O
Medications O O
: O O

None O O

Follow O O
up O O
Service O O
: O O

Please O O
follow O O
up O O
with O O
Dr. O O
Ner O O

PCP O O
Name O O
: O O

ANERM O O
, O O
CHRETTA O O

Provider O O
Number O O
: O O

25911 O O

This O O
report O O
was O O
created O O
by O O
WAGES O O
, O O
THAA O O
01/12/2005 O O
09:18 O O
AM O O

Admission O O
Date O O
: O O

2018-05-26 O O

Discharge O O
Date O O
: O O

2018-05-31 O O

Date O O
of O O
Birth O O
: O O

1935-11-10 O O

Sex O O
: O O

F O O

Service O O
: O O

MEDICINE O O

Allergies O O
: O O

Codeine O O
/ O O
Iodine O O

Attending O O
: O O
Derrick O O
L. O O
Mayo O O
, O O
M.D. O O

Chief O O
Complaint O O
: O O

large B-Disease B-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
, O O
transfer O O
from O O
OSH O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

Thoracentesis O O
2018-05-27 O O

History O O
of O O
Present O O
Illness O O
: O O

82 O O
F O O
with O O
h/o O O
COPD B-Disease B-Disease
, O O
CAD B-Disease B-Disease
, O O
pafib B-Disease B-Disease
and O O
SSS B-Disease O
s/p O O
pacer O O
on O O
05-08 O O
for O O
symptomatic B-Disease B-Disease
pauses I-Disease I-Disease
is O O
transferred O O
for O O
large B-Disease B-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
? O O
needing O O
drainage O O
and O O
CHF B-Disease B-Disease
. O O

She O O
was O O
admitted O O
to O O
Cambridge O O
Hospital O O
2018-05-24 O O
with O O
ARF B-Disease B-Disease
( O O
Cr O O
3.5 O O
up O O
from O O
0.9 O O
) O O
and O O
SOB B-Disease B-Disease
. O O

According O O
to O O
her O O
guardian O O
she O O
was O O
discharged O O
to O O
her O O
NH O O
for O O
a O O
few O O
days O O
after O O
her O O
pacer O O
was O O
placed O O
05-08 O O
, O O
which O O
was O O
complicated O O
by O O
a B-Disease O
PTX I-Disease O
requiring O O
CT O O
placement O O
which O O
had O O
been O O
d/c O O
'd O O
in O O
the O O
hospital O O
after O O
resolution O O
of O O
her B-Disease O
PTX I-Disease O
. O O

She O O
had O O
some O B-Disease
nausea B-Disease I-Disease
/ O O
vomiting B-Disease B-Disease
and O O
generally O O
was O O
taking O O
poor O O
pos O O
at O O
her O O
NH O O
. O O

There O O
had O O
been O O
some O O
concern O O
her B-Disease B-Disease
nausea I-Disease I-Disease
was O O
due O O
to O O
her O O
amiodarone O O
which O O
had O O
been O O
discontinued O O
about O O
1 O O
week O O
ago O O
. O O

She O O
was O O
then O O
sent O O
to O O
Franklin O O
Medical O O
Center O O
05-24 O O
with O O
lethargy B-Disease B-Disease
and O O
n/v B-Disease B-Disease
. O O

At O O
Erich O O
Lindemann O O
Mental O O
Health O O
Center O O
she O O
was O O
discovered O O
to O O
have O O
ARF B-Disease B-Disease
, O O
a B-Disease B-Disease
large I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
, O O
and O O
bilateral B-Disease B-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
. O O

She O O
was O O
treated O O
with O O
IVF O O
for O O
her B-Disease B-Disease
ARF I-Disease I-Disease
. O O

She O O
underwent O O
a O O
TTE O O
at O O
Erich O O
Lindemann O O
Mental O O
Health O O
Center O O
today O O
( O O
05-26 O O
) O O
showing O O
mod-lg B-Disease B-Disease
circumferential I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
without O O
evidence O O
of O O
RV B-Disease B-Disease
diastolic I-Disease I-Disease
collapse I-Disease I-Disease
and O O
no O O
MV O B-Disease
inflow O I-Disease
evidence O O
of O O
tamponade B-Disease B-Disease
, O O
pacer O O
wire O O
located O O
in O O
RV O O
apex O O
. O O

There O O
was O O
still O O
concern O O
for O O
her B-Disease B-Disease
effusion I-Disease I-Disease
contributing O O
to O O
her B-Disease B-Disease
SOB I-Disease I-Disease
at O O
the O O
OSH O O
so O O
she O O
was O O
transferred O O
for O O
drainage O O
and O O
treatment O O
of O O
CHF B-Disease B-Disease
. O O

Today O O
she O O
only O O
complains O O
of O O
some B-Disease B-Disease
SOB I-Disease I-Disease
, O O
which O O
she O O
says O O
remains O O
largely O O
unchanged O O
over O O
the O O
past O O
few O O
days O O
. O O

She O O
denies O O
any B-Disease B-Disease
CP I-Disease I-Disease
/ O O
cough B-Disease B-Disease
/ O O
fever B-Disease B-Disease
/ O O
abd B-Disease B-Disease
pain I-Disease I-Disease
/ O O
diarrhea B-Disease B-Disease
/ O O
black B-Disease B-Disease
or I-Disease O
bloody I-Disease B-Disease
stools I-Disease I-Disease
/ O O
headache B-Disease B-Disease
. O O

Past O O
Medical O O
History O O
: O O

htn B-Disease O

afib B-Disease O
, O O
SSS B-Disease O

COPD B-Disease B-Disease

CAD B-Disease B-Disease

pacer O O
DDDR O O
( O O
Vitatron O O
CL860 O O
) O O
placed O O
05-08 O O
for O O
SSS B-Disease B-Disease
with O O
symptomatic B-Disease B-Disease
bradycardia I-Disease I-Disease
, O O
c/b O O
R B-Disease O
PTX I-Disease B-Disease
requiring O O
chest O O
tube O O

GERD B-Disease B-Disease

CVA B-Disease B-Disease

hypothyroidism B-Disease B-Disease

legally B-Disease O
blind I-Disease B-Disease

Social O O
History O O
: O O

NH O O
resident O O
, O O
guardian O O
Robert O O
Murrell O O

Family O O
History O O
: O O

NC O O

Physical O O
Exam O O
: O O

Exam O O
: O O
T O O
96.2 O O
HR O O
70 O O
BP O O
118/46 O O
R O O
24 O O
sat O O
90% O O
on O O
60%FM O O

pulsus B-Disease O
parodoxus I-Disease O
= O O
6-8 O O
mm O O

gen O O
: O O
mild B-Disease B-Disease
resp I-Disease I-Disease
distress I-Disease I-Disease
speaking O O
in O O
full O O
sentences O O
but O O
using O O
accessory O O
muscles O O

HEENT O O
: O O
mmm O O
, O O
JVP O O
at O O
14 O O
cm O O
, O O
no O O
bruits B-Disease B-Disease
, O O
supple O O

CV O O
: O O
RRR O O
, O O
02-19 O O
sys O O
m O O
at O O
RUSB O O

pulm O O
: O O
no O O
BS O O
01-15 O O
way O O
up O O
bilat O O
, O O
no O O
consolidation B-Disease B-Disease

abd O O
: O O
s/nt/slightly O O
distended B-Disease B-Disease
, O O
dec B-Disease O
BS I-Disease O
, O O
no O O
CVA B-Disease B-Disease
tenderness I-Disease I-Disease

ext O O
: O O
1+ B-Disease B-Disease
LE I-Disease I-Disease
edema I-Disease I-Disease

Pertinent O O
Results O O
: O O

ECG O O
: O O
a O O
paced O O
at O O
70 O O
bpm O O
/ O O
nml O O
axis O O
, O O
LBBB B-Disease B-Disease
, O O
no O O
ST B-Disease B-Disease
or I-Disease I-Disease
TW I-Disease I-Disease
changes I-Disease I-Disease

CXR O O
at O O
Erich O O
Lindemann O O
Mental O O
Health O O
Center O O
05-26 O O
: O O
bilateral B-Disease O
pleural I-Disease O
eff I-Disease O
and O O
pericardial B-Disease O
eff I-Disease O

CT O O
chest O O
at O O
Erich O O
Lindemann O O
Mental O O
Health O O
Center O O
05-25 O O
: O O
large B-Disease B-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
, O O
bilat B-Disease B-Disease
pleural I-Disease I-Disease
eff I-Disease I-Disease
with O O
underlying B-Disease B-Disease
consolidation I-Disease I-Disease
which O O
could O O
represent O O
PNA B-Disease B-Disease
vs. O O
atelectasis B-Disease B-Disease

TTE O O
at O O
Erich O O
Lindemann O O
Mental O O
Health O O
Center O O
05-26 O O
: O O
mod-lg B-Disease O
circumferential I-Disease O
pericardial I-Disease O
eff I-Disease O
, O O
no O O
evidence O O
of O O
RV B-Disease B-Disease
diastolic I-Disease I-Disease
collapse I-Disease I-Disease
, O O
no O O
MV O B-Disease
inflow O I-Disease
evidence O O
of O O
tamponade B-Disease B-Disease
, O O
pacer O B-Disease
lead O I-Disease
located O O
in O O
RV O O
apex O O

head O O
CT O O
at O O
Erich O O
Lindemann O O
Mental O O
Health O O
Center O O
05-24 O O
: O O
atrophy B-Disease B-Disease
, O O
dense B-Disease B-Disease
calcification I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
tentorium I-Disease I-Disease
, O O
most O O
likely O O
of O O
metabolic O B-Disease
etiology O I-Disease

IMAGING O O
AT O O
Providence O O
Behavioral O O
Health O O
Hospital O O
: O O

ECHO O O
2018-05-28 O O

IMPRESSION O O
: O O
Moderate B-Disease B-Disease
to I-Disease I-Disease
large I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
( O O
minimal B-Disease B-Disease
fluid I-Disease I-Disease
anteriorly I-Disease I-Disease
( O O
1cm O O
), O O
? O O
bloody B-Disease B-Disease
). O O

No O O
definite B-Disease B-Disease
tamponade I-Disease I-Disease
physiology I-Disease I-Disease
. O O

Pacer O O
seen O O
in O O
RV O O
apex O O
, O O
but O O
cannot O O
exclude O O
perforation B-Disease B-Disease
. O O

CXR O O
2018-05-30 O O

FINDINGS O O
: O O
The O O
lung O O
volumes O O
are O O
Moderate O B-Disease
bilateral B-Disease I-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
are O O
unchanged O O
. O O

Mild B-Disease B-Disease
pulmonary I-Disease I-Disease
edema I-Disease I-Disease
is O O
unchanged O O
. O O

Lung O O
volumes O O
are O O
low B-Disease O
. O O

Bibasilar B-Disease B-Disease
atelectasis I-Disease I-Disease
is O O
unchanged O O
. O O

IMPRESSION O O
: O O
Unchanged B-Disease B-Disease
moderate I-Disease I-Disease
bilateral I-Disease I-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
and O O
mild B-Disease B-Disease
CHF I-Disease I-Disease
. O O

RENAL O O
US O O
2018-05-28 O O

FINDINGS O O
: O O
The O O
right O O
kidney O O
measures O O
11 O O
cm O O
in O O
length O O
, O O
the O O
left O O
kidney O O
measures O O
9.7 O O
cm O O
in O O
length O O
. O O

No O O
hydronephrosis B-Disease B-Disease
is O O
seen O O
. O O

No O O
urinary B-Disease B-Disease
calculi I-Disease I-Disease
are O O
seen O O
. O O

The O O
bladder O O
appears O O
unremarkable O O
and O O
contains O O
a O O
Foley O O
catheter O O
. O O

IMPRESSION O O
: O O
No O O
evidence O O
of O O
hydronephrosis B-Disease B-Disease
. O O

Brief O O
Hospital O O
Course O O
: O O

A/P O O
: O O

82 O O
y/o O O
f O O
w O O
h/o O O
afib B-Disease B-Disease
, O O
SSS B-Disease O
s/p O O
pacer O O
05-08 O O
c/b O O
PTX B-Disease B-Disease
requiring O O
CT O O
, O O
CAD B-Disease B-Disease
, O O
who O O
was O O
readmitted O O
05-24 O O
with O O
ARF B-Disease B-Disease
and O O
lethargy B-Disease B-Disease
, O O
found O O
to O O
have O O
a B-Disease B-Disease
large I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
and O O
bilateral B-Disease B-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
, O O
with O O
echo O O
showing O O
no O O
evidence O O
of O O
tamponade B-Disease B-Disease
, O O
who O O
is O O
transferred O O
for O O
possible O O
pericardial O O
effusion O O
drainage O O
and O O
treatment O O
of O O
CHF B-Disease B-Disease
, O O
as O O
well O O
as O O
drainage O O
of O O
bilateral B-Disease B-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
. O O

She O O
had O O
a O O
BNP O O
of O O
> O O
5000 O O
on O O
admission O O
. O O

Since O O
admission O O
, O O
she O O
ruled O O
out O O
for O O
MI B-Disease B-Disease
by O O
enzymes O O
, O O
and O O
had O O
a O O
right O O
sided O O
thoracentesis O O
which O O
yielded O O
transudative B-Disease B-Disease
fluid I-Disease I-Disease
. O O

WBC O O
s O O
since O O
admission O O
were O O
as O O
high O O
as O O
14,000 O O
but O O
normalized O O
. O O

She O O
also O O
had O O
2 O O
echocardiograms O O
which O O
revealed O O
persistent B-Disease B-Disease
pericardial I-Disease I-Disease
effusions I-Disease I-Disease
. O O

She O O
has O O
been O O
gently O O
diuresed O O
but O O
has O O
worsening B-Disease B-Disease
ARF I-Disease I-Disease
. O O

Her B-Disease B-Disease
O2 I-Disease I-Disease
requirement I-Disease I-Disease
has O O
increased O O
despite O O
diuresis O O
. O O

She O O
denies O O
any O B-Disease
CP B-Disease I-Disease
/ O O
cough B-Disease B-Disease
/ O O
fever B-Disease B-Disease
, O O
abdominal B-Disease B-Disease
pain I-Disease I-Disease
/ O O
diarrhea B-Disease B-Disease
, O O
black B-Disease B-Disease
or I-Disease I-Disease
bloody I-Disease I-Disease
stools I-Disease I-Disease
or O O
headache B-Disease B-Disease
. O O

Her O O
urine O O
output O O
decreased B-Disease O
to O O
nearly O O
zero O O
. O O

In O O
the O O
setting O O
of O O
her B-Disease B-Disease
ongoing I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
, O O
she O O
was O O
transferred O O
for O O
closer O O
observation O O
to O O
the O O
CCU O O
. O O

The O O
CCU O O
fellow O O
and O O
team O O
declined O O
to O O
do O O
pericardial O O
drainage O O
, O O
as O O
the O O
pt O O
was O O
hemodynamically O O
stable O O
, O O
without O O
change B-Disease O
in I-Disease O
appearance I-Disease O
of I-Disease O
effusion I-Disease B-Disease
by O O
echo O O
performed O O
at O O
bedside O O
by O O
cards O O
fellow O O
. O O

As O O
she O O
was O O
felt O O
by O O
the O O
CCU O O
to O O
be O O
a O O
poor O O
candidate O O
for O O
right O O
heart O O
cath O O
, O O
was O O
hemodynamically O O
stable O O
with O O
blood O O
pressure O O
110 O O
s- O O
120 O O
s O O
systolic O O
and O O
pulse O O
70 O O
s- O O
80 O O
s O O
, O O
she O O
was O O
called O O
out O O
of O O
the O O
CCU O O
and O O
back O O
to O O
the O O
cardiac O O
floor O O
without O O
intervention O O
. O O

The O O
procedure O O
team O O
was O O
called O O
to O O
consider O O
doing O O
a O O
left O O
thoracentesis O O
, O O
but O O
she O O
was O O
declined O O
because O O
it O O
was O O
felt O O
that O O
her B-Disease B-Disease
effusions I-Disease I-Disease
were O O
transudative B-Disease B-Disease
, O O
secondary O O
to O O
CHF B-Disease B-Disease
, O O
and O O
it O O
was O O
recommended O O
to O O
treat O O
CHF B-Disease B-Disease
. O O

The O O
pt O O
continued O O
to O O
have O O
low B-Disease B-Disease
urine I-Disease I-Disease
output I-Disease I-Disease
. O O

She O O
was O O
given O O
a O O
lasix O O
drip O O
IV O O
upon O O
call-out O O
of O O
the O O
ICU O O
, O O
and O O
additional O O
boluses O O
of O O
IV O O
lasix O O
, O O
200 O O
mg O O
then O O
300 O O
mg O O
IV O O
were O O
given O O
with O O
a O O
good O O
response O O
, O O
however O O
, O O
she O O
remained O O
net B-Disease B-Disease
positive I-Disease I-Disease
fluid I-Disease I-Disease
balance I-Disease I-Disease
. O O

Renal O O
consultants O O
did O O
not O O
feel O O
there O O
was O O
an O O
emergent O O
need O O
for O O
dialysis O O
. O O

A O O
nitro O O
drip O O
was O O
started O O
in O O
an O O
effort O O
to O O
decrease O O
her O O
preload O O
and O O
afterload O O
. O O

On O O
call O O
out O O
from O O
the O O
CCU O O
, O O
the O O
pt O O
was O O
satting O O
93% O O
on O O
4-5L O O
NC O O
, O O
and O O
through O O
the O O
following O O
night O O
, O O
her B-Disease B-Disease
oxygen I-Disease I-Disease
requirement I-Disease I-Disease
increased O O
to O O
NRB O O
, O O
wherein O O
she O O
was O O
satting O O
upper O O
80 O O
s- O O
low O O
90 O O
s. O O

ABG O O
that O O
evening O O
was O O
7.29/51/56 O O
on O O
4L O O
NC O O
and O O
early O O
the O O
next O O
morning O O
, O O
was O O
7.25/62/64 O O
on O O
NRB O O
. O O

A O O
CXR O O
was O O
performed O O
the O O
evening O O
of O O
5/16 O O
, O O
showing O O
moderate B-Disease B-Disease
sized I-Disease I-Disease
bilateral I-Disease I-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
, O O
stable B-Disease B-Disease
cardiomegaly I-Disease I-Disease
and O O
a O O
possible O O
RLL B-Disease B-Disease
infiltrate I-Disease I-Disease
. O O

Vancomycin O O
and O O
Zosyn O O
were O O
started O O
. O O

She O O
was O O
afebrile B-Disease B-Disease
. O O

The O O
morning O O
of O O
5/17 O O
, O O
her O B-Disease
pulsus O I-Disease
parodoxicus O I-Disease
was O O
12 O O
. O O

Because O O
of O O
her O B-Disease
ABG O I-Disease
, O O
and O O
declining O B-Disease
clinical O I-Disease
status O I-Disease
, O O
the O O
CCU O O
was O O
notified O O
for O O
possible O O
transfer O O
. O O

The O O
CMED O O
CSRU O O
Intern O O
called O O
the O O
Murphy O O
, O O
Robert O O
Leigh O O
, O O
to O O
give O O
her O O
the O O
update O O
with O O
regards O O
to O O
the O B-Disease
pt O I-Disease
's O I-Disease
deteriorating O I-Disease
clinical O I-Disease
status O I-Disease
. O O

It O O
was O O
felt O O
that O O
given O O
her O O
age O O
, O O
multiple B-Disease B-Disease
co-morbidities I-Disease I-Disease
, O O
that O O
her O O
prognosis O O
was O O
poor O O
even O O
prior O O
to O O
CCU O O
admission O O
, O O
possible O O
pericardial O B-Disease
drainage O I-Disease
or O O
repeat O O
thoracenteses O O
. O O

Goals O O
of O O
care O O
were O O
clarified O O
with O O
her O O
Murphy O O
, O O
Robert O O
Sanchez O O
. O O

Explained O O
to O O
Lewin O O
that O O
pt O O
will O O
likely O O
need O O
to O O
be O O
intubated O O
, O O
as O O
she O O
cannot O O
lie O O
flat O O
, O O
and O O
most O O
likely O O
cannot O O
undergo O O
pericardial O O
drainage O O
, O O
thoracentesis O O
, O O
or O O
right O O
heart O O
cath O O
with O O
BiPAP O O
( O O
which O O
would O O
have O O
been O O
the O O
next O O
measure O O
after O O
NRB O O
, O O
and O O
prior O O
to O O
intubation O O
). O O

Explained O O
that O O
despite O O
these O O
invasive O O
measures O O
, O O
she O O
still O O
has O O
a O O
very O O
poor O O
prognosis O O
. O O

Odell O O
stated O O
she O O
had O O
been O O
thinking O O
about O O
this O O
all O O
night O O
of O O
2018-05-30 O O
, O O
and O O
agreed O O
that O O
this O O
is O O
not O O
what O O
the O O
pt O O
would O O
have O O
wanted O O
. O O

Odell O O
does O O
not O O
believe O O
the O O
pt O O
would O O
want O O
to O O
be O O
intubated O O
, O O
with O O
central O O
line O O
, O O
right O O
heart O O
cath O O
, O O
in O O
the O O
CCU O O
. O O

She O O
requested O O
the O O
patient O O
be O O
made O O
Comfort O O
Measures O O
Only O O
. O O

She O O
was O O
DNR/DNI O O
on O O
admission O O
. O O

This O O
was O O
documented O O
in O O
the O O
computer O O
, O O
confirmed O O
with O O
Cardiology O O
attending O O
and O O
fellow O O
, O O
and O O
conveyed O O
to O O
the O O
CCU O O
staff O O
, O O
who O O
were O O
informed O O
she O O
may O O
need O O
to O O
go O O
for O O
transfer O O
( O O
which O O
was O O
subsequently O O
cancelled O O
). O O

The O O
pt O O
will O O
be O O
made O O
comfortable O O
, O O
with O O
goals O O
of O O
care O O
shifted O O
towards O O
suppressing O O
her B-Disease B-Disease
air I-Disease I-Disease
hunger I-Disease I-Disease
and O O
pain B-Disease B-Disease
. O O

#. O O
SOB B-Disease B-Disease
: O O
Most O O
consistent O O
with O O
CHF B-Disease B-Disease
by O O
exam O O
, O O
although O O
unknown O O
what O O
the O O
severity O O
of O O
her B-Disease B-Disease
COPD I-Disease I-Disease
is O O
currently O O
. O O

TTE O O
revealed O O
large B-Disease B-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
. O O

Pt O O
is O O
now O O
s/p O O
drainage O O
of O O
right B-Disease B-Disease
pleural I-Disease I-Disease
effusion I-Disease I-Disease
, O O
diagnostic O O
and O O
therapeutic O O
, O O
with O O
studies O O
consistent O O
with O O
transudate B-Disease B-Disease
, O O
etiology O O
most O O
likely O O
02-15 O O
CHF B-Disease B-Disease
. O O

We O O
continued O O
her O O
albuterol O O
/ O O
atrovent O O
nebs O O
, O O
diuresis O O
with O O
IV O O
lasix O O
drip O O
and O O
boluses O O
. O O

Her O O
05-27 O O
CXR O O
post O O
procedure O O
w/o O O
PNX B-Disease B-Disease
, O O
effusion B-Disease B-Disease
much O O
improved O O
, O O
yet O O
her O O
05-28 O O
CXR O O
worse O O
than O O
05-27 O O
with O O
some O O
reaccumulation O O
of O O
right B-Disease B-Disease
pleural I-Disease I-Disease
effusion I-Disease I-Disease
. O O

Then O O
, O O
on O O
05-29 O O
, O O
she O O
demonstrated O O
bilateral B-Disease B-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
( O O
reaccumulated O O
), O O
right B-Disease B-Disease
lower I-Disease I-Disease
lobe I-Disease I-Disease
infiltrate I-Disease I-Disease
( O O
started O O
on O O
vanco O O
/ O O
zosyn O O
)-> O O
put O O
on O O
face O O
mask O O
, O O
given O O
lasix O O
x O O
1 O O
bolus O O
100 O O
mg O O
, O O
responded O O
somewhat O O
and O O
o2 O O
sat O O
stable O O
in O O
low O O
90 O O
s. O O

She O O
was O O
given O O
200 O O
mg O O
IV O O
lasix O O
X O O
1 O O
with O O
an O O
additional O O
100 O O
cc O O
of O O
urine O O
output O O
the O O
evening O O
of O O
5/16 O O
. O O

Her O O
lasix O O
gtt O O
continued O O
during O O
this O O
time O O
. O O

Her O O
oxygen O O
sats O O
did O O
not O O
improve O O
. O O

She O O
was O O
then O O
made O O
CMO O O
. O O

See O O
above O O
. O O

#. O O
Pericardial B-Disease B-Disease
effusion I-Disease I-Disease
: O O
unclear O O
etiology O O
, O O
OSH O O
had O O
raised O O
question O O
of O O
RV B-Disease B-Disease
perforation I-Disease I-Disease
from O O
pacer O O
, O O
however O O
she O O
had O O
a O O
normal O O
echo O O
appearance O O
of O O
lead O O
, O O
no O O
tamponade B-Disease B-Disease
by O O
exam O O
. O O

This O O
has O O
still O O
be O O
known O O
to O O
occur O O
during O O
the O O
placement O O
of O O
pacemaker O O
. O O

It O O
was O O
felt O O
posthumously O O
that O O
her B-Disease B-Disease
large I-Disease I-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease
was O O
most O O
likely O O
secondary O O
to O O
a B-Disease O
complication I-Disease O
of O O
pacer O O
placement O O
, O O
although O O
this O O
was O O
not O O
seen O O
on O O
imaging O O
. O O

In O O
the O O
last O O
12 O O
hours O O
of O O
her O O
life O O
, O O
her O B-Disease
pulsus O I-Disease
was O O
12 O O
, O O
and O O
she O O
was O O
felt O O
to O O
likely O O
to O O
have O O
aspect O O
of O O
tamponade B-Disease B-Disease
physiology I-Disease I-Disease
, O O
since O O
her O O
preload O O
was O O
reduced O O
. O O

#. O O
CHF B-Disease B-Disease
: O O
normal O O
EF O O
on O O
TTE O O
so O O
possibly O O
with O O
diastolic B-Disease B-Disease
dysfunction I-Disease I-Disease
, O O
ruled O O
out O O
for O O
MI B-Disease B-Disease

- O O
See O O
course O O
of O O
diuresis O O
above O O
. O O

- O O
We O O
continued O O
ASA O O
/ O O
imdur O O
/ O O
CCB O O
/ O O
hold O O
diovan O O
until O O
pt O O
was O O
made O O
CMO O O
. O O

#. O O
Pleural B-Disease B-Disease
effusions I-Disease I-Disease
: O O
Likely O O
due O O
to O O
CHF B-Disease B-Disease
although O O
had O O
some B-Disease B-Disease
leukocytosis I-Disease I-Disease
at O O
admission O O
to O O
OSH O O
. O O

Mary O O
studies O O
c/w O O
transudate B-Disease B-Disease
. O O

- O O
After O O
she O O
was O O
made O O
CMO O O
, O O
the O O
pt O O
was O O
started O O
on O O
Morphine O O
gtt O O
to O O
maximize O O
comfort O O
and O O
minimize O O
air B-Disease B-Disease
hunger I-Disease I-Disease
. O O

#. O O
Afib/SSS B-Disease O
: O O
She O O
was O O
A-paced O O
, O O
pacer O O
placed O O
05-08 O O
in O O
DDDR O O
mode O O
, O O
complicated O O
by O O
PTX B-Disease B-Disease
requiring O O
chest O O
tube O O
which O O
resolved O O
and O O
tube O O
was O O
removed O O
during O O
admit O O
for O O
pacer O O
, O O
no O O
evidence O O
of O O
PTX B-Disease B-Disease
on O O
most O O
recent O O
CXR O O
. O O

Her O O
pacer O O
wires O O
in O O
correct O O
position O O
. O O

We O O
continued O O
amiodarone O O
until O O
pt O O
was O O
made O O
CMO O O
. O O

Anticoagulation O O
has O O
not O O
been O O
given O O
this O O
admission O O
. O O

She O O
was O O
a O O
poor O O
anticoagulation O O
candidate O O
. O O

We O O
started O O
her O O
on O O
dilt O O
for O O
additional O O
a O O
fib O O
control O O
( O O
revert O O
back O O
to O O
a B-Disease O
fib I-Disease O
on O O
05-29 O O
), O O
which O O
was O O
stopped O O
when O O
the O O
pt O O
was O O
made O O
CMO O O
. O O

#. O O
Oliguric B-Disease B-Disease
ARF I-Disease I-Disease
: O O
likely O O
prerenal O B-Disease
due O O
to O O
n/v B-Disease B-Disease
poor B-Disease I-Disease
po I-Disease I-Disease
intake I-Disease I-Disease
and O O
poor B-Disease B-Disease
forward I-Disease I-Disease
flow I-Disease I-Disease
, O O
However O O
, O O
need O O
to O O
continue O O
diuresis O O
. O O

Her O O
urine O O
lytes O O
consistent O O
with O O
ATN B-Disease O
, O O
FENA O O
4% O O
. O O

Renal O O
u/s O O
negative O O
for O O
hydronephrosis B-Disease B-Disease
. O O

Renal O O
consultants O O
did O O
not O O
feel O O
that O O
there O O
was O O
an O O
indication O O
for O O
urgent O O
hemodialysis O O
. O O

She O O
continued O O
to O O
put O O
out O O
low B-Disease B-Disease
amounts I-Disease I-Disease
of I-Disease I-Disease
urine I-Disease I-Disease
throughout O O
the O O
admission O O
, O O
despite O O
aggressive O O
diuresis O O
with O O
IV O O
lasix O O
gtt O O
and O O
boluses O O
. O O

See O O
above O O
. O O

#. O O
ID O O
: O O
initially O O
had O O
leukocytosis B-Disease B-Disease
at O O
admission O O
, O O
with O O
chest O O
CT O O
showing O O
possible O O
underlying B-Disease B-Disease
consolidations I-Disease I-Disease
vs. O O
atelectasis B-Disease B-Disease
, O O
levoflox O O
started O O
05-24 O O
and O O
subsequently O O
stopped O O
( O O
no O O
consolidations B-Disease B-Disease
on O O
CXR O O
and O O
afebrile B-Disease B-Disease
). O O

U/A O O
on O O
05-27 O O
c/w O O
UTI B-Disease B-Disease
. O O

Pt O O
now O O
on O O
IV O O
Ceftriaxone O O
( O O
was O O
on O O
levoflox O O
since O O
05-24 O O
however O O
UA O O
now O O
floridly B-Disease B-Disease
positive I-Disease I-Disease
( O O
more O O
so O O
than O O
UA O O
at O O
OSH O O
) O O
so O O
felt O O
possibly O O
levo-resistant B-Disease B-Disease
. O O

Pt O O
started O O
on O O
CTX O O
05-27 O O
. O O

She O O
was O O
empirically O O
started O O
on O O
vanco/zosyn O O
for O O
empiric O O
hosp O O
acquired O O
pna O O
coverage O O

- O O
possible O O
opacity B-Disease B-Disease
on O O
CXR O O
- O O
along O O
w/ O O
leukocytosis B-Disease B-Disease
. O O

#. O O
Anemia B-Disease B-Disease
: O O
Unclear O O
source O O
. O O

She O O
was O O
guiaic O O
negative O O
. O O

- O O
no O O
transfusions O O
, O O
CMO/DNR/DNI O B-Disease

#. O O
FEN O O
: O O
check O O
lytes O O
, O O
most O O
recently O O
normal O O
. O O

cardiac/renal O O
diet O O

#. O O
Access O O
: O O
PIV O O

#. O O
Code O O
: O O
DNR/DNI/CMO O O
verified O O
with O O
Robert O O
Marks O O
2018-05-29 O O

#. O O
Communication O O
: O O
Guardian O O
Robert O O
Fitzgerald O O
( O O
520 O O
) O O
328 O O
5499 O O
. O O

Medications O O
on O O
Admission O O
: O O

aranesp O O
100 O O
mcg O O
( O O
X1 O O
05-26 O O
) O O

diltiazem O O
CD O O
240 O O
mg O O

paxil O O
20 O O
mg O O
daily O O

detrol O O
LA O O
4 O O
mg O O
daily O O

EC O O
ASA O O
81 O O
mg O O
daily O O

pepcid O O
20 O O
mg O O
daily O O

amiodarone O O
200 O O
mg O O
daily O O

levofloxacin O O
250 O O
mg O O
IV O O
daily O O
( O O
started O O
05-24 O O
) O O

levothyroxine O O
50 O O
mcg O O
daily O O

diovan O O
160 O O
mg O O
daily O O

imdur O O
60 O O
mg O O
daily O O

albuterol-ipratroprium O O
INH O O
2 O O
sprays O O
tid O O
prn O O

Discharge O O
Disposition O O
: O O

Expired O O

Discharge O O
Diagnosis O O
: O O

1. O O
Pulmonary B-Disease B-Disease
Edema I-Disease I-Disease
and O O
Hypoxic B-Disease B-Disease
Respiratory I-Disease I-Disease
Failure I-Disease I-Disease

2. O O
Large B-Disease B-Disease
pericardial I-Disease I-Disease
effusion I-Disease I-Disease

3. O O
Moderate B-Disease B-Disease
bilateral I-Disease I-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease

4. O O
Congestive B-Disease B-Disease
Heart I-Disease I-Disease
Failure I-Disease I-Disease

5. O O
Paroxysmal B-Disease B-Disease
Atrial I-Disease I-Disease
Fibrillation I-Disease I-Disease

6. O O
Sick B-Disease B-Disease
sinus I-Disease I-Disease
syndrome I-Disease I-Disease
status O O
post O O
pacer O O
placement O O

7. O O
Coronary B-Disease B-Disease
Artery I-Disease I-Disease
Disease I-Disease I-Disease

Discharge O O
Condition O O
: O O

Expired O O

Discharge O O
Instructions O O
: O O

Not O O
applicable O O

Followup O O
Instructions O O
: O O

Not O O
applicable O O

Jessica O O
Ashley O O
MD O O
19-617 O O

Completed O O
by O O
: O O
James O O
Weishaar O O
MD O O
01-503 O O
2018-05-31 O O
@ O O
1428 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Barry O O
Smith O O
on O O
: O O
FRI O O
2018-06-01 O O
8:26 O O
AM O O

( O O
End O O
of O O
Report O O
) O O

523704694 O O

PRGH O O

67119280 O O

480282 O O

10/23/1999 O O
12:00:00 O O
AM O O

Discharge O O
Summary O O

Signed O O

DIS O O

Admission O O
Date O O
: O O

10/23/1999 O O

Report O O
Status O O
: O O

Signed O O

Discharge O O
Date O O
: O O

11/02/1999 O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

Left B-Disease B-Disease
sided I-Disease I-Disease
spastic I-Disease I-Disease
hemiparesis I-Disease I-Disease
, O O
status O O
post O O
surgical O O
correction O O
of O O
C-1 O O
, O O
C-2 O B-Disease
dural O I-Disease
AVM O I-Disease
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Ms. O O
Breunlinke O O
is O O
a O O
69 O O
year-old O O
right O O
handed O O
woman O O
, O O
status O O
post O O
surgical O O
correction O O
of O O
a O B-Disease
C-1 O I-Disease
to O I-Disease
C-2 O I-Disease
dural O I-Disease
AVM O I-Disease
in O O
January O O
, O O
1998 O O
, O O
now O O
presenting O O
with O O
a O O
one O O
month O O
history O O
of O O
increasing B-Disease B-Disease
left I-Disease I-Disease
sided I-Disease I-Disease
weakness I-Disease I-Disease
and O O
pain B-Disease B-Disease
with O O
spasticity B-Disease B-Disease
, O O
occasional O B-Disease
difficulty B-Disease I-Disease
swallowing I-Disease I-Disease
and O O
abdominal B-Disease B-Disease
pain I-Disease I-Disease
. O O

She O O
was O O
originally O O
admitted O O
to O O
the O O
Verg O O
Medical O O
Center O O
in O O
January O O
, O O
1998 O O
, O O
because O O
of O O
a O O
one O O
year O O
history O O
of O O
left B-Disease B-Disease
sided I-Disease I-Disease
weakness I-Disease I-Disease
and O O
spasticity B-Disease B-Disease
. O O

She O O
was O O
found O O
to O O
have O O
intermedullary B-Disease B-Disease
lesion I-Disease I-Disease
at I-Disease I-Disease
C1-2 I-Disease I-Disease
level I-Disease I-Disease
which O O
on O O
biopsy O O
showed O O
abnormal B-Disease B-Disease
vasculature I-Disease I-Disease
, O O
hemosiderin B-Disease B-Disease
deposit I-Disease I-Disease
, O O
leading O O
in O O
turn O O
to O O
the O O
discovery O O
of O O
a B-Disease B-Disease
dural I-Disease I-Disease
arteriovenous I-Disease I-Disease
malformation I-Disease I-Disease
at O O
that O O
level O O
which O O
was O O
surgically O O
corrected O O
. O O

The O O
postoperative O O
period O O
was O O
complicated O O
by O O
transient B-Disease B-Disease
swallowing I-Disease I-Disease
difficulty I-Disease I-Disease
, O O
increasing B-Disease B-Disease
left I-Disease I-Disease
sided I-Disease I-Disease
weakness I-Disease I-Disease
and O O
urinary B-Disease B-Disease
retention I-Disease I-Disease
. O O

She O O
was O O
discharged O O
to O O
inpatient O O
rehabilitation O O
where O O
she O O
made O O
significant O O
progress O O
toward O O
recovery O O
. O O

As O O
of O O
the O O
beginning O O
of O O
September O O
, O O
1999 O O
, O O
she O O
was O O
able O O
to O O
swallow O O
without O O
difficulty O B-Disease
, O O
urinate O O
without O O
difficulty O B-Disease
( O O
although O O
bowel O O
movements O O
have O O
been O O
problematic B-Disease O
) O O
. O O

Functionally O O
, O O
she O O
was O O
at O O
the O O
level O O
of O O
pre-gait O O
training O O
and O O
able O O
to O O
stand O O
and O O
take O O
several O O
steps O O
with O O
upper O O
body O O
support O O
. O O

Over O O
the O O
past O O
4-5 O O
weeks O O
her B-Disease O
functional I-Disease O
level I-Disease O
has O O
progressively O O
deteriorated O O
. O O

She O O
is O O
now O O
unable O O
to O O
stand O O
and O O
needs O O
assistance O O
to O O
sit O O
up O O
. O O

Her O O
left O O
arm O O
has O O
developed O O
a B-Disease B-Disease
flexure I-Disease I-Disease
contraction I-Disease I-Disease
and O O
she O O
reports O O
intermitttent B-Disease B-Disease
pain I-Disease I-Disease
in I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
arm I-Disease I-Disease
and I-Disease I-Disease
leg I-Disease I-Disease
which O O
occurs O O
both O O
spontaneously O O
and O O
is O O
also O O
triggered O O
by O O
contact O O
. O O

She O O
has O O
developed O O
some O B-Disease
new B-Disease I-Disease
swallowing I-Disease I-Disease
difficulty I-Disease I-Disease
and O O
since O O
her O O
transfer O O
to O O
a O O
long O O
term O O
inpatient O O
care O O
facility O O
, O O
she O O
has O O
lost O O
ten O O
pounds O O
. O O

She O O
denies O O
dysuria B-Disease B-Disease
or O O
excessive B-Disease B-Disease
urinary I-Disease I-Disease
frequency I-Disease I-Disease
. O O

Over O O
the O O
past O O
several O O
weeks O O
she O O
has O O
also O O
developed O O
severe B-Disease B-Disease
intermittent I-Disease I-Disease
abdominal I-Disease I-Disease
pain I-Disease I-Disease
, O O
localized O O
to O O
the O O
suprapubic O O
area O O
, O O
left O O
greater O O
than O O
right O O
, O O
occurring O O
intermittently O O
. O O

The O O
patient O O
feels O O
this O O
is O O
secondary O O
to O O
her B-Disease B-Disease
hemorrhoids I-Disease I-Disease
, O O
although O O
it O O
does O O
not O O
clearly O O
localize O O
to O O
the O O
rectum O O
. O O

This B-Disease B-Disease
pain I-Disease I-Disease
often O O
follows O O
bowel O O
movement O O
but O O
does O O
occur O O
spontaneously O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Significant O O
for O O
Insulin B-Disease B-Disease
dependent I-Disease I-Disease
diabetes I-Disease I-Disease
mellitus I-Disease I-Disease
, O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
, O O
hypothyroidism B-Disease B-Disease
, O O
hypertension B-Disease B-Disease
, O O
depression B-Disease B-Disease
, O O
frequent B-Disease B-Disease
urinary I-Disease I-Disease
tract I-Disease I-Disease
infections I-Disease I-Disease
, O O
neuropathic B-Disease B-Disease
pain I-Disease I-Disease
syndrome I-Disease I-Disease
and O O
osteoporosis B-Disease B-Disease
. O O

MEDICATION O O
: O O

On O O
admission O O
include O O
Cozaar O O
75 O O
mg O O
q.d. O O
, O O
Coumadin O O
2 O O
mg/1 O O
mg O O
alternate O O
days O O
, O O
Synthroid O O
175 O O
mcg O O
q.d. O O
, O O
Zoloft O O
50 O O
mg O O
q.d. O O
, O O
Zantac O O
150 O O
mg O O
b.i.d. O O
, O O
Diabeta O O
25 O O
mg O O
q.d. O O
, O O
Proctofoam O O
1% O O
q.i.d. O O
, O O
Demerol O O
100 O O
mg O O
q O O
6 O O
p.r.n. O O
, O O
OsCal O O
2 O O
tabs O O
t.i.d. O O
, O O
multivitamins O O
and O O
KCl O O
supplements O O
, O O
Dulcolax O O
5 O O
mg O O
q.d. O O
, O O
Senokot O O
2 O O
tabs O O
q O O
h.s. O O
, O O
Metamucil O O
1 O O
tablespoon O O
b.i.d. O O
, O O
Detrol O O
2 O O
mg O O
b.i.d. O O
, O O
Neurontin O O
200 O O
mg O O
t.i.d. O O
, O O
HydroDIURIL O O
12.5 O O
mg O O
q.d. O O
, O O
Valium O O
10 O O
mg O O
q O O
8 O O
p.r.n. O O
muscle B-Disease B-Disease
spasm I-Disease I-Disease
, O O
Insulin O O
by O O
sliding O O
scale O O
and O O
levofloxacin O O
500 O O
mg O O
q.d. O O
beginning O O
October O O
23 O O
, O O
1999 O O
. O O

ALLERGIES O O
: O O

The O O
patient O O
is O O
allergic B-Disease B-Disease
to O O
Hydralazine O O
, O O
codeine O O
, O O
ace O O
inhibitors O O
, O O
Nifedipine O O
and O O
Percocet O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

On O O
admission O O
, O O
heart O O
is O O
regular O O
rate O O
and O O
rhythm O O
without O O
murmur B-Disease B-Disease
. O O

Lungs O O
are O O
clear O O
to O O
auscultation O O
bilaterally O O
. O O

Abdomen O O
is O O
soft O O
, O O
with O O
marked B-Disease B-Disease
suprapubic I-Disease I-Disease
tenderness I-Disease I-Disease
and O O
reduced B-Disease B-Disease
bowel I-Disease I-Disease
sounds I-Disease I-Disease
. O O

Anal O O
tone O O
is O O
reduced B-Disease O
. O O

Rectal O O
examination O O
is O O
nontender B-Disease B-Disease
and O O
stool O O
is O O
guaiac O O
negative O O
. O O

Neurologically O O
, O O
the O O
patient O O
is O O
alert O O
and O O
oriented O O
times O O
three O O
with O O
normal O O
speech O O
, O O
language O O
and O O
repetition O O
. O O

Cranial O O
nerves O O
: O O

pupils O O
are O O
4-6 O O
mm O O
bilaterally O O
, O O
extraocular O O
movements O O
were O O
full O O
without O O
nystagmus B-Disease B-Disease
. O O

Eye O O
closure O O
and O O
smile O O
are O O
symmetric O O
. O O

Tongue O O
is O O
midline O O
. O O

Facial O O
sensation O O
is O O
sensation O O
. O O

Strength O O
: O O

The O O
tone O O
is O O
markedly B-Disease B-Disease
increased I-Disease I-Disease
in I-Disease I-Disease
bot I-Disease I-Disease
legs I-Disease I-Disease
with O O
left O O
greater O O
than O O
right O O
. O O

Left O O
arm O O
shows O O
a B-Disease B-Disease
flexor I-Disease I-Disease
contracture I-Disease I-Disease
and O O
markedly B-Disease B-Disease
increased I-Disease I-Disease
tone I-Disease I-Disease
. O O

The O O
right O O
arm O O
shows O O
moderate B-Disease B-Disease
increased I-Disease I-Disease
tone I-Disease I-Disease
. O O

Power O O
: O O

The O O
left O O
upper O O
extremity O O
shows O O
reduction B-Disease B-Disease
in I-Disease I-Disease
motor I-Disease I-Disease
power I-Disease I-Disease
ranging O O
from O O
2/5 O O
in O O
the O O
triceps O O
, O O
4/5 O O
in O O
the O O
biceps O O
, O O
and O O
3-4/5 O O
in O O
the O O
wrists O O
and O O
hand O O
intrinsics O O
. O O

The O O
right O O
upper O O
extremity O O
shows O O
generalized B-Disease B-Disease
reduction I-Disease I-Disease
in I-Disease I-Disease
strength I-Disease I-Disease
, O O
4/5 O O
in O O
all O O
joints O O
. O O

In O O
the O O
lower O O
extremities O O
on O O
the O O
left O O
hip O O
flexor O O
is O O
1/5 O O
, O O
knee O O
flexion O O
and O O
extension O O
is O O
3/5 O O
and O O
4/5 O O
respectively O O
and O O
plantar O O
and O O
dorsiflexion O O
is O O
4/5 O O
. O O

The O O
right O O
lower O O
extremity O O
shows O O
a O O
3/5 O O
on O O
hip O O
flexion O O
, O O
4/5 O O
at O O
knee O O
flexion O O
and O O
extension O O
and O O
full O O
power O O
on O O
dorsi O O
and O O
plantar O O
flexion O O
. O O

Reflexes O O
: O O

Upper O O
extremities O O
are O O
very O B-Disease
brisk O I-Disease
bilaterally O I-Disease
and O O
symmetrical O O
3+. O O
There O O
is O O
positive B-Disease B-Disease
tremor I-Disease I-Disease
reflex I-Disease I-Disease
on I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
and O O
absent B-Disease O
on I-Disease O
the I-Disease O
right I-Disease O
. O O

Lower O O
extremities O O
show O O
patellar O O
reflexes O O
3+ O O
left O O
, O O
4+ O O
right O O
, O O
no O O
cross O B-Disease
deductor O I-Disease
reflexes O I-Disease
and O O
absent O B-Disease
ankle O I-Disease
jerks O I-Disease
. O O

There O O
is O O
no O O
clonus B-Disease B-Disease
on I-Disease O
the I-Disease O
right I-Disease O
but O O
sustained B-Disease B-Disease
clonus I-Disease I-Disease
( I-Disease O
10-12 I-Disease O
beats I-Disease O
) I-Disease O
on I-Disease O
the I-Disease O
left I-Disease O
. O O

Plantar O O
responses O O
: O O

toes O O
are O O
upgoing O O
on O O
the O O
left O O
, O O
down O O
going O O
on O O
the O O
right O O
. O O

Sensory O O
: O O

The O O
patient O O
has O O
diminished B-Disease B-Disease
vibration I-Disease I-Disease
and I-Disease I-Disease
propioception I-Disease I-Disease
in I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
and I-Disease I-Disease
lower I-Disease I-Disease
extremity I-Disease I-Disease
and O O
decreased B-Disease B-Disease
temperature I-Disease I-Disease
, O I-Disease
light O I-Disease
touch O I-Disease
and O I-Disease
pinprick O I-Disease
sensation O I-Disease
in O I-Disease
the O I-Disease
right O I-Disease
upper O I-Disease
and O I-Disease
lower O I-Disease
extremity O I-Disease
consistent O O
with O O
a B-Disease B-Disease
high I-Disease I-Disease
cervical I-Disease I-Disease
spinal I-Disease I-Disease
sensory I-Disease I-Disease
level I-Disease I-Disease
. O O

Cerebellar O O
; O O
The O O
patient O O
demonstrates O O
an B-Disease B-Disease
intention I-Disease I-Disease
tremor I-Disease I-Disease
on O O
finger O O
to O O
nose O O
with O O
the O O
left O O
hand O O
. O O

Fine O O
motor O O
movements O O
are O O
slow B-Disease B-Disease
but O O
accurate O O
in O O
the O O
left O O
and O O
right O O
hands O O
. O O

LABORATORY O O
DATA O O
: O O

Sodium O O
140 O O
, O O
potassium O O
3.8 O O
, O O
chloride O O
100 O O
, O O
bicarbonate O O
of O O
30 O O
, O O
BUN O O
of O O
13 O O
, O O
creatinine O O
0.8 O O
, O O
serum O O
glucose O O
228 O O
. O O

White O O
blood O O
count O O
is O O
7,000 O O
. O O

Hematocrit O O
is O O
37.6 O O
, O O
platelet O O
count O O
is O O
148,000 O O
. O O

Prothrombin O O
time O O
is O O
15.9 O O
with O O
an O O
INR O O
of O O
1.7 O O
. O O

PTT O O
is O O
24 O O
. O O

Urinalysis O O
from O O
October O O
21 O O
, O O
is O O
positive O O
for O O
Citrobacter B-Disease B-Disease
susceptible O I-Disease
to O O
ciprofloxacin O O
, O O
gentamycin O O
, O O
nitrofurantoin O O
, O O
tetracycline O O
and O O
Bactrim O O
. O O

Electrocardiogram O O
shows O O
no O O
P-waves B-Disease B-Disease
. O O

The O O
patient O O
is O O
fully O O
paced O O
. O O

HOSPITAL O O
COURSE O O
: O O

On O O
admission O O
, O O
a O O
CT O O
scan O O
of O O
the O O
head O O
with O O
and O O
without O O
contrast O O
was O O
performed O O
, O O
showing O O
a B-Disease B-Disease
missing I-Disease I-Disease
posterior I-Disease I-Disease
arch I-Disease I-Disease
at I-Disease I-Disease
C-1 I-Disease I-Disease
and O I-Disease
metallic O I-Disease
clips O I-Disease
at O I-Disease
the O I-Disease
craniocervical O I-Disease
junction O I-Disease
consistent O O
with O O
prior O O
surgical O O
intervention O O
. O O

No O O
arteriovenous B-Disease B-Disease
malformations I-Disease I-Disease
are O O
identified O O
; O O
there O O
is O O
no O O
evidence O O
of O O
recurrence B-Disease O
of O O
her B-Disease B-Disease
former I-Disease I-Disease
vascular I-Disease I-Disease
malformation I-Disease I-Disease
. O O

No O O
intraspinal B-Disease B-Disease
lesions I-Disease I-Disease
are O O
identified O O
. O O

Upon O O
further O O
review O O
of O O
Dr. O O
Laymie O O
Fields O O
, O O
Department O O
of O O
Neuroradiology O O
, O O
review O O
of O O
the O O
cervical O O
spine O O
on O O
CT O O
reveals O O
no O O
extrinsic B-Disease B-Disease
compressive I-Disease I-Disease
lesions I-Disease I-Disease
impacting O I-Disease
the O I-Disease
spinal O I-Disease
cord O I-Disease
and O O
no O O
enhancing B-Disease B-Disease
lesions I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
spinal I-Disease I-Disease
cord I-Disease I-Disease
with O O
contrast O O
. O O

Angiography O O
performed O O
on O O
October O O
31 O O
, O O
1999 O O
, O O
showed O O
normal B-Disease O
vascular I-Disease O
distribution I-Disease O
of I-Disease O
the I-Disease O
head I-Disease O
and I-Disease O
neck I-Disease O
with O O
no O O
recurrence B-Disease O
of I-Disease O
arteriovenous I-Disease B-Disease
malformation I-Disease I-Disease
. O O

During O O
this O O
admission O O
, O O
the O O
patient O O
was O O
started O O
on O O
Baclofen O O
10 O O
mg O O
p.o. O O
t.i.d. O O
for O O
spasticity B-Disease B-Disease
. O O

Coumadin O O
was O O
discontinued O O
. O O

The O O
patient O O
was O O
given O O
aspirin O O
325 O O
mg O O
p.o. O O
q.d. O O

The O O
patient O O
was O O
also O O
given O O
Valium O O
5-10 O O
mg O O
p.o. O O
t.i.d. O O
for O O
muscle B-Disease B-Disease
spasm I-Disease I-Disease
. O O

She O O
was O O
continued O O
on O O
Demerol O O
50 O O
mg O O
q O O
6-8 O O
hours O O
p.r.n. O O
for O O
left B-Disease B-Disease
arm I-Disease I-Disease
and I-Disease I-Disease
leg I-Disease I-Disease
pain I-Disease I-Disease
. O O

Upon O O
further O O
review O O
of O O
CT O O
and O O
angiography O O
results O O
with O O
Neuroradiology O O
and O O
Neurology O O
service O O
, O O
it O O
was O O
decided O O
that O O
CT O O
myelography O O
was O O
not O O
indicated O O
at O O
this O O
time O O
. O O

Note O O
, O O
the O O
patient O O
is O O
not O O
a O O
candidate O O
for O O
magnetic O O
resonance O O
imaging O O
secondary O O
to O O
ferromagnetic O O
intracardiac O O
pacing O O
device O O
. O O

DISPOSITION O O
: O O

The O O
patient O O
was O O
discharged O O
back O O
to O O
Raka O O
St O O
, O O
Mcape O O
Garl O O
, O O
long O O
term O O
facility O O
. O O

We O O
recommend O O
daily O O
physical O O
therapy O O
and O O
occupational O O
therapy O O
to O O
maximize O O
functional B-Disease O
capacity I-Disease O
with O O
optimization O O
of O O
pharmacological O O
regimen O O
for O O
spasticity B-Disease B-Disease
including O O
Baclofen O O
, O O
Valium O O
and O O
adequate O O
analgesia O O
. O O

The O O
patient O O
is O O
to O O
followup O O
in O O
Neurology O O
clinic O O
, O O
Verg O O
Medical O O
Center O O
with O O
Dr. O O
Deida O O
K. O O
Areke O O
and O O
/ O O
or O O
Dr. O O
Istranmuna O O
Cord O O
in O O
4-6 O O
weeks O O
time O O
. O O

Dictated O O
By O O
: O O

DEIDA O O
K. O O
LONG O O
, O O
M.D. O O

Attending O O
: O O

ISTRANMUNA O O
B. O O
CORD O O
, O O
M.D. O O
VR52 O O
PH501/3560 O O

Batch O O
: O O

1445 O O

Index O O
No. O O
MUZHFDOZK0 O O

D O O
: O O

11/02/99 O O

T O O
: O O

11/02/99 O O
KE9 O O

655358166 O O
WGH O O

5367777 O O

33714 O O

8114836 O O

10/12/2004 O O
12:00:00 O O
AM O O

OB O O
Discharge O O
Summary O O

Signed O O

DIS O O

Report O O
Status O O
: O O

Signed O O
OB O O
EMR O O
L O O
and O O
D O O

DISCHARGE O O
SUMMARY O O

NAME O O
: O O

JUARISY O O
DUHESMITRE O O

UNIT O O
NUMBER O O
: O O

683-54-33 O O

ADMISSION O O
DATE O O
: O O

20041012 O O

DISCHARGE O O
DATE O O
: O O

20041015 O O

PRINCIPAL O O
DISCHARGE O O
DIAGNOSIS O O
: O O

Vaginal O O
Delivery O O
With O O
Second B-Disease B-Disease
Degree I-Disease I-Disease
Laceration I-Disease I-Disease

ASSOCIATED O O
DIAGNOSES O O
: O O

Abnormal B-Disease B-Disease
Pap I-Disease I-Disease
Test I-Disease I-Disease
, O O
history O O
of O O
; O O
Bacterial B-Disease B-Disease
Vaginitis I-Disease I-Disease
; O O
Contraception O O
Management O O
; O O
Hiv O O
Counseled O O

PRINCIPAL O O
PROCEDURE O O
OR O O
OPERATION O O
: O O

Spontaneous O O
Vertex O O
Vaginal O O
Delivery O O

ASSOCIATED O O
PROCEDURES O O
OR O O
OPERATIONS O O
: O O

POSTPARTUM O O
DIAGNOSTIC O O
PROCEDURES O O
: O O

None O O

OTHER O O
POSTPARTUM O O
THERAPIES O O
: O O

Antimicrobial O O
Therapy O O

HISTORY O O
AND O O
REASON O O
FOR O O
HOSPITALIZATION O O
: O O

Srom B-Disease O
In O O
Labor B-Disease O

PHYSICAL O O
EXAMINATION O O
: O O

MOUTH O O
NORMAL O O
NECK O O
NORMAL O O
thyroid O O
wnl O O
BREASTS O O
NORMAL O O
no O O
distinct B-Disease B-Disease
masses I-Disease I-Disease
NIPPLES O O
NORMAL O O
inverted B-Disease O
[ O O
b O O
] O O
, O O
evert O O
w O O
/ O O
stimulation O O
CHEST O O
NORMAL O O
LCTA O O
COR O O
NORMAL O O
RRR O O
ABDOMEN O O
NORMAL O O
gravid O O
EXTREM O O
NORMAL O O
SKIN O O
NORMAL O O
NODES O O
NORMAL O O
VULVA O O
NORMAL O O
no O O
lesions B-Disease B-Disease
, O O
white B-Disease O
d I-Disease O
/ I-Disease O
c I-Disease O
at I-Disease O
introitus I-Disease O
VAGINA O O
NORMAL O O
sml B-Disease O
amt I-Disease O
thin I-Disease O
white I-Disease O
d I-Disease O
/ I-Disease O
c I-Disease O
ph O O
4.5 O O
, O O
koh O O
+amine O O
, O O
NS O O
+clue O O
, O O
neg O O
trich O O
CERVIX O O
NORMAL O O
1/100/0 O O
srom B-Disease O
clear O O
OS O O
NORMAL O O
closed O O
ADNEXAE O O
NORMAL O O
no O O
palp B-Disease B-Disease
masses I-Disease I-Disease
, O O
NT O O
UTERUS O O
NORMAL O O
gravid O O
UTERINE O O
SIZE O O
IN O O
WEEKS O O
NORMAL O O
term O O
RECTUM O O
NORMAL O O
no O O
ext B-Disease B-Disease
lesions I-Disease I-Disease

HOSPITAL O O
COURSE O O
( O O
include O O
complications O O
if O O
any O O
) O O
: O O

This O O
21 O O
year O O
old O O
Gravida O O
2 O O
Para O O
0010 O O
was O O
admitted O O
to O O
the O O
Life O O
Valley O O
Medical O O
Center O O
Obstetrical O O
service O O
on O O
10/12/2004 O O
at O O
08:41 O O
am O O
for O O
the O O
indication O O
( O O
s O O
) O O
: O O

srom B-Disease O
in O O
labor B-Disease O
. O O

She O O
delivered O O
a O O
3680 O O
gram O O
male O O
infant O O
on O O
10/12/2004 O O
at O O
10:17 O O
pm O O
with O O
apgar O O
scores O O
of O O
9 O O
and O O
9 O O
at O O
one O O
and O O
five O O
minutes O O
respectively O O
at O O
40.0 O O
weeks O O
gestation O O
via O O
spontaneous O O
vertex O O
vaginal O O
delivery O O
. O O

During O O
her O O
labor O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

srom B-Disease O
. O O

During O O
her O O
delivery O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

none O O
. O O

Postpartum O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

none O O
. O O

She O O
was O O
discharged O O
on O O
10/15/2004 O O
at O O
01:52 O O
pm O O
in O O
good O O
condition O O
. O O

DISCHARGE O O
ACTIVITY O O
: O O

No O O
Restrictions O O

DISCHARGE O O
DIET O O
: O O

No O O
Restrictions O O

POSTPARTUM O O
DISPOSITION O O
: O O

Home O O
Under O O
Care O O
Of O O
Home O O
Health O O
Agency O O

POSTPARTUM O O
CARE O O
SITE O O
: O O

Alle O O
Rehabilitation O O
Hospital O O

POSTPARTUM O O
RETURN O O
APPOINTMENT O O
( O O
DAYS O O
) O O
: O O

42 O O

BREAST O O
FEEDING O O
AT O O
DISCHARGE O O
: O O

Yes O O

MEDICATION O O
( O O
S O O
) O O
ON O O
DISCHARGE O O
: O O

Metronidazole O O
Tablets O O
( O O
Flagyl O O
) O O
; O O
Multivitamins O O
And O O
Folate O O
Capsules O O
( O O
Stuart O O
Prenatal O O
With O O
Folate O O
) O O

Electronically O O
Signed O O
: O O

Thorerogodlethrelf O O
, O O
Cisperna O O
M O O
10/17/2004 O O
6:01:02 O O
PM O O

910458031 O O

NVH O O

23238893 O O

1/12/1991 O O
12:00:00 O O
AM O O

Discharge O O
Summary O O

Signed O O

DIS O O

Admission O O
Date O O
: O O

01/12/1991 O O

Report O O
Status O O
: O O

Signed O O

Discharge O O
Date O O
: O O

01/20/1991 O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

METASTATIC B-Disease B-Disease
ADENOCARCINOMA I-Disease I-Disease
OF I-Disease O
UNKNOWN I-Disease O
PRIMARY I-Disease O
. O O

SECONDARY O O
DIAGNOSIS O O
: O O

INTRAUTERINE B-Disease O
PREGNANCY I-Disease O
AT I-Disease O
23 I-Disease O
WEEKS I-Disease O
. O O

HYPERCALCEMIA B-Disease B-Disease
. O O

INFERIOR B-Disease B-Disease
VENA I-Disease I-Disease
CAVA I-Disease I-Disease
OBSTRUCTION I-Disease I-Disease
. O O

IMPENDING B-Disease B-Disease
SPINAL I-Disease I-Disease
CORD I-Disease I-Disease
COMPRESSION I-Disease I-Disease
. O O

IDENTIFICATION O O
DATA O O
: O O

The O O
patient O O
is O O
a O O
34-year-old O O
female O O
with O O
a B-Disease B-Disease
22 I-Disease I-Disease
week I-Disease I-Disease
intrauterine I-Disease I-Disease
pregnancy I-Disease I-Disease
who O O
was O O
transferred O O
from O O
Bri O O
Health O O
with O O
diffuse B-Disease B-Disease
metastatic I-Disease I-Disease
adenocarcinoma I-Disease I-Disease
of I-Disease O
unknown I-Disease O
primary I-Disease O
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

The O O
patient O O
was O O
in O O
her O O
usual O O
state O O
of O O
excellent O O
health O O
until O O
July O O
of O O
1991 O O
when O O
she O O
first O O
noted O O
a B-Disease B-Disease
left I-Disease I-Disease
clavicular I-Disease I-Disease
mass I-Disease I-Disease
. O O

Subsequently O O
, O O
the B-Disease B-Disease
mass I-Disease I-Disease
continued O O
to O O
increase O O
in O O
size O O
. O O

On O O
12/23 O O
, O O
she O O
was O O
seen O O
by O O
Dr. O O
Stonge O O
at O O
Bri O O
Health O O
where O O
a B-Disease B-Disease
3 I-Disease I-Disease
x I-Disease I-Disease
7 I-Disease I-Disease
cm I-Disease I-Disease
left I-Disease I-Disease
mid I-Disease I-Disease
clavicular I-Disease I-Disease
mass I-Disease I-Disease
was O O
noted O O
. O O

A O O
fine O O
needle O O
aspirate O O
of O O
this B-Disease B-Disease
mass I-Disease I-Disease
reportedly O O
revealed O O
giant B-Disease B-Disease
cell I-Disease I-Disease
tumor I-Disease I-Disease
. O O

The O O
patient O O
was O O
initially O O
told O O
that O O
this O O
was O O
a B-Disease B-Disease
benign I-Disease I-Disease
tumor I-Disease I-Disease
and O O
that O O
it O O
could O O
simply O O
be O O
watched O O
and O O
definitively O O
treated O O
after O O
the O O
delivery O O
of O O
her O O
baby O O
. O O

Subsequently O O
, O O
the B-Disease B-Disease
mass I-Disease I-Disease
progressively O O
increased O O
in O O
size O O
and O O
the O O
patient O O
had O O
developed O O
significant B-Disease B-Disease
discomfort I-Disease I-Disease
in I-Disease I-Disease
this I-Disease I-Disease
region I-Disease I-Disease
. O O

On O O
1/5 O O
, O O
the O O
patient O O
underwent O O
a O O
local O O
tumor O O
debulking O O
at O O
Bri O O
Health O O
under O O
local O O
anesthesia O O
. O O

The O O
pathology O O
, O O
unfortunately O O
, O O
revealed O O
an B-Disease B-Disease
aggressive I-Disease I-Disease
adenocarcinoma I-Disease I-Disease
( O I-Disease
micropapillary O I-Disease
type O I-Disease
; O O
mucin O O
producing O O
) O O
. O O

This O O
prompted O O
further O O
staging O O
work-up O O
. O O

The O O
patient O O
subsequently O O
had O O
a O O
limited O O
chest O O
CT O O
at O O
Bri O O
Health O O
which O O
showed O O
diffuse B-Disease B-Disease
bilateral I-Disease I-Disease
pulmonary I-Disease I-Disease
metastases I-Disease I-Disease
, O O
metastases B-Disease B-Disease
to I-Disease I-Disease
the I-Disease I-Disease
sternum I-Disease I-Disease
, I-Disease O
rib I-Disease O
, I-Disease O
multiple I-Disease B-Disease
spinal I-Disease I-Disease
levels I-Disease I-Disease
; O O
internal B-Disease B-Disease
mammary I-Disease I-Disease
lymphadenopathy I-Disease I-Disease
. O O

The O O
poor O O
prognosis O O
for O O
the O O
patient O O
and O O
child O O
were O O
discussed O O
and O O
after O O
the O O
patient O O
decided O O
to O O
have O O
an O O
elective O O
abortion O O
, O O
an O O
abdominal O O
CT O O
scan O O
was O O
obtained O O
which O O
revealed O O
diffuse B-Disease B-Disease
metastatic I-Disease I-Disease
lesions I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
liverspine I-Disease I-Disease
, I-Disease O
ribs I-Disease O
and I-Disease O
most I-Disease O
of I-Disease O
the I-Disease O
lymph I-Disease O
nodes I-Disease O
. O O

There O O
was O O
no O O
obvious B-Disease B-Disease
GIor I-Disease I-Disease
pancreatic I-Disease I-Disease
tumor I-Disease I-Disease
identified O O
. O O

The O O
patient O O
had O O
a B-Disease B-Disease
very I-Disease I-Disease
firm I-Disease I-Disease
nodule I-Disease I-Disease
at O I-Disease
the O I-Disease
vertex O I-Disease
of O I-Disease
her O I-Disease
calvarium O I-Disease
. O O

A O O
specimen O O
was O O
obtained O O
by O O
fine O O
needle O O
aspiration O O
and O O
the O O
pathology O O
of O O
this O O
was O O
consistent O O
with O O
adenocarcinoma B-Disease B-Disease
. O O

The O O
patient O O
was O O
transferred O O
to O O
Nimaconwood O O
Valley O O
Hospital O O
for O O
management O O
of O O
her B-Disease B-Disease
cancer I-Disease I-Disease
and O O
termination O O
of O O
the B-Disease O
pregnancy I-Disease O
. O O

Over O O
the O O
past O O
four O O
weeks O O
, O O
the O O
patient O O
reported O O
progressive B-Disease B-Disease
shortness I-Disease I-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
and O O
mid B-Disease B-Disease
thoracic I-Disease I-Disease
back I-Disease I-Disease
pain I-Disease I-Disease
. O O

She O O
has O O
had O O
no O O
motor B-Disease B-Disease
weakness I-Disease I-Disease
, O O
abnormal B-Disease B-Disease
sensation I-Disease I-Disease
, O O
numbness B-Disease B-Disease
, O O
tingling B-Disease B-Disease
or O O
incontinence B-Disease B-Disease
of I-Disease I-Disease
bowel I-Disease I-Disease
or I-Disease I-Disease
bladder I-Disease I-Disease
. O O

She O O
denied O O
fevers B-Disease B-Disease
, O O
chills B-Disease B-Disease
or O O
sweats B-Disease B-Disease
. O O

There O O
has O O
been O O
no O O
GI B-Disease B-Disease
or I-Disease I-Disease
GU I-Disease I-Disease
symptoms I-Disease I-Disease
except O O
for O O
constipation B-Disease B-Disease
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Unremarkable O O
. O O

MEDICATIONS O O
: O O

On O O
admission O O
included O O
Percocet O O
for O O
pain B-Disease B-Disease
and O O
multivitamins O O
. O O

ALLERGIES O O
: O O

NO O O
KNOWN B-Disease B-Disease
DRUG I-Disease I-Disease
ALLERGIES I-Disease I-Disease
. O O

FAMILY O O
HISTORY O O
: O O

The O O
patient O O
&apos;s O O
father O O
died O O
at O O
age O O
69 O O
with O O
metastatic B-Disease B-Disease
prostate I-Disease I-Disease
cancer I-Disease I-Disease
. O O

The O O
patient O O
&apos;s O O
sister O O
has O O
a O O
history O O
of O O
cervical B-Disease B-Disease
cancer I-Disease I-Disease
. O O

SOCIAL O O
HISTORY O O
: O O

The O O
patient O O
is O O
married O O
and O O
lives O O
with O O
her O O
husband O O
. O O

She O O
has O O
no O O
children O O
. O O

She O O
is O O
a O O
nonsmoker O O
. O O

She O O
drinks O O
socially O O
. O O

She O O
has O O
not O O
had O O
any O O
alcoholic O O
beverages O O
during O O
this B-Disease O
pregnancy I-Disease O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

On O O
admission O O
revealed O O
a O O
pleasant O O
, O O
comfortable O O
, O O
tired O O
appearing O O
female O O
. O O

The O O
patient O O
was O O
afebrile O B-Disease
. O O

Blood O O
pressure O O
was O O
98/64 O O
. O O

Pulse O O
82 O O
. O O

Respiratory O O
rate O O
20 O O
. O O

Skin O O
exam O O
revealed O O
a B-Disease B-Disease
right I-Disease I-Disease
posterior I-Disease I-Disease
parietal I-Disease I-Disease
scalp I-Disease I-Disease
nodle I-Disease I-Disease
measuring O O
2 O O
x O O
3 O O
cm O O
which O O
was O O
very O O
firm O O
. O O

There O O
was O O
a B-Disease B-Disease
1 I-Disease I-Disease
cm I-Disease I-Disease
firm I-Disease I-Disease
nodule I-Disease I-Disease
at I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
thoracic I-Disease I-Disease
region I-Disease I-Disease
of O O
the O O
back O O
between O O
the O O
midline O O
and O O
the O O
scapula O O
. O O

There O O
was O O
a B-Disease B-Disease
1 I-Disease I-Disease
cm I-Disease I-Disease
firm I-Disease I-Disease
nodule I-Disease I-Disease
in O I-Disease
the O I-Disease
right O I-Disease
upper O I-Disease
quadrant O I-Disease
of O I-Disease
the O I-Disease
abdomen O I-Disease
. O O

HEENT O O
exam O O
was O O
unremarkable O O
. O O

Neck O O
was O O
supple O O
. O O

There O O
was O O
no O O
jugular B-Disease B-Disease
venous I-Disease I-Disease
distention I-Disease I-Disease
. O O

There O O
was O O
no O O
lymphadenopathy B-Disease B-Disease
. O O

Back O O
was O O
without O O
CVA B-Disease B-Disease
tenderness I-Disease I-Disease
. O O

There O O
was O O
no O O
scapular B-Disease B-Disease
tenderness I-Disease I-Disease
. O O

There O O
was O O
mild B-Disease B-Disease
lower I-Disease I-Disease
thoracic I-Disease I-Disease
tenderness I-Disease I-Disease
. O O

Lungs O O
were O O
clear O O
to O O
auscultation O O
. O O

There O O
were O O
no O O
rales B-Disease B-Disease
or O O
wheezes B-Disease B-Disease
. O O

There O O
was O O
no O O
egophony B-Disease B-Disease
. O O

Cardiac O O
exam O O
was O O
tachycardic B-Disease B-Disease
and O O
regular O O
, O O
normal O O
S1 O O
and O O
S2 O O
. O O

There O O
was O O
a B-Disease B-Disease
II I-Disease I-Disease
/ I-Disease I-Disease
VI I-Disease I-Disease
systolic I-Disease I-Disease
ejection I-Disease I-Disease
murmur I-Disease I-Disease
loudest O I-Disease
at O I-Disease
the O I-Disease
left O I-Disease
upper O I-Disease
sternal O I-Disease
border O I-Disease
. O O

There O O
was O O
no O O
heave B-Disease B-Disease
. O O

Abdomen O O
was O O
gravid B-Disease O
. O O

Bowel O O
sounds O O
were O O
present O O
. O O

The O O
abdomen O O
was O O
tympanitic O B-Disease
and O O
nontender B-Disease B-Disease
. O O

The O O
liver O O
was O O
11 O O
cm O O
by O O
percussion O O
. O O

There O O
was O O
no O O
liver O B-Disease
edge O I-Disease
palpable O I-Disease
, O O
no O O
spleen O B-Disease
tip O I-Disease
palpable O I-Disease
. O O

Rectal O O
revealed O O
normal O O
muscle O O
tone O O
, O O
heme O O
negative O O
stool O O
. O O

Extremities O O
revealed O O
1+ B-Disease B-Disease
bipedal I-Disease I-Disease
edema I-Disease I-Disease
on O O
admission O O
. O O

Neurological O O
examination O O
revealed O O
the O O
patient O O
to O O
be O O
alert O O
and O O
oriented O O
times O O
three O O
. O O

Cranial O O
nerves O O
II O O
- O O
XII O O
were O O
intact O O
. O O

Motor O O
was O O
5/5 O O
. O O

Sensation O O
was O O
intact O O
to O O
light O O
touch O O
. O O

Deep O O
tendon O O
reflexes O O
were O O
1-2+ O O
and O O
symmetric O O
bilaterally O O
. O O

Toes O O
were O O
downgoing O O
. O O

LABORATORY O O
DATA O O
: O O

On O O
admission O O
included O O
an O O
ALT O O
of O O
108 O O
, O O
AST O O
of O O
286 O O
. O O

Total O O
bilirubin O O
3.0 O O
, O O
direct O O
bilirubin O O
of O O
2.0 O O
. O O

Alkaline O O
phosphatase O O
1148 O O
. O O

LDH O O
806 O O
. O O

Calcium O O
11.8 O O
. O O

Albumin O O
2.3 O O
. O O

Hematocrit O O
was O O
30.6 O O
. O O

White O O
blood O O
cell O O
count O O
was O O
11.14 O O
. O O

PT O O
was O O
13.2 O O
. O O

PTT O O
was O O
29.8 O O
. O O

HOSPITAL O O
COURSE O O
: O O

The O O
patient O O
had O O
an O O
elective O O
termination O O
of O O
her B-Disease O
pregnancy I-Disease O
on O O
1/13/91 O O
. O O

The O O
work-up O O
for O O
the O O
extent O O
of O O
the B-Disease B-Disease
patient I-Disease I-Disease
&apos;s I-Disease I-Disease
Disease I-Disease I-Disease
included O O
MRI O O
scan O O
of O O
the O O
cervical O O
and O O
thoracic O O
spine O O
which O O
revealed O O
multiple B-Disease B-Disease
metastatic I-Disease I-Disease
lesions I-Disease I-Disease
in I-Disease I-Disease
the I-Disease I-Disease
vertebral I-Disease I-Disease
bodies I-Disease I-Disease
; O O
a B-Disease B-Disease
T3 I-Disease I-Disease
lesion I-Disease I-Disease
extending O O
from O O
the O O
body O O
to O O
the O O
right O O
neural O O
for O O
amina O O
with O O
foraminal B-Disease B-Disease
obstruction I-Disease I-Disease
. O O

An B-Disease B-Disease
epidural I-Disease I-Disease
mass I-Disease I-Disease
was O O
present O O
at O O
T10 O O
which O O
was O O
extending O O
from O O
the O O
lamina O O
or O O
spinous O O
process O O
anteriorly O O
and O O
almost O O
compressing O O
the O O
spinal O O
cord O O
. O O

An O O
abdominal O O
and O O
pelvic O O
CT O O
scan O O
with O O
IV O O
contrast O O
revealed O O
bilateral B-Disease B-Disease
pulmonary I-Disease I-Disease
nodules I-Disease I-Disease
and O O
bilateral B-Disease B-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
, O O
extensive B-Disease B-Disease
liver I-Disease I-Disease
metastases I-Disease I-Disease
, O O
narrowing B-Disease B-Disease
of I-Disease I-Disease
the I-Disease I-Disease
intra I-Disease I-Disease
hepatic I-Disease I-Disease
IVC I-Disease I-Disease
and O O
distention B-Disease B-Disease
of I-Disease I-Disease
the I-Disease I-Disease
azygous I-Disease I-Disease
system I-Disease I-Disease
suggestive O O
of O O
IVC B-Disease B-Disease
obstruction I-Disease I-Disease
by O O
liver B-Disease B-Disease
metastases I-Disease I-Disease
; O O
ascites B-Disease B-Disease
; O O
multiple B-Disease B-Disease
bony I-Disease I-Disease
metastases I-Disease I-Disease
; O O
and O O
an B-Disease B-Disease
isolated I-Disease I-Disease
splenic I-Disease I-Disease
metastases I-Disease I-Disease
. O O

A O O
bone O O
scan O O
revealed O O
increased B-Disease B-Disease
uptake I-Disease I-Disease
in I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
chest I-Disease I-Disease
wall I-Disease I-Disease
, I-Disease O
left I-Disease O
anterior I-Disease O
ribs I-Disease O
four I-Disease O
to I-Disease O
six I-Disease O
, O O
and O O
increased B-Disease B-Disease
uptake I-Disease I-Disease
in I-Disease O
the I-Disease O
left I-Disease O
and I-Disease O
right I-Disease O
lateral I-Disease O
skull I-Disease O
in O O
the O O
area O O
of O O
the O O
parotids O O
. O O

Ahead O O
CT O O
scan O O
revealed O O
a B-Disease B-Disease
metastatic I-Disease I-Disease
lesion I-Disease I-Disease
in O I-Disease
the O I-Disease
right O I-Disease
vertex O I-Disease
of O I-Disease
the O I-Disease
calvarium O I-Disease
but O O
no O O
intracranial B-Disease B-Disease
abnormalities I-Disease I-Disease
. O O

Work-up O O
for O O
the O O
source O O
of O O
the B-Disease B-Disease
primary I-Disease I-Disease
tumor I-Disease I-Disease
which O O
is O O
still O O
unknown O O
included O O
a O O
mammogram O O
which O O
identified O O
no O O
suspicious B-Disease B-Disease
microcalcifications I-Disease I-Disease
and O O
no O O
dominant B-Disease B-Disease
masses I-Disease I-Disease
. O O

The O O
abdominal O O
and O O
pelvic O O
CT O O
scans O O
showed O O
no O O
suspicious B-Disease B-Disease
GI I-Disease I-Disease
masses I-Disease I-Disease
, O O
no O O
pancreatic B-Disease B-Disease
mass I-Disease I-Disease
; O O
a B-Disease B-Disease
2 I-Disease I-Disease
cm I-Disease I-Disease
ovarian I-Disease I-Disease
cyst I-Disease I-Disease
. O O

The O O
review O O
of O O
the O O
pathology O O
from O O
Bri O O
Health O O
confirmed O O
a B-Disease B-Disease
high I-Disease I-Disease
grade I-Disease I-Disease
adenocarcinoma I-Disease I-Disease
. O O

Erica O O
and O O
basic O O
cystic O O
protein O O
stains O O
are O O
still O O
pending O O
. O O

Serum O O
markers O O
were O O
normal O O
. O O

The O O
CEA O O
was O O
less O O
than O O
0.7 O O
. O O

The O O
hCG O O
on O O
admission O O
was O O
30,710 O O
and O O
on O O
1/19 O O
was O O
805 O O
. O O

The O O
CA-125 O O
was O O
still O O
pending O O
and O O
alphafeto O O
protein O O
is O O
still O O
pending O O
. O O

Hypercalcemia B-Disease B-Disease
: O O

The O O
patient O O
presented O O
with O O
a O O
serum O O
calcium O O
of O O
11.8 O O
and O O
an O O
albumin O O
of O O
2.3 O O
on O O
admission O O
. O O

She O O
received O O
three O O
days O O
of O O
intravenous O O
etidronate O O
with O O
normal O O
saline O O
diuresis O O
and O O
the O O
serum O O
calcium O O
subsequently O O
decreased O O
to O O
9.0 O O
. O O

The O O
patient O O
was O O
then O O
switched O O
to O O
po O O
etidronate O O
. O O

IVC B-Disease B-Disease
obstruction I-Disease I-Disease
: O O

The O O
patient O O
has O O
extensive B-Disease B-Disease
hepatic I-Disease I-Disease
metastases I-Disease I-Disease
and O O
by O O
CT O O
scan O O
there O O
is O O
obstruction B-Disease B-Disease
of I-Disease I-Disease
the I-Disease I-Disease
intrahepatic I-Disease I-Disease
IVC I-Disease I-Disease
. O O

This O O
has O O
resulted O O
in O O
marked B-Disease B-Disease
bilateral I-Disease I-Disease
lower I-Disease I-Disease
extremity I-Disease I-Disease
and I-Disease I-Disease
presacral I-Disease I-Disease
edema I-Disease I-Disease
with O O
ascites B-Disease B-Disease
. O O

The B-Disease O
patient I-Disease O
&apos;s I-Disease O
low I-Disease O
serum I-Disease O
albumin I-Disease O
is O O
also O O
contributing O O
to O O
her B-Disease B-Disease
extensive I-Disease I-Disease
edema I-Disease I-Disease
. O O

Hypoxia B-Disease B-Disease
and O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
: O O

Although O O
the O O
patient O O
&apos;s O O
room O O
air O O
saturation O O
was O O
96% O O
during O O
this O O
admission O O
, O O
she O O
subjectively O O
complained O O
of O O
increased B-Disease B-Disease
shortness I-Disease I-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
. O O

It O O
was O O
felt O O
that O O
the B-Disease B-Disease
patient I-Disease I-Disease
&apos;s I-Disease I-Disease
extensive I-Disease I-Disease
pulmonary I-Disease I-Disease
metastases I-Disease I-Disease
and O O
bilateral B-Disease B-Disease
pleural I-Disease I-Disease
effusions I-Disease I-Disease
resulted O O
in O O
increased B-Disease B-Disease
work I-Disease I-Disease
of I-Disease I-Disease
respiration I-Disease I-Disease
and O O
a O O
sensation O O
of O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
. O O

Impending B-Disease B-Disease
spinal I-Disease I-Disease
cord I-Disease I-Disease
compression I-Disease I-Disease
: O O

The O O
patient O O
had O O
back B-Disease B-Disease
pain I-Disease I-Disease
on O O
admission O O
without O O
any B-Disease O
focal I-Disease B-Disease
neurological I-Disease I-Disease
signs I-Disease I-Disease
. O O

The O O
MRI O O
scan O O
on O O
admission O O
revealed O O
an B-Disease B-Disease
impending I-Disease I-Disease
cord I-Disease I-Disease
compression I-Disease I-Disease
at O O
the O O
level O O
of O O
T10 O O
. O O

She O O
was O O
started O O
on O O
Decadron O O
and O O
on O O
1/17 O O
began O O
the O O
first O O
of O O
ten O O
radiation O O
treatments O O
to O O
two O O
fields O O
( O O
T2 O O
to O O
T5 O O
and O O
T9 O O
to O O
T11 O O
) O O
. O O

Per O O
the O O
patient O O
&apos;s O O
wishes O O
, O O
Dr. O O
Dalywoo O O
Droreite O O
the O O
Windgo O O
Hospital O O
was O O
consulted O O
for O O
a O O
second O O
opinion O O
regarding O O
the O O
management O O
of O O
her B-Disease B-Disease
malignancy I-Disease I-Disease
. O O

Dr. O O
Linke O O
recommended O O
chemotherapy O O
with O O
PFL O O
. O O

Per O O
the O O
patient O O
&apos;s O O
wishes O O
, O O
she O O
was O O
transferred O O
to O O
the O O
Windgo O O
Hospital O O
for O O
chemotherapy O O
. O O

ALT O O
was O O
53 O O
. O O

AST O O
was O O
89 O O
. O O

Her O O
LDH O O
was O O
394 O O
. O O

Her O O
alkaline O O
phosphatase O O
was O O
1514 O O
. O O

Total O O
bilirubin O O
was O O
2.1 O O
. O O

Direct O O
bilirubin O O
was O O
1.4 O O
. O O

Albumin O O
was O O
2.3 O O
. O O

Calcium O O
9.1 O O
. O O

Hematocrit O O
was O O
32.5 O O
. O O

White O O
blood O O
cell O O
count O O
was O O
16.89 O O
. O O

PT O O
was O O
12.9 O O
. O O

PTT O O
was O O
27.3 O O
. O O

DISPOSITION O O
: O O

MEDICATIONS O O
: O O

On O O
discharge O O
included O O
etidronate O O
, O O
475 O O
mg O O
IV O O
q O O
day O O
; O O
heparin O O
, O O
5000 O O
units O O
subcutaneously O O
b.i.d. O O
; O O
Decadron O O
, O O
4 O O
mg O O
po O O
q O O
six O O
hours O O
; O O
MS O O
Contin O O
, O O
45 O O
mg O O
po O O
b.i.d. O O
; O O
Pepcid O O
, O O
20 O O
mg O O
po O O
b.i.d. O O
; O O
Senekot O O
, O O
one O O
tablet O O
po O O
t.i.d. O O
; O O
Bronkosol O O
, O O
0.25 O O
cc O O
q O O
four O O
hours O O
. O O

It O O
was O O
decided O O
to O O
have O O
the B-Disease O
patient I-Disease O
&apos;s I-Disease O
medical I-Disease O
and I-Disease O
oncological I-Disease O
issues I-Disease O
managed O O
at O O
Windgo O O
Hospital O O
. O O

At O O
the O O
time O O
of O O
discharge O O
, O O
the O O
patient O O
&apos;s O O
electrolytes O O
were O O
within O O
normal O O
limits O O
. O O

BD452/5255 O O

RUTHU O O
PAIN O O
, O O
M.D. O O
KW25 O O

D O O
: O O

01/20/91 O O

Batch O O
: O O

8050 O O

Report O O
: O O

H7691U2 O O

T O O
: O O

01/24/91 O O

Dictated O O
By O O
: O O

CEALME O O
PAIN O O
, O O
M.D. O O

498710998 O O

CMC O O

14172445 O O

04/29/1992 O O
12:00:00 O O
AM O O

Discharge O O
Summary O O

Signed O O

DIS O O

Admission O O
Date O O
: O O

04/29/1992 O O

Report O O
Status O O
: O O

Signed O O

Discharge O O
Date O O
: O O

05/28/1992 O O

DISCHARGE O O
DIAGNOSES O O
: O O

1. O O
Carotid B-Disease B-Disease
stenosis I-Disease I-Disease
. O O

2. O O
Aortic B-Disease B-Disease
stenosis I-Disease I-Disease
. O O

3. O O
Coronary B-Disease B-Disease
artery I-Disease I-Disease
Disease I-Disease I-Disease
. O O

PRESENT O O
ILLNESS O O
: O O

The O O
patient O O
is O O
a O O
76-year-old O O
female O O
who O O
was O O
admitted O O
to O O
the O O
medicine O O
service O O
on O O
04-29-92 O O
with O O
a O O
past O O
history O O
significant O O
for O O
aortic B-Disease B-Disease
stenosis I-Disease I-Disease
and O O
chest B-Disease B-Disease
pain I-Disease I-Disease
who O O
presented O O
for O O
evaluation O O
for O O
aortic O O
valve O O
replace-ment O O
. O O

The O O
patient O O
has O O
a O O
history O O
of O O
exertional B-Disease B-Disease
angina I-Disease I-Disease
and O O
chest B-Disease B-Disease
pain I-Disease I-Disease
associated O O
with O O
light-headedness B-Disease B-Disease
for O O
nine O O
years O O
which O O
was O O
noted O O
to O O
increase O O
in O O
frequency O O
over O O
the O O
past O O
year O O
, O O
then O O
upon O O
admission O O
had O O
light-headedness B-Disease B-Disease
and O O
chest B-Disease B-Disease
pain I-Disease I-Disease
with O O
a B-Disease B-Disease
dull I-Disease I-Disease
pressure I-Disease I-Disease
in I-Disease O
her I-Disease O
neck I-Disease O
to O O
her O O
substernal O O
area O O
, O O
with O O
only O O
minimal O B-Disease
exertion O I-Disease
such O O
as O O
&quot; O B-Disease
walking O I-Disease
across O O
the O O
room O O
&quot; O O
. O O

She O O
states O O
this O B-Disease
light-headedness B-Disease I-Disease
is O O
often O O
associated O O
with O O
shortness B-Disease B-Disease
of I-Disease I-Disease
breath I-Disease I-Disease
and O O
diaphoresis B-Disease B-Disease
occasionally O O
with O O
nausea B-Disease B-Disease
. O O

She O O
denies O O
any O B-Disease
vomiting B-Disease I-Disease
, O O
states O O
that O O
the B-Disease B-Disease
episodes I-Disease I-Disease
usually O O
last O O
about O O
five O O
minutes O O
and O O
are O O
relieved O O
with O O
rest O O
. O O

The B-Disease B-Disease
pain I-Disease I-Disease
and O O
light-headedness B-Disease O
is O O
now O O
severely O B-Disease
lifestyle O I-Disease
limiting O I-Disease
and O O
the O O
patient O O
requested O O
evaluation O O
for O O
possible O O
aortic O O
valve O O
replacement O O
. O O

Cardiac O B-Disease
risk O I-Disease
factors O I-Disease
hypercholesterolemia B-Disease I-Disease
, O O
hypertension B-Disease B-Disease
, O O
no O O
history O O
of O O
tobacco O O
use O O
, O O
diabetes B-Disease B-Disease
or O O
family O O
history O O
. O O

Past O O
medical O O
history O O
is O O
as O O
stated O O
above O O
, O O
aortic B-Disease B-Disease
stenosis I-Disease I-Disease
, O O
found O O
to O O
be O O
critical O O
on O O
echocardiogram O O
on O O
4-13-92 O O
, O O
done O O
in O O
Otte O O
A O O
, O O
New O O
Jersey O O
and O O
was O O
found O O
to O O
have O O
left B-Disease B-Disease
ventricular I-Disease I-Disease
hypertrophy I-Disease I-Disease
and O O
ejection O O
fraction O O
of O O
58% O O
, O O
no O O
right B-Disease B-Disease
heart I-Disease I-Disease
wall I-Disease I-Disease
motion I-Disease I-Disease
abnormali-ties I-Disease I-Disease
and O O
an O O
aortic O O
valve O O
gradient O O
of O O
greater O O
than O O
100 O O
. O O

She O O
also O O
has O O
a O O
history O O
of O O
uterine B-Disease B-Disease
fibroids I-Disease I-Disease
, O O
status O O
post O O
total O O
abdominal O O
hysterectomy O O
. O O

She O O
has O O
known B-Disease B-Disease
bilateral I-Disease I-Disease
carotid I-Disease I-Disease
Disease I-Disease I-Disease
, O O
stated O O
to O O
be O O
greater O O
than O O
70% O O
bilaterally O O
. O O

She O O
has O O
a O O
history O O
of O O
glaucoma B-Disease B-Disease
and O O
a O O
questionable O O
history O O
of O O
claudication B-Disease B-Disease
in I-Disease I-Disease
her I-Disease I-Disease
legs I-Disease I-Disease
as O O
well O O
as O O
a O O
history O O
of O O
hypertension B-Disease B-Disease
. O O

Medications O O
on O O
admission O O
were O O
only O O
aspirin O O
p.r.n. O O
and O O
Timoptic O O
solution O O
0.5% O O
to O O
the O O
left O O
eye O O
twice O O
a O O
day O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

On O O
physical O O
examination O O
she O O
was O O
afebrile B-Disease B-Disease
with O O
a O O
blood O O
pressure O O
of O O
170/100 O O
, O O
heart O O
rate O O
of O O
70 O O
. O O

HEENT O O
examination O O
notable O O
for O O
bilateral B-Disease B-Disease
arcussenilis I-Disease I-Disease
but O O
otherwise O O
unremarkable O O
. O O

Her O O
neck O O
showed O O
no O O
JVD B-Disease B-Disease
, O O
there O O
was O O
a B-Disease B-Disease
slow I-Disease I-Disease
carotid I-Disease I-Disease
upstroke I-Disease I-Disease
bilaterally I-Disease I-Disease
, O O
there O O
were O O
bilateral B-Disease B-Disease
carotid I-Disease I-Disease
bruits I-Disease I-Disease
versus O O
transmitted B-Disease B-Disease
murmur I-Disease I-Disease
. O O

Chest O O
was O O
clear O O
to O O
auscultation O O
bilaterally O O
. O O

Cardiac O O
examination O O
revealed O O
a O O
regular O O
rate O O
and O O
rhythm O O
with O O
a O O
normal O O
S1 O O
and O O
S2 O O
, O O
3/6 O B-Disease
systolic B-Disease I-Disease
murmur I-Disease I-Disease
at I-Disease I-Disease
the I-Disease I-Disease
right I-Disease I-Disease
upper I-Disease I-Disease
sternal I-Disease I-Disease
border I-Disease I-Disease
, O O
no O O
gallop B-Disease B-Disease
was O O
detected O O
. O O

Her O O
abdomen O O
was O O
soft O O
, O O
nontender B-Disease B-Disease
with O O
good O O
bowel O O
sounds O O
. O O

Extremi-ties O O
: O O

There O O
is O O
no O O
clubbing B-Disease B-Disease
, O O
cyanosis B-Disease B-Disease
or O O
edema B-Disease B-Disease
and O O
her O O
peripheral O O
pulses O O
were O O
trace O B-Disease
palpable O I-Disease
. O O

LAB O O
/ O O
X-RAY O O
DATA O O
: O O

Labs O O
on O O
admission O O
: O O

Sodium O O
141 O O
, O O
potassium O O
5.0 O O
, O O
BUN O O
18 O O
, O O
creatinine O O
1.0 O O
, O O
PT O O
12.3 O O
, O O
PTT O O
24 O O
, O O
WBC O O
7.6 O O
, O O
hematocrit O O
41 O O
, O O
platelets O O
278,000 O O
. O O

EKG O O
revealed O O
a O O
normal O O
sinus O O
rhythm O O
with O O
a O O
rate O O
of O O
69 O O
, O O
left B-Disease B-Disease
ventricular I-Disease I-Disease
hyper-trophy I-Disease I-Disease
with O O
poor B-Disease B-Disease
anterior I-Disease I-Disease
progression I-Disease I-Disease
of I-Disease I-Disease
R-waves I-Disease I-Disease
. O O

HOSPITAL O O
COURSE O O
: O O

She O O
was O O
admitted O O
and O O
evaluated O O
by O O
the O O
cardiac O O
surgery O O
service O O
after O O
having O O
undergone O O
cardiac O O
catheterization O O
which O O
revealed O O
a O B-Disease
70% B-Disease I-Disease
stenosis I-Disease I-Disease
of I-Disease I-Disease
her I-Disease I-Disease
left I-Disease I-Disease
circumflex I-Disease I-Disease
artery I-Disease I-Disease
, O O
50% B-Disease B-Disease
stenosis I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
anterior I-Disease I-Disease
descending I-Disease I-Disease
and O I-Disease
10% B-Disease I-Disease
stenosis I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
right I-Disease I-Disease
coronary I-Disease I-Disease
artery I-Disease I-Disease
. O O

Carotid O O
angiography O O
revealed O O
left B-Disease B-Disease
internal I-Disease I-Disease
carotid I-Disease I-Disease
stenosis I-Disease I-Disease
of I-Disease O
90% I-Disease O
, O O
right B-Disease O
internal I-Disease O
carotid I-Disease O
artery I-Disease O
&quot; I-Disease O
critical I-Disease B-Disease
stenosis I-Disease I-Disease
&quot; I-Disease I-Disease
. O O

On O O
05-01-92 O O
she O O
was O O
taken O O
to O O
the O O
operating O O
room O O
at O O
which O O
time O O
she O O
underwent O O
an O O
aortic O O
valve O O
replacement O O
with O O
a O O
# O O
19 O O
St. O O
Jude O O
valve O O
, O O
coronary O O
artery O O
bypass O O
graft O O
times O O
one O O
with O O
saphenous O O
vein O O
graft O O
from O O
the O O
posterior O O
descending O O
artery O O
to O O
the O O
obtuse O O
marginal O O
and O O
right O O
carotid O O
endarterectomy O O
. O O

This O O
was O O
performed O O
by O O
Dr. O O
Medicine O O
and O O
Dr. O O
Room O O
. O O

The O O
patient O O
tolerated O O
the O O
procedure O O
well O O
and O O
was O O
found O O
postoperatively O O
to O O
have O O
some B-Disease B-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
extremity I-Disease I-Disease
weakness I-Disease I-Disease
on O O
proximal O O
greater O O
than O O
distal O O
musculature O O
. O O

She O O
was O O
extubated O O
on O O
postoperative O O
day O O
number O O
one O O
and O O
otherwise O O
had O O
an O O
unremarkable O O
postoperative O O
course O O
with O O
the O O
exception O O
of O O
her B-Disease B-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
extremity I-Disease I-Disease
weakness I-Disease I-Disease
. O O

On O O
05-04-92 O O
she O O
was O O
evaluated O O
by O O
the O O
neurology O O
service O O
, O O
who O O
recommended O O
a O O
CT O O
scan O O
, O O
however O O
no O O
evidence O O
of O O
infarction B-Disease B-Disease
was O O
detected O O
. O O

There O O
was O O
only O O
diffuse B-Disease B-Disease
small I-Disease I-Disease
vessel I-Disease I-Disease
Disease I-Disease I-Disease
noted O O
. O O

On O O
05-05-92 O O
she O O
was O O
noted O O
to O O
convert O O
to O O
atrial B-Disease B-Disease
fibrillation I-Disease I-Disease
which O O
resolved O O
spontaneously O O
a O O
few O O
days O O
later O O
. O O

However O O
, O O
on O O
05-07-92 O O
there O O
was O O
a O O
a O O
question O O
of O O
a B-Disease B-Disease
new I-Disease I-Disease
event I-Disease I-Disease
with O O
addition O O
to O O
the B-Disease B-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
extremity I-Disease I-Disease
weakness I-Disease I-Disease
, O O
some B-Disease O
noted I-Disease O
right I-Disease B-Disease
upper I-Disease I-Disease
and I-Disease I-Disease
right I-Disease I-Disease
lower I-Disease I-Disease
extremity I-Disease I-Disease
discoordination I-Disease I-Disease
. O O

She O O
was O O
begun O O
on O O
a O O
heparin O O
drip O O
. O O

On O O
5-9-92 O O
the B-Disease B-Disease
right-sided I-Disease I-Disease
symptoms I-Disease I-Disease
worsened O O
and O O
she O O
also O O
had O O
some B-Disease O
elements I-Disease O
of I-Disease O
aphasia I-Disease B-Disease
. O O

She O O
underwent O O
angiography O O
on O O
5-9-92 O O
which O O
showed O O
the O O
right O O
internal O O
carotid O O
artery O O
to O O
be O O
patent O O
, O O
however O O
there O O
was O O
highly O B-Disease
significant B-Disease I-Disease
stenosis I-Disease I-Disease
of I-Disease I-Disease
the I-Disease I-Disease
left I-Disease I-Disease
carotid I-Disease I-Disease
artery I-Disease I-Disease
and O O
she O O
was O O
taken O O
to O O
the O O
operating O O
room O O
later O O
that O O
day O O
for O O
a O O
left O O
carotid O O
endarterectomy O O
. O O

She O O
was O O
taken O O
postoperatively O O
the O O
ICU O O
where O O
she O O
was O O
extubated O O
on O O
postoperative O O
day O O
number O O
one O O
and O O
by O O
5-11-92 O O
she O O
was O O
noted O O
to O O
have O O
markedly O B-Disease
increased O I-Disease
use O I-Disease
of O I-Disease
her O I-Disease
right O I-Disease
side O I-Disease
, O O
resolving O B-Disease
aphasia B-Disease I-Disease
and O O
she O O
was O O
transferred O O
to O O
the O O
floor O O
with O O
the B-Disease B-Disease
residual I-Disease I-Disease
deficit I-Disease I-Disease
only O O
noted O O
to O O
be O O
some B-Disease B-Disease
left I-Disease I-Disease
upper I-Disease I-Disease
extremity I-Disease I-Disease
weakness I-Disease I-Disease
. O O

She O O
was O O
worked O O
up O O
aggressively O O
with O O
the O O
physical O O
therapy O O
and O O
occupational O O
services O O
, O O
made O O
good O O
progress O O
and O O
began O O
ambulating O O
with O O
assistance O O
with O O
a O O
walker O O
but O O
with O O
minimal O O
assistance O O
from O O
an O O
aid O O
. O O

She O O
was O O
feeding O O
herself O O
and O O
was O O
very O O
enthusiastic O O
and O O
energetic O O
in O O
her O O
participation O O
in O O
her O O
rehabilitation O O
activities O O
. O O

She O O
was O O
maintained O O
on O O
heparin O O
therapy O O
initially O O
but O O
this O O
was O O
quickly O O
switched O O
over O O
to O O
Coumadin O O
anticoagulation O O
therapy O O
which O O
she O O
will O O
need O O
to O O
be O O
on O O
long-term O O
for O O
her O O
aortic O O
valve O O
replacement O O
. O O

DISPOSITION O O
: O O

She O O
is O O
transferred O O
to O O
Rockdempbanri O O
Hospital O O
on O O
05-28-92 O O
to O O
continue O O
her O O
rehabilitation O O
. O O

Discharge O O
medications O O
: O O

Lopressor O O
100 O O
mg O O
p.o. O O
b.i.d. O O
; O O
Nifedipine O O
10 O O
mg O O
p.o. O O
t.i.d. O O
; O O
Timoptic O O
solution O O
0.5% O O
OS O O
b.i.d. O O
; O O
Coumadin O O
1 O O
mg O O
alternating O O
with O O
1.5 O O
mg O O
q.o.d. O O
at O O
q.h.s. O O
and O O
Haldol O O
2 O O
mg O O
p.o. O O
q.h.s. O O
p.r.n. O O
in O O
the O O
evening O O
, O O
only O O
for O O
agitation B-Disease B-Disease
associated O O
with O O
confusion B-Disease B-Disease
. O O

Upon O O
discharge O O
it O O
was O O
the O O
recommendation O O
of O O
the O O
cardiology O O
team O O
that O O
the O O
patient O O
&apos;s O O
prothrombin O O
time O O
be O O
monitored O O
weekly O O
and O O
be O O
kept O O
at O O
a O O
ratio O O
of O O
3-4 O O
IU O O
. O O

Dictated O O
By O O
: O O

NIEIE O O
FREIERM O O
, O O
M.D. O O
ZX O O
681 O O
/ O O
0201 O O
/ O O
RISHAN O O
MISHON O O
ROOM O O
, O O
M.D. O O

BREUNTIK O O

D O O
: O O

05/26/92 O O

T O O
: O O

05/27/92 O O

Batch O O
: O O

U886 O O

Report O O
: O O

LH486L9 O O

346176858 O O
SC O O

29574503 O O

4164300 O O

12/9/2005 O O
12:00:00 O O
AM O O

SVD O B-Disease

DIS O O

Admission O O
Date O O
: O O

12/09/2005 O O

Report O O
Status O O
: O O

Discharge O O
Date O O
: O O

12/12/2005 O O

****** O O
DISCHARGE O O
ORDERS O O
****** O O

CHAFFBITZ O O
, O O
LI O O
183-67-53-0 O O
U69 O O

Room O O
: O O

DEALPERSANDERSWAUKE O O
MISSJEANES O O
MACOMTOMA O O
GLANDSTATE O O
MEDICAL O O
CENTER O O

Service O O
: O O

OBS O O

DISCHARGE O O
PATIENT O O
ON O O
: O O

12/12/05 O O
AT O O
10:00 O O
AM O O

CONTINGENT O O
UPON O O

Not O O
Applicable O O

WILL O O
D O O
/ O O
C O O
ORDER O O
BE O O
USED O O
AS O O
THE O O
D O O
/ O O
C O O
SUMMARY O O
: O O

YES O O

Attending O O
: O O

GRENDZISKLEEB O O
, O O
DELMRU O O
CENI O O
, O O
M.D. O O

DISPOSITION O O
: O O

Home O O

DISCHARGE O O
MEDICATIONS O O
: O O

DERMOPLAST O O
TOPICAL O O
TP O O
Q12H O O
PRN O O
Pain B-Disease B-Disease
DOCUSATE O O
SODIUM O O
100 O O
MG O O
PO O O
BID O O
PRN O O
Constipation B-Disease B-Disease
IBUPROFEN O O
400-600 O O
MG O O
PO O O
Q6H O O
PRN O O
Pain B-Disease B-Disease

Food O O
/ O O
Drug O O
Interaction O O
Instruction O O

Take O O
with O O
food O O
PRENATAL O O
MULTIVITAMINS O O
( O O
STUARTNATAL O O
1+1 O O
) O O
1 O O
TAB O O
PO O O
QD O O
TUCKS O O
( O O
WITCH O O
HAZEL O O
) O O
TOPICAL O O
TP O O
Q4H O O
PRN O O
Pain B-Disease B-Disease

DIET O O
: O O

No O O
Restrictions O O

ACTIVITY O O
: O O

Walking O O
as O O
tolerated O O

FOLLOW O O
UP O O
APPOINTMENT O O
( O O
S O O
) O O
: O O

Dr O O
Grendziskleeb O O
6 O O
weeks O O
, O O

ALLERGY O O
: O O

NKA B-Disease O

ADMIT O O
DIAGNOSIS O O
: O O

labor B-Disease O
at I-Disease O
term I-Disease O

PRINCIPAL O O
DISCHARGE O O
DIAGNOSIS O O
; O O
Responsible O O
After O O
Study O O
for O O
Causing O O
Admission O O
) O O

SVD O O
OTHER O O
DIAGNOSIS O O
; O O
Conditions O O
, O O
Infections O O
, O O
Complications O O
, O O
affecting O O
Treatment O O
/ O O
Stay O O

SVD O O
OPERATIONS O O
AND O O
PROCEDURES O O
: O O

Primary O O
Anesthesia O O
: O O

Epidural O O
Vaginal O O
delivery O O
: O O

Spontaneous O O
Episiotomy O O
: O O

Median O O
Placenta O O
: O O

Delivery O O
: O O

Spontaneous O O
Condition O O
: O O

Normal O O

Staff O O
Obstetrician O O
( O O
supervising O O
) O O
: O O

BOORMKAYSSCAJE O O
, O O
PA O O
A. O O
, O O
M.D. O O
Delivery O O

OTHER O O
TREATMENTS O O
/ O O
PROCEDURES O O
( O O
NOT O O
IN O O
O.R. O O
) O O

none O O

BRIEF O O
RESUME O O
OF O O
HOSPITAL O O
COURSE O O
: O O

G3 O O
T1 O O
P0 O O
A1 O O
L1 O O

Estimated O O
EDC O O
: O O

12/09/05 O O

Maternal O O
transfer O O
: O O

No O O

Initial O O
newborn O O
exam O O
: O O

No O O
observed B-Disease B-Disease
abnormalities I-Disease I-Disease

ADDITIONAL O O
COMMENTS O O
: O O

DISCHARGE O O
CONDITION O O
: O O

Stable O O

TO O O
DO O O
/ O O
PLAN O O
: O O

No O O
dictated O O
summary O O

ENTERED O O
BY O O
: O O

BOORMKAYSSCAJE O O
, O O
PA O O
A. O O
, O O
M.D. O O
( O O
TI84 O O
) O O
12/10/05 O O
02:58 O O
AM O O

****** O O
END O O
OF O O
DISCHARGE O O
ORDERS O O
****** O O

Admission O O
Date O O
: O O

2011-09-23 O O

Discharge O O
Date O O
: O O

2011-10-06 O O

Date O O
of O O
Birth O O
: O O

2011-09-23 O O

Sex O O
: O O

M O O

Service O O
: O O

NEONATOLOGY O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Ken O O
Nansteel-Miller O O
is O O
the O O
triplet O O
#3 O O
of O O
a B-Disease B-Disease
spontaneous I-Disease I-Disease
triamniotic-trichorionic I-Disease I-Disease
triplet I-Disease I-Disease
pregnancy I-Disease I-Disease
born O O
to O O
a O O
39-year-old O O
G4 O O
P1 O O
spontaneous O O
abortion O O
2 O O
woman O O
. O O

Prenatal O O
screens O O
: O O

Blood O O
type O O
A O O
positive O O
, O O
antibody O O
negative O O
, O O
rubella O O
immune O O
, O O
RPR O O
nonreactive O O
, O O
hepatitis O O
B O O
surface O O
antigen O O
negative O O
, O O
group O O
beta O O
Strep O O
status O O
unknown O O
. O O

The O O
mother O O
was O O
followed O O
closely O O
and O O
received O O
betamethasone O O
2011-08-22 O O
. O O

She O O
was O O
admitted O O
on O O
2011-08-25 O O
for O O
nausea B-Disease B-Disease
, O O
vomiting B-Disease B-Disease
, O O
and O O
a B-Disease B-Disease
shortened I-Disease I-Disease
cervix I-Disease I-Disease
. O O

She O O
was O O
treated O O
with O O
bed O O
rest O O
and O O
prn O O
terbutaline O O
. O O

Other O O
medications O O
including O O
Prozac O O
. O O

The O O
babies O O
were O O
born O O
by O O
elective O O
cesarean O O
section O O
at O O
34 O O
weeks O O
gestation O O
. O O

This O O
triplet O O
#3 O O
emerged O O
with O O
spontaneous O B-Disease
respirations O I-Disease
, O O
and O O
required O O
blow-by O O
oxygen O O
in O O
the O O
delivery O O
room O O
. O O

Apgars O O
were O O
seven O O
at O O
one O O
minute O O
and O O
eight O O
at O O
five O O
minutes O O
. O O

He O O
was O O
admitted O O
to O O
the O O
Neonatal O O
Intensive O O
Care O O
Unit O O
for O O
treatment O O
of O O
prematurity B-Disease B-Disease
. O O

PHYSICAL O O
EXAM O O
UPON O O
ADMISSION O O
TO O O
THE O O
NEONATAL O O
INTENSIVE O O
CARE O O
UNIT O O
: O O

Weight O O
1.7 O O
kg O O
, O O
length O O
41.5 O O
cm O O
, O O
head O O
circumference O O
29 O O
cm O O
, O O
all O O
10th-25th O O
percentile O O
for O O
34 O O
weeks O O
. O O

General O O
: O O
Nondysmorphic B-Disease O
preterm O O
male O O
in O O
mild B-Disease B-Disease
respiratory I-Disease I-Disease
distress I-Disease I-Disease
. O O

Head O O
, O O
eyes O O
, O O
ears O O
, O O
nose O O
, O O
and O O
throat O O
: O O

Anterior O O
fontanel O O
open O O
and O O
flat O O
. O O

Symmetric O B-Disease
facial O I-Disease
features O I-Disease
. O O

Positive O O
red O O
reflex O O
bilaterally O O
. O O

Palate O O
intact O O
. O O

Chest O O
: O O
Mild B-Disease B-Disease
intercostal I-Disease I-Disease
and I-Disease I-Disease
sternal I-Disease I-Disease
retractions I-Disease I-Disease
. O O

Breath O O
sounds O O
equal O O
with O O
fair O O
aeration O O
. O O

Cardiovascular O O
: O O
Regular O O
, O O
rate O O
, O O
and O O
rhythm O O
, O O
no O O
murmur B-Disease B-Disease
. O O

Femoral O O
pulses O O
+2 O O
. O O

Abdomen O O
is O O
soft O O
, O O
nontender B-Disease B-Disease
, O O
nondistended B-Disease B-Disease
, O O
no O O
masses B-Disease B-Disease
, O O
positive O O
bowel O O
sounds O O
. O O

Genitourinary O O
: O O
Normal O O
preterm O O
male O O
. O O

Testes O O
descended O O
bilaterally O O
. O O

Spine O O
straight O O
with O O
normal O O
sacrum O O
. O O

Hips O O
stable O O
. O O

Neurologic O O
: O O
Appropriate O O
tone O O
and O O
reflexes O O
. O O

HOSPITAL O O
COURSE O O
BY O O
SYSTEMS O O
INCLUDING O O
PERTINENT O O
LABORATORY O O
DATA O O
: O O

1. O O
Respiratory O O
: O O
Lincoln O O
required O O
nasal O O
cannula O O
O2 O O
for O O
approximately O O
the O O
first O O
8-12 O O
hours O O
of O O
life O O
. O O

He O O
weaned O O
to O O
room O O
air O O
and O O
remained O O
on O O
room O O
air O O
the O O
rest O O
of O O
his O O
Neonatal O O
Intensive O O
Care O O
Unit O O
admission O O
. O O

He O O
has O O
had O O
no O O
episodes O O
of O O
spontaneous B-Disease B-Disease
apnea I-Disease I-Disease
during O O
admission O O
. O O

2. O O
Cardiovascular O O
: O O
Falmouth O O
has O O
maintained O O
normal O O
heart O O
rates O O
and O O
blood O O
pressures O O
. O O

No O O
murmurs B-Disease B-Disease
have O O
been O O
noted O O
. O O

3. O O
Fluids O O
, O O
electrolytes O O
, O O
and O O
nutrition O O
: O O

Beverly O O
was O O
initially O O
NPO O O
and O O
maintained O O
on O O
intravenous O O
fluids O O
. O O

Enteral O O
feeds O O
were O O
started O O
on O O
day O O
of O O
life O O
#1 O O
, O O
and O O
gradually O O
advanced O O
to O O
full O O
volume O O
. O O

His O O
maximum O O
caloric O O
intake O O
was O O
24 O O
calories O O
per O O
ounce O O
. O O

At O O
the O O
time O O
of O O
discharge O O
, O O
he O O
is O O
breastfeeding O O
or O O
taking O O
Enfamil O O
fortified O O
to O O
24 O O
calories O O
/ O O
ounce O O
with O O
intake O O
approximately O O
150 O O
cc O O
/ O O
kg O O
/ O O
day O O
. O O

Discharge O O
weight O O
is O O
1.89 O O
kg O O
. O O

4. O O
Gastrointestinal O O
: O O
Boston O O
required O O
treatment O O
for O O
unconjungated B-Disease B-Disease
hyperbilirubinemia I-Disease I-Disease
with O O
phototherapy O O
. O O

His O O
peak O O
serum O O
bilirubin O O
occurred O O
on O O
day O O
of O O
life O O
three O O
with O O
a O O
total O O
of O O
8.3 O O
/ O O
0.2 O O
direct O O
, O O
8.1 O O
indirect O O
mg/dl O O
. O O

He O O
received O O
phototherapy O O
for O O
approximately O O
72 O O
hours O O
. O O

Rebound O O
bilirubin O O
on O O
day O O
of O O
life O O
#7 O O
was O O
6.6 O O
, O O
and O O
total O O
was O O
0.2 O O
direct O O
. O O

5. O O
Neurological O O
: O O
Wellesley O O
has O O
maintained O O
a O O
normal O O
neurological O O
examination O O
. O O

Throughout O O
admission O O
, O O
there O O
are O O
no O O
neurological B-Disease B-Disease
concerns I-Disease I-Disease
at O O
the O O
time O O
of O O
discharge O O
. O O

6. O O
Sensory O O
: O O

Audiology O O
: O O
Hearing O O
screening O O
was O O
performed O O
with O O
automated O O
auditory O O
brain O O
stem O O
responses O O
. O O

Nantucket O O
passed O O
in O O
both O O
ears O O
. O O

CONDITION O O
ON O O
DISCHARGE O O
: O O
Good O O
. O O

DISCHARGE O O
/ O O
DISPOSITION O O
: O O
Home O O
with O O
parents O O
. O O

PRIMARY O O
PEDIATRICIAN O O
: O O
Dr. O O
Penny O O
Scott O O
, O O
8400 O O
S. O O
Maple O O
Blvd. O O
, O O
Arbour-Fuller O O
Hospital O O
, O O
New O O
Hampshire O O
25344 O O
, O O
phone O O
number O O
617-6198 O O
. O O

Fax O O
number O O
( O O
317 O O
) O O
497-7408 O O
. O O

CARE O O
AND O O
RECOMMENDATIONS O O
AT O O
THE O O
TIME O O
OF O O
DISCHARGE O O
: O O

1. O O
Feeding O O
: O O
Breast O O
feeding O O
or O O
Enfamil O O
24 O O
calories O O
/ O O
ounce O O
. O O

2. O O
Medications O O
: O O
Ferrous O O
sulfate O O
0.15 O O
cc O O
po O O
q O O
day O O
25 O O
mg O O
/ O O
ml O O
dilution O O
. O O

3. O O
Car O O
seat O O
position O O
screening O O
was O O
performed O O
. O O

Waltham O O
was O O
monitored O O
for O O
90 O O
minutes O O
without O O
any O O
episodes O O
of O O
apnea B-Disease B-Disease
or O O
oxygen B-Disease B-Disease
desaturation I-Disease I-Disease
. O O

4. O O
State O O
Newborn O O
Screens O O
were O O
sent O O
on O O
09-27 O O
and O O
2011-10-05 O O
with O O
no O O
notification O O
of O O
abnormal B-Disease B-Disease
results I-Disease I-Disease
to O O
date O O
. O O

5. O O
No O O
immunizations O O
administered O O
. O O

Plan O O
is O O
to O O
receive O O
hepatitis O B-Disease
B O I-Disease
in O O
the O O
pediatrician O O
's O O
office O O
, O O
once O O
he O O
reaches O O
a O O
weight O O
of O O
2 O O
kg O O
. O O

6. O O
Immunizations O O
recommended O O
: O O
Synagis O O
RSV O O
prophylaxis O O
should O O
be O O
considered O O
from O O
October O O
through O O
April O O
for O O
infants O O
who O O
meet O O
any O O
of O O
the O O
following O O
three O O
criteria O O
: O O

1) O O
Born O O
at O O
less O O
than O O
32 O O
weeks O O
, O O

2) O O
born O O
between O O
32 O O
and O O
35 O O
weeks O O
with O O
plans O O
for O O
daycare O O
during O O
RSV O O
season O O
, O O
with O O
a O O
smoker O O
in O O
the O O
household O O
, O O
or O O
with O O
preschool O O
siblings O O
, O O
or O O

3) O O
with O O
chronic B-Disease B-Disease
lung I-Disease I-Disease
Disease I-Disease I-Disease
. O O

Influenza O O
immunization O O
should O O
be O O
considered O O
annually O O
in O O
the O O
fall O O
for O O
preterm O O
infants O O
with O O
chronic B-Disease B-Disease
lung I-Disease I-Disease
Disease I-Disease I-Disease
once O O
they O O
reach O O
six O O
months O O
of O O
age O O
. O O

Before O O
this O O
age O O
, O O
the O O
family O O
and O O
other O O
caregivers O O
should O O
be O O
considered O O
for O O
immunization O O
against O O
influenza B-Disease B-Disease
to O O
protect O O
the O O
infant O O
. O O

FOLLOW-UP O O
APPOINTMENTS O O
: O O
Dr. O O
Parramore O O
on O O
10-10 O O
. O O

DISCHARGE O O
DIAGNOSES O O
: O O

1. O O
Prematurity B-Disease B-Disease
at I-Disease O
34 I-Disease O
weeks I-Disease O
gestation I-Disease O
. O O

2. O O
Triplet O O
#3 O O
of O O
triplet O B-Disease
gestation O I-Disease
. O O

3. O O
Unconjugated B-Disease B-Disease
hyperbilirubinemia I-Disease I-Disease
. O O

Reviewed O O
By O O
: O O
Janna O O
L. O O
Desorbo O O
, O O
M.D. O O

00-112 O O

Dictated O O
By O O
: O O
Jeannette O O
D. O O
Rede O O
, O O
M.D. O O

MEDQUIST36 O O

D O O
: O O
2011-10-06 O O
04:03 O O

T O O
: O O
2011-10-06 O O
06:19 O O

JOB O O
#: O O

02566 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Bernice O O
Jenkins O O
on O O
: O O
FRI O O
2011-10-07 O O
4:01 O O
PM O O

( O O
End O O
of O O
Report O O
) O O

Admission O O
Date O O
: O O

2015-11-09 O O

Discharge O O
Date O O
: O O

2015-11-16 O O

Date O O
of O O
Birth O O
: O O

2015-11-09 O O

Sex O O
: O O

F O O

Service O O
: O O

CMED O O
CCU O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Baby O O
girl O O
Fritsche O O
is O O
the O O
1670 O O
gram O O
product O O
of O O
a O O
31 O O
and O O
06-17 O O
week O O
gestation O O
born O O
to O O
a O O
34 O O
- O O
year-old O O
G2 O O
P1 O O
now O O
2 O O
woman O O
. O O

Fetal O O
screens O O
, O O
O O O
positive O O
, O O
antibody O O
negative O O
, O O
RPR O O
nonreactive O O
, O O
rubella O O
immune O O
, O O
hepatitis O O
surface O O
antigen O O
negative O O
, O O
GBS O O
unknown O O
. O O

IVF B-Disease B-Disease
pregnancy I-Disease I-Disease
complicated O O
by O O
IUGR B-Disease B-Disease
, O O
2 B-Disease O
vessel I-Disease O
cord I-Disease O
, O O
normal O O
fetal O O
echo O O
reverse O O
diastolic O O
flow O O
and O O
demise B-Disease B-Disease
of I-Disease I-Disease
twin I-Disease I-Disease
A I-Disease I-Disease
at O O
27 O O
weeks O O
. O O

Twin O O
B O O
with O O
normal O O
fetal O O
survey O O
was O O
transferred O O
to O O
Boston O O
Medical O O
Center O O
at O O
26 O O
and O O
2/7 O O
weeks O O
with O O
IUGR B-Disease B-Disease
of I-Disease O
twin I-Disease O
A I-Disease O
was O O
first O O
noted O O
, O O
presented O O
with O O
preterm B-Disease B-Disease
labor I-Disease I-Disease
at O O
31 O O
weeks O O
. O O

Betamethasone O O
complete O O
at O O
approximately O O
26 O O
weeks O O
and O O
31 O O
weeks O O
. O O

Mother O O
was O O
on O O
clindamycin O O
since O O
11-04 O O
. O O

PPROM B-Disease B-Disease
with O O
bleeding B-Disease B-Disease
and O O
transverse B-Disease B-Disease
lie I-Disease I-Disease
prompted O O
cesarean O O
section O O
. O O

Abruption B-Disease B-Disease
noted O O
. O O

Apgars O O
were O O
6 O O
and O O
9 O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

On O O
admission O O
weight O O
1670 O O
grams O O
approximately O O
50 O O
th O O
percentile O O
, O O
length O O
43 O O
cm O O
50 O O
th O O
percentile O O
, O O
head O O
circumference O O
not O O
done O O
. O O

Anterior O O
fontanel O O
soft O O
, O O
flat O O
, O O
cap O O
and O O
prong O O
CPAP O O
in O O
place O O
. O O

Nondysmorphic B-Disease B-Disease
intact O I-Disease
Veliz O I-Disease
. O O

Comfortable O O
with O O
good O O
aeration O O
, O O
clear O B-Disease
breath O I-Disease
sounds O I-Disease
, O O
does O O
grunt O O
intermittently O O
when O O
disturbed O B-Disease
. O O

No O O
murmur B-Disease B-Disease
. O O

Normal O O
pulses O O
. O O

Soft O O
abdomen O O
, O O
3 O O
vessel O O
cord O O
. O O

No O O
hepatosplenomegaly B-Disease B-Disease
. O O

Normal O O
female O O
genitalia O O
. O O

Positive O O
vaginal B-Disease O
tag I-Disease O
. O O

Patent O O
anus O O
. O O

No O O
hip B-Disease B-Disease
click I-Disease I-Disease
. O O

No O O
sacral B-Disease B-Disease
dimple I-Disease I-Disease
. O O

Moves O O
all O O
extremities O O
. O O

Decrease B-Disease B-Disease
tone I-Disease I-Disease
, O O
ruddy O B-Disease
, O O
warm O O
, O O
well O O
perfused O O
with O O
peripheral O O
IV O O
in O O
left O O
hand O O
. O O

HOSPITAL O O
COURSE O O
: O O

Respiratory O O
. O O

Mills O O
was O O
admitted O O
to O O
the O O
newborn O O
intensive O O
care O O
unit O O
with O O
moderate B-Disease B-Disease
respiratory I-Disease I-Disease
distress I-Disease I-Disease
. O O

Infant O O
placed O O
on O O
CPAP O O
. O O

X-ray O O
revealed O O
mild B-Disease B-Disease
respiratory I-Disease I-Disease
distress I-Disease I-Disease
syndrome I-Disease I-Disease
. O O

She O O
remained O O
on O O
CPAP O O
for O O
a O O
total O O
of O O
24 O O
hours O O
at O O
which O O
time O O
she O O
transitioned O O
to O O
room O O
air O O
and O O
continues O O
to O O
be O O
stable O O
in O O
room O O
air O O
. O O

Caffeine O O
citrate O O
was O O
initiated O O
on O O
11-14 O O
for O O
apnea B-Disease B-Disease
and O O
bradycardia B-Disease B-Disease
of I-Disease O
prematurity I-Disease B-Disease
. O O

She O O
is O O
currently O O
receiving O O
11 O O
mg O O
po O O
every O O
day O O
. O O

Cardiovascular O O
. O O

Has O O
been O O
cardiovascular O O
stable O O
throughout O O
hospital O O
course O O
. O O

Heart O O
ranges O O
130 O O
s O O
to O O
160 O O
s. O O

Blood O O
pressure O O
most O O
recently O O
60/37 O O
with O O
a O O
mean O O
of O O
44 O O
. O O

Fluid O O
and O O
electrolyte O O
. O O

Birth O O
weight O O
was O O
1670 O O
grams O O
50 O O
th O O
percentile O O
, O O
length O O
43 O O
cm O O
50 O O
th O O
percentile O O
. O O

Head O O
circumference O O
not O O
done O O
. O O

Infant O O
was O O
initially O O
started O O
on O O
80 O O
cc O O
per O O
kilo O O
per O O
day O O
of O O
D10W O O
. O O

Enteral O O
feedings O O
were O O
initiated O O
on O O
day O O
of O O
life O O
#1 O O
. O O

Infant O O
achieved O O
full O O
enteral O O
feedings O O
by O O
day O O
of O O
life O O
6 O O
. O O

She O O
is O O
currently O O
receiving O O
150 O O
cc O O
per O O
kilo O O
per O O
day O O
of O O
Special O O
Care O O
20 O O
. O O

Her O O
discharge O O
weight O O
is O O
1477 O O
gm O O
. O O

Her O O
most O O
recent O O
set O O
of O O
electrolytes O O
were O O
on O O
2015-11-13 O O
with O O
a O O
sodium O O
of O O
143 O O
, O O
a O O
potassium O O
of O O
6.3 O O
hemolyzed O O
, O O
a O O
chloride O O
of O O
113 O O
and O O
a O O
total O O
CO2 O O
of O O
17 O O
. O O

She O O
will O O
need O O
advance O O
calorie O O
density O O
for O O
better O O
growth O O
. O O

GI O O
. O O
Bilirubin O O
peaked O O
on O O
day O O
of O O
life O O
#2 O O
of O O
9.0 O O
/ O O
0.3 O O
. O O

Infant O O
is O O
under O O
phototherapy O O
, O O
which O O
was O O
discontinued O O
on O O
11-13 O O
. O O

Most O O
recent O O
bilirubin O O
was O O
on O O
11-14 O O
of O O
4.8 O O
/ O O
0.3 O O
. O O

Hematology O O
. O O

Hematocrit O O
on O O
admission O O
was O O
53.7 O O
. O O

She O O
has O O
not O O
required O O
any O O
blood O O
transfusions O O
. O O

Infectious O O
Disease O O
. O O

A O O
CBC O O
and O O
blood O O
culture O O
obtained O O
on O O
admission O O
. O O

CBC O O
had O O
a O O
white O O
blood O O
cell O O
count O O
of O O
9 O O
, O O
17 O O
polys O O
, O O
0 O O
bands O O
, O O
platelets O O
of O O
326 O O
. O O

She O O
received O O
48 O O
hours O O
of O O
ampicillin O O
and O O
gentamycin O O
with O O
negative O O
blood O O
cultures O O
and O O
antibiotics O O
were O O
discontinued O O
. O O

Neurological O O
. O O

She O O
has O O
been O O
appropriate O O
for O O
gestational O O
age O O
. O O

Head O O
ultrasound O O
was O O
performed O O
on O O
2015-11-16 O O
and O O
was O O
normal O O
. O O

Sensory O O
, O O
hearing O O
screen O O
has O O
not O O
yet O O
been O O
performed O O
, O O
but O O
should O O
be O O
done O O
prior O O
to O O
discharge O O
. O O

CONDITION O O
AT O O
DISCHARGE O O
: O O

Stable O O
. O O

DISCHARGE O O
DISPOSITION O O
: O O

To O O
Boston O O
Medical O O
Center O O
. O O

PRIMARY O O
PEDIATRICIAN O O
: O O

Dr. O O
Kim O O
Adams O O
. O O

Telephone O O
number O O
is O O
( O O
261 O O
) O O
564-6894 O O
. O O

CARE O O
AND O O
RECOMMENDATIONS O O
: O O

Continue O O
150 O O
cc O O
per O O
kilo O O
per O O
day O O
of O O
Special O O
Care O O
20 O O
calories O O
advancing O O
caloric O O
intake O O
as O O
required O O
to O O
maintain O O
weight O O
gain O O
of O O
3 O O
grams O O
per O O
kilogram O O
per O O
day O O
. O O

Medications O O
, O O
continue O O
caffeine O O
citrate O O
of O O
11 O O
mg O O
po O O
every O O
day O O
. O O

Car O O
seat O O
position O O
screening O O
has O O
not O O
yet O O
been O O
done O O
. O O

State O O
newborn O O
screen O O
was O O
sent O O
on O O
day O O
of O O
life O O
#3 O O
and O O
at O O
discharge O O
. O O

Initial O O
results O O
were O O
within O O
normal O O
limits O O
. O O

Immunizations O O
received O O
, O O
infant O O
has O O
not O O
received O O
any O O
immunizations O O
to O O
date O O
. O O

State O O
newborn O O
screen O O
was O O
sent O O
on O O
2015-11-12 O O
. O O

Immunizations O O
: O O
recommended O O
Synagis O O
RSV O O
prophylaxis O O
should O O
be O O
considered O O
from O O
November O O
through O O
March O O
for O O
infants O O
who O O
meet O O
any O O
of O O
the O O
following O O
3 O O
criteria O O
, O O
born O O
at O O
less O O
than O O
32 O O
weeks O O
, O O
born O O
between O O
32 O O
and O O
35 O O
weeks O O
with O O
2 O O
of O O
the O O
following O O
, O O
daycare O O
during O O
RSV O O
season O O
, O O
a O O
smoker O O
in O O
the O O
household O O
, O O
neuromuscular B-Disease B-Disease
Disease I-Disease I-Disease
and O O
weight B-Disease B-Disease
abnormalities I-Disease I-Disease
or O O
school O O
age O O
siblings O O
with O O
chronic B-Disease B-Disease
lung I-Disease I-Disease
Disease I-Disease I-Disease
. O O

Influenza O O
immunization O O
is O O
recommended O O
annually O O
in O O
the O O
fall O O
for O O
all O O
infants O O
once O O
they O O
reach O O
6 O O
months O O
of O O
age O O
. O O

Before O O
this O O
age O O
and O O
for O O
the O O
first O O
24 O O
months O O
of O O
the O O
child O O
's O O
life O O
immunizations O O
against O O
influenza B-Disease B-Disease
is O O
recommended O O
for O O
household O O
contacts O O
and O O
out O O
of O O
home O O
care O O
givers O O
. O O

DISCHARGE O O
DIAGNOSES O O
: O O

Premature B-Disease B-Disease
infant I-Disease I-Disease
born O I-Disease
at O O
31 O O
and O O
6/7 O O
weeks O O
gestation O O
, O O
resolved O O
respiratory B-Disease B-Disease
distress I-Disease I-Disease
syndrome I-Disease I-Disease
. O O

Rule O O
out O O
sepsis B-Disease B-Disease
with O O
antibiotic O O
. O O

Hyperbilirubinemia B-Disease B-Disease
resolving O O
. O O

Apnea B-Disease B-Disease
and O O
bradycardia B-Disease B-Disease
of I-Disease O
prematurity I-Disease B-Disease
. O O

Tai O O
Pamela O O
Wendell O O
, O O
Oklahoma O O
05158 O O

Dictated O O
By O O
: O O
Kurt O O
S O O
Imperato O O
, O O
M.D. O O

MEDQUIST36 O O

D O O
: O O
2015-11-15 O O
21:17:13 O O

T O O
: O O
2015-11-16 O O
06:38:42 O O

Job O O
#: O O

82694 O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Debbie O O
TRAN O O
on O O
: O O
MON O O
2015-11-16 O O
9:57 O O
AM O O

( O O
End O O
of O O
Report O O
) O O

699905656 O O
SC O O

06100044 O O

921737 O O

1/17/1993 O O
12:00:00 O O
AM O O

Discharge O O
Summary O O

Signed O O

DIS O O

Admission O O
Date O O
: O O

01/17/1993 O O

Report O O
Status O O
: O O

Signed O O

Discharge O O
Date O O
: O O

01/21/1993 O O

DISCHARGE O O
DIAGNOSIS O O
: O O

1. O O
RIGHT O O
SIDED O O
SCIATICA O O
PROCEDURE O O
: O O

Right O O
laminectomy O O
and O O
discectomy O O
by O O
Dr. O O
Small O O
, O O
Neurosurgery O O
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

The O O
patient O O
is O O
a O O
42 O O
year O O
old O O
gentleman O O
who O O
suffered O O
lower B-Disease B-Disease
back I-Disease I-Disease
pain I-Disease I-Disease
during O O
an O O
accident O O
at O O
work O O
in O O
1990 O O
. O O

This O O
gradually O O
increased O O
until O O
June O O
1992 O O
where O O
he O O
had O O
recurrent B-Disease B-Disease
severe I-Disease I-Disease
right I-Disease I-Disease
sided I-Disease I-Disease
sciatica I-Disease I-Disease
. O O

In O O
September O O
1992 O O
CT O O
myelogram O O
showed O O
a B-Disease B-Disease
lateral I-Disease I-Disease
L-1 I-Disease I-Disease
S-1 I-Disease I-Disease
disc I-Disease I-Disease
bulge I-Disease I-Disease
and O O
small B-Disease B-Disease
L-4-4 I-Disease I-Disease
bulge I-Disease I-Disease
. O O

He O O
has O O
had O O
no O O
change O B-Disease
in O I-Disease
pain B-Disease I-Disease
in O O
the O O
last O O
few O O
months O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Negative O O
. O O

ALLERGIES O O
: O O

None O O
. O O

MEDICATIONS O O
: O O

None O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

He O O
was O O
found O O
to O O
be O O
healthy O O
. O O

His O O
examination O O
was O O
completely O O
unremarkable O O
. O O

He O O
had O O
5 O O
out O O
of O O
5 O O
strength O O
diffusely O O
, O O
normal O O
deep O O
tendon O O
reflexes O O
and O O
normal O O
sensation O O
. O O

HOSPITAL O O
COURSE O O
: O O

He O O
was O O
admitted O O
, O O
taken O O
to O O
the O O
operating O O
room O O
where O O
he O O
underwent O O
L5-S1 O O
right O O
hemilaminectomy O O
and O O
discectomy O O
. O O

He O O
tolerated O O
the O O
procedure O O
well O O
, O O
was O O
taken O O
to O O
the O O
floor O O
in O O
stable O O
condition O O
. O O

Over O O
the O O
next O O
three O O
days O O
he O O
increased O O
his O O
activity O O
gradually O O
, O O
was O O
able O O
to O O
do O O
stairs O O
with O O
Physical O O
Therapy O O
and O O
had O O
pain B-Disease B-Disease
which O O
could O O
be O O
controlled O O
with O O
oral O O
analgesics O O
. O O

DISPOSITION O O
: O O

MEDICATIONS O O
: O O

He O O
is O O
discharged O O
on O O
Percocet O O
, O O
Colace O O
and O O
Motrin O O
. O O

Dictated O O
By O O
: O O

NASA O O
R. O O
SMALL O O
, O O
M.D. O O
IX97 O O

Attending O O
: O O

VIENNIEZUTACHANT O O
WAVE O O
, O O
M.D. O O
NN08 O O
QM838/6096 O O

Batch O O
: O O

8704 O O

Index O O
No. O O
AFUFB928WZ O O

D O O
: O O

01/20/93 O O

T O O
: O O

01/22/93 O O

965367286 O O
WGH O O

4025213 O O

465655 O O

9246470 O O

12/19/2006 O O
12:00:00 O O
AM O O

ED O O
Discharge O O
Summary O O

Unsigned O O

DIS O O

Report O O
Status O O
: O O

Unsigned O O

ED O O
DISCHARGE O O
NOTIFICATION O O

CIENNE O O
, O O
GUTAOI O O

MRN O O
: O O

4025213 O O

Age O O
: O O

42y O O

REGISTRATION O O
DATE O O
: O O

12/19/2006 O O
08:13 O O
PM O O

PRELIMINARY O O
REPORT O O

This O O
is O O
to O O
notify O O
you O O
that O O
your O O
patient O O
, O O
CIENNE O O
, O O
GUTAOI O O
arrived O O
in O O
the O O
Emergency O O
Department O O
at O O
Well O O
General O O
Hospital O O
on O O
12/19/2006 O O
08:13 O O
PM O O
. O O

The O O
patient O O
presented O O
with O O
a O O
chief O O
complaint O O
of O O
SOB B-Disease B-Disease
. O O

Following O O
triage O O
, O O
the O O
patient O O
left O O
without O O
being O O
seen O O
. O O

If O O
you O O
need O O
additional O O
information O O
please O O
call O O
366-686-5449 O O
. O O

PCP O O
Name O O
: O O

ELKSOBEBEUCH O O
, O O
IEVE O O

Provider O O
Number O O
: O O

66130 O O

